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Abstract 
Jeremy Christopher Petravicz: Challenging the Dogma: Evaluating the Role of 
Astrocyte Calcium Signaling in Physiology and Behavior. 
(Under the direction of Ken. D. McCarthy, Ph.D.) 
  
 Gliotransmission represents one of the most important conceptual shifts in 
neuroscience in the past several decades.  Gliotransmission refers to the process 
whereby glial cells release specific neurotransmitters that modulate synaptic 
transmission via pre- and postsynaptic activation of G-protein coupled (GPCR) and 
ionotropic receptors.  Astrocytes release glutamate, ATP or D-serine upon activation 
of a wide range of Gq-GPCRs to modulate neuronal activity in the numerous regions 
of the brain.  These “gliotransmitters” modulate spontaneous and evoked neuronal 
activity at both excitatory and inhibitory synapses, and affect heterosynaptic 
depression and long term potentiation in the hippocampus.  The theory of astrocyte 
Ca2+-dependent modulation of neuronal activity is built upon the hypothesis that 
activation of Gq-GPCRs on astrocytes leads to Inositol trisphosphate (IP3) receptor-
mediated calcium increases that trigger the release of gliotransmitters.  However, 
evidence supporting this hypothesis has primarily relied on non-physiological 
methods for increasing or decreasing glial Ca2+.  For example, uncaging of Ca2+ or 
chelation of intracellular Ca2+ in astrocytes affects synaptic transmission.    However 
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the usage of these methods does not specifically target IP3 receptor-mediated Ca2+ 
increases, considered the primary source of Ca2+ changes in astrocytes for 
gliotransmission.  
 To probe the role of IP3 receptors (IP3R) in Ca2+-dependent release of 
gliotransmitters from astrocytes, we have used the IP3R type 2 (IP3R2) knockout 
mouse model.  Through a combination of Ca2+ imaging and electrophysiology 
experiments we found that deletion of IP3R2 in astrocytes blocks intracellular Ca2+ 
increases in astrocytes in response to Gq GCPR activation.  Further, that lack of 
IP3R-mediated Ca2+ increases does not affect excitatory synaptic transmission of 
both CA1 and CA3 pyramidal neurons in the hippocampus. Analysis of IP3R2 
conditional knockout mice reveals specific behavioral changes in acoustic startle 
response and spatial learning in the Morris Water Maze.  These novel findings 
represent a departure from the established theory of gliotransmission and are a 
significant step forward in our understanding of the role of astrocytic IP3R-mediated 
Ca2+ increases in physiology. 
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Chapter I. General Introduction 
1.1. Glial Cells in the Central and Peripheral Nervous System 
The study of glial cells in the brain has become a rapidly progressing field of 
research in neuroscience in the last 30 years.  Originally, it was thought that glial 
cells played a purely supporting role in the brain, providing neurons with metabolic 
support and maintaining extracellular potassium levels (Somjen, 1988).  In the last 
several decades however, this view of glial cells has changed.  Glial cells play an 
active role in both physiological and pathological processes in the nervous system.  
Several different subtypes of glial cells have been identified in both the peripheral 
and central nervous system.  These subtypes of glial cells have distinct functional 
roles in the nervous system, from supporting and maintaining the neuromuscular 
junction to mediating immune responses in the brain.  One of the unifying features 
that have been indentified in nearly all glia subtypes is the use of Ca2+ signaling to 
interact with their environment.  This introduction will present a brief discussion of 
the various glial subtypes, focusing on their role in nervous system function and 
involvement in Ca2+ signaling.
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1.2. Radial Glia and Ventricular Zone Astrocytes 
The primary glial subtype found in the embryonic brain during development is 
the radial glia.  Radial glia provide scaffolding in the developing ventricular zone (VZ) 
for the migration of excitatory neurons.  Radial glias later differentiate into other glial 
subtypes, primarily astrocytes.  Along with glial cells in the neocortical subventricular 
zone (SVZ), radial glia are also the cells from which the majority of excitatory 
neurons and some populations of interneurons are produced (Doetsch et al., 1999; 
Tamamaki et al., 2001; Malatesta et al., 2008).  Radial glia-derived neuroblasts from 
the SVZ migrate to the olfactory bulb using the rostral migratory stream to form 
inhibitory interneurons (Luskin, 1998).   
Calcium signaling is thought to be the primary method by which radial glia 
communicate with developing neurons to guide their migration.  Both radial and SVZ 
glia express multiple spatial and temporal patterns of Ca2+ activity that rely on 
intracellular stores. Calcium waves in VZ radial glia are critical for their proliferation 
and are reliant upon purinergic receptor activation and the phospholipase C-inositol-
1,4,5-trisphosphate (PLC-IP3) pathway (Weissman et al., 2004).  In the SVZ, several 
different patterns of Ca2+ fluctuations were shown to be present at embryonic stages 
(Owens and Kriegstein, 1998).  Recently it was shown that glutamate released in a 
Ca2+-dependent manner from subventricular zone (SVZ) glial cells (primarily 
astrocyte-like cells) is critical for the survival of neuroblasts entering the rostral 
migratory stream during their migration to the olfactory bulb (Platel et al., 2010).  
These data indicate that both during development and in the postnatal brain, Ca2+ 
3 
 
signaling in radial glia and SVZ glial cells is important for the migration of neuronal 
precursors and formation of the cortex and olfactory bulb. 
 
1.3. Schwann Cells in the Peripheral Nervous System 
In the peripheral nervous system (PNS), the primary glial subtype is the 
Schwann cell.  Myelinating Schwann cells ensheathe sections of individual nerve 
axons in the PNS to promote saltatory conductance along the length of the axon.  A 
single nerve axon is ensheathed by multiple myelinating Schwann cells, but a single 
Schwann cell only contacts a single axon.  In contrast, non-myelinating Schwann 
cells bundle multiple axon fibers together by surrounding them with their cell bodies 
to promote axonal maintenance (Griffin and Thompson, 2008).  Both of these types 
of Schwann cells contribute to the development and survival of peripheral neurons.   
Schwann cells are especially crucial to the neuromuscular junction (NMJ) 
where they promote synaptogenesis, regulate synaptic maintenance and potentially 
modulate NMJ function.  Perisynaptic Schwann cells (PSC) at both amphibian and 
mammalian NMJ can induce synaptogenesis through the NRG-1/ErbB signaling 
pathway and other unidentified soluble factors (Peng et al., 2003; Reddy et al., 2003; 
Hayworth et al., 2006).  Furthermore, these PSCs are involved in the long term 
maintenance and reinervation of endplates of adult NMJ (Reynolds and Woolf, 1992; 
Reddy et al., 2003; Hayworth et al., 2006).  PSCs are also involved in modulation of 
NMJ synaptic function.  PSCs will respond to synaptic activity with Ca2+ increases 
through the Gq-GPCR-PLC-IP3 pathway to modulate NMJ synaptic activity through 
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the release of nitrous oxide (NO) or glutamate (Thomas and Robitaille, 2001; Pinard 
et al., 2003; Rousse and Robitaille, 2006) . 
PSCs in vivo undergo change to the amplitude and temporal kinetics of their 
Ca2+ responses in an activity dependent manner (Belair et al., 2010).  Blockade of 
nicotinic receptors (nAChRs) at the NMJ resulted in tuning of PSCs Ca2+ signals that 
occurred independently of changes to presynaptic release, indicating that PSCs 
display a form of Ca2+ plasticity (Belair et al., 2010).  Immunohistochemical studies 
indicate that both myelinating and non-myelinating Schwann cells in the PNS highly 
express IP3 recepor type 3 (IP3R3) and to a lesser degree IP3 receptor type 2 
(IP3R2), with inconclusive staining for IP3 receptor type 1 (IP3R1) (Martinez-Gomez 
and Dent, 2007; Toews et al., 2007). This is in contrast to the central nervous 
system where IP3R3 is primarily found in neuronal cells, and IP3R2 is primarily 
expressed by glial cells (Sharp et al., 1999; Holtzclaw et al., 2002; Hertle and 
Yeckel, 2007).  The functional differences in IP3R subtypes may play a role in the 
changes in Ca2+ kinetics observed at PSCs, but further research is needed to 
determine the causes of the signaling changes. 
 
1.4. Oligodendrocytes in the Central Nervous System 
The CNS corollary to the myelinating Schwann cell is the oligodendrocyte, the 
glial cell responsible for all myelination of nerve axons in the CNS.  In contrast to 
Schwann cells in the PNS, a single oligodendrocyte is capable of contacting and 
ensheathing multiple neuronal axons.  Myelination in the CNS is a highly regulated 
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process involving multiple pools of oligodendrocyte progenitor cells during 
development and is partially modulated by neuronal activity and a specific 
differentiation program involving Notch1 and γ-secretase signaling pathways (see 
review by Bradl and Lassmann, 2010).  Degeneration of the myelin sheath is 
associated with the immune disorder Multiple Sclerosis (MS), where abnormally 
activated T-cells recognize CNS myelin and initiates a demyelinating inflammatory 
response (Kaushansky et al., 2010).  During the course of MS, a series of 
myelinating and demyelinating phases occur, however the ability to remyelinate 
decreases over time for unknown reasons (Piaton et al., 2009).  Further research 
into the therapies targeting oligodendrocytes may yield future treatments for MS. 
Calcium signaling in oligodendrocytes is complex, involving multiple Ca2+ 
sources.  While most of the data concerning Ca2+ regulation is originally from culture 
studies, there is increasing evidence from in situ studies.  Oligodendrocytes express 
a wide range of Ca2+ permeable channels, as well as mechanisms for release from 
internal stores.  Ca2+ influx across the plasma membrane of oligodendrocytes occurs 
by a number of different mechanisms.  Oligodendrocytes can sense and respond to 
ATP release by neurons, and possibly astrocytes, with Ca2+ signals through 
activation of either metabotropic P2Y receptors (linked to IP3R based stores) or 
ionotropic P2X receptors (allowing Ca2+ influx from the extracellular space) (James 
and Butt, 2001).  Glutamate applied to brain slices also elicits Ca2+ signals in 
oligodendrocytes, primarily through the activation of Ca2+ permeable α-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainite (KA) and N-methyl-D-
aspartate (NMDA) receptor (Karadottir et al., 2005; Salter and Fern, 2005; Butt, 
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2006; Micu et al., 2006).  Oligodendrocytes also release Ca2+ from internal stores 
through both IP3Rs and ryanodine receptors (RyRs), another endoplasmic reticulum 
(ER) Ca2+ release channel.  Cultured oligodendrocytes express both IP3R2 and 
RyR3, and there is extensive functional cross talk between the two Ca2+ release 
channels (Haak et al., 2001).   
While Ca2+ signaling in adult oligodendrocytes may be important in the 
maintenance of myelination, in oligodendrocyte precursor cells (OPCs) Ca2+ 
signaling is important for their survival and differentiation (Soliven, 2001).  OPCs 
respond to neurotransmitters with Ca2+ increases that can affect their migration, 
proliferation, gene transcription, development and communication with other cells 
(Cohen et al., 1996; He et al., 1996; Belachew et al., 2000; Schmidt et al., 2000; 
Agresti et al., 2005).  Similar to mature oligodendrocytes, OPCs can express iGluRs 
permeable to Ca2+, which are involved in OPC migration (Holtzclaw et al., 1995; 
Deng et al., 2003; Gudz et al., 2006).  OPCs also express purinergic receptors 
linked to both Ca2+ influx and release from internal stores.  Purinergic signaling in 
response to neuronal activity is important in the triggering of OPC differentiation into 
myelinating oligodendrocytes (Stevens et al., 2002; Ishibashi et al., 2006).  Based on 
the literature discussed above, proper Ca2+ signaling and regulation by OPCs and 
mature oligodendrocytes are critical to their development, maturation and proper 
function in the nervous system. 
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1.5. NG2 Chondroitin Sulphate Proteoglycan Cells in the Central Nervous 
System 
A recently described subtype of glial cells is the NG2 chondroitin sulfate 
proteoglycan expressing glial cells, or NG2 cells.  NG2 is a membrane proteoglycan 
found on the surface of several cell types including OPCs, brain capillary endothelial 
cells and aortic smooth muscles cells (Levine and Nishiyama, 1996).  NG2 glia are a 
population of non-neuronal cells in the brain marked by the expression of NG2 and 
the alpha platelet-derived growth factor receptor (PDGFRα) (Dawson et al., 2003; 
Nishiyama et al., 2009).  They represent a substantial population (estimated to be 
between 5-10%) of the brain, and can respond to neuronal activity.  Evidence 
suggests that a proportion of NG2 cells are a separate population of glial cells from 
oligodendrocytes, microglia and astrocytes in the brain. 
Morphologically, NG2 cells were thought to display a similar stellate shape to 
astrocytes, but further morphological work has refined this view.  Whereas 
astrocytes display several large processes that undergo a series of branches to 
produce a volume of fine process surrounding the cell body, NG2 cells have a small 
cell body with small processes that branch earlier and repeatedly (Wigley et al., 
2007).  Electrophysiologically, NG2 cells express both AMPA receptors and γ-
aminobutyric acid (GABA) receptors (Bergles et al., 2000; Lin and Bergles, 2004).  
Additionally, NG2 cells also possess several types of potassium and sodium 
currents; however, the exact channels involved and their role in various brain 
regions is not fully known (Lin and Bergles, 2002; Schools et al., 2003; Chittajallu et 
al., 2004). 
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NG2 cells make direct synaptic contact with neurons in the hippocampus and 
cerebellum, in marked contrast to astrocytes, which typically ensheathe synapses in 
those regions.  For example in the hippocampus, theta-burst stimulation of Schaffer 
collaterals induces an AMPA receptor-dependent long term potentiation (LTP) of 
NG2 cell EPSCs (Ge et al., 2006).   This long term potentiation of the NG2 cell 
response is due to increased insertion of Ca2+ permeable AMPA receptors at these 
synapses.  In the cerebellum, a single NG2 cell forms multiple synapses with an 
individual climbing fiber (Lin et al., 2005).  This is in contrast to one of the other 
resident glial types, Bergmann glia,  which contact climbing fibers and can sense 
ectopic release of glutamate at site removed from the nerve terminal (Matsui and 
Jahr, 2004). 
Calcium signaling in NG2 cells has not been fully elucidated.  NG2 cells 
express Ca2+ permeable AMPA receptors, which are undoubtedly involved in Ca2+-
dependent processes in these cells.  NG2 cells associated with optic nerves display 
spontaneous and neuronal evoked Ca2+ responses, similar to astrocytes from the 
same preparation (Hamilton et al., 2009).  The same group has also shown that NG2 
cells display Ca2+ increases through AMPA receptors and purinergic receptors (P2Y1 
and P2X7) upon axonal stimulation as well as mechanical stimulation of astrocytes 
(Hamilton et al., 2010). Calcium signals evoked by activation of P2Y1 but not P2X7 
receptors indicates release from intracellular stores via IP3Rs, but to date there are 
no direct studies of IP3R-mediated calcium release in NG2 cells.  This presents an 
extensive knowledge gap in how NG2 cells might be responding to neuronal activity. 
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1.6. Microglia in the Central Nervous System 
Microglia are not considered “true” glial cells as they are derived from 
mesodermal tissue whereas all glial cells are derived from ectodermal tissue. 
Microglia can be found in all regions of the brain and spinal cord and historically has 
been assigned the function of the brain’s resident immune cell.  Microglial cells are 
involved in injury responses by migrating to the site of insult to act as phagocytes, 
clearing dying cells and release inflammatory molecules (Streit and Kincaid-Colton, 
1995).   
Research on the function of resident microglial cells in their inactivated state 
has been difficult due to limitations of culturing cells or using acute brains slices.  
Methods used to study microglial cells typically cause them to enter an activated 
state, in which their expression of ion channels, calcium signaling and secreted 
molecules undergo a series of changes (Farber and Kettenmann, 2005).   Advances 
in in vivo imaging has allowed the study of resting microglia and given some insight 
into their potential physiological roles in the brain. For example, it was recently 
shown using in vivo imaging that the microglial response to injury in the spinal cord 
can be modulated by ATP and NO (Dibaj et al., 2010).  Wake et al. (2009) found that 
microglia can associate with neuronal synapses to potentially monitor synaptic 
function and turnover of synaptic connections in ischemia. 
One of the hallmarks of microglial cells is that they can enter an activated 
state in response to changes in their local environment.  Upon activation, microglial 
cells drastically change their gene expression profiles, most notably by increasing 
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their expression of ion channels.  Activated microglia express several ion channels, 
including inward rectifying potassium channels and chloride channels (Eder, 1998; 
Boucsein et al., 2000).  Microglia can also express a wide variety of neurotransmitter 
receptors, both ionotropic and metabotropic, as well as cytokine/chemokine 
receptors (see review by Farber and Kettenmann, 2005).  These changes in ion 
channel and receptor compliment can influence the immune response of microglial 
cells.   
The current literature indicates that microglial Ca2+ signaling is 
mechanistically similar to most glial cells.  One of the most prevalent receptor 
systems expressed by microglia which is connected to Ca2+ signaling are purinergic 
receptors.  Microglia express both ionotropic P2X and metabotropic P2Y receptors.  
Activation of P2Y receptors on microglia are involved in chemotaxis to sites of injury, 
through activation of Gi/o (Langosch et al., 1994; Honda et al., 2001; Haynes et al., 
2006).  P2X receptors, particularly P2X7, play a major role in the activation of 
microglia and Ca2+ signaling of microglial cells.  Activation of P2X7 receptors leads to 
depolarization of the microglial membrane and influx of Ca2+ from the extracellular 
space to trigger the Ca2+-dependent release of various substances such as TNFα 
and IL-1β (Hide et al., 2000; Brough et al., 2002).  Additionally, when microglial cells 
are activated they display a chronic increase in their basal Ca2+ levels that impedes 
receptor based signaling and can modulate the release of substances such as NO 
and cytokines (Hoffmann et al., 2003).  Based on these studies, microglial Ca2+ 
signaling and homeostasis appear to have similarities to other glial subtypes even 
though microglia are derived from a distinct dermal tissue during development. 
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1.7. Specialized Glial Cells 
Two specialized subtypes of glial cells are the Muller cells of the retina and 
the Bergmann glia of the cerebellum.  Each possesses distinct functional and 
morphological specializations based on their location, and respond to neuronal 
activity with Ca2+ increases similar to other glial subtypes. 
 
Muller Cells in the Retina 
Muller cells comprise nearly 90% of the glial cells in the retina and make 
extensive contacts with retinal neuron subtypes.  Muller cells typically have a cell 
body located in the inner nuclear layer of the retina, with two major processes that 
extend in either direction into the plexiform layers (Robinson and Dreher, 1990).  
This morphology allows Muller cells to contact all layers in the retina.  It has recently 
been suggested that this unique morphology allows the Muller cell to act as an in 
vivo correlate of optical fibers, to allow transmission of light through the retinal layers 
to the photoreceptors (Franze et al., 2007).  Muller cells are an important source of 
trophic factors for the survival of ganglion cells, synaptogenesis and physiology of 
the retina.  Muller cells express and release nerve growth factor (NGF), brain-
derived neurotrophic factor (BDNF), transforming growth factor β (TGFβ) and 
numerous other trophic factors (Chakrabarti et al., 1990; Anderson et al., 1995; Seki 
et al., 2005). 
Muller cells express a wide range of neurotransmitter receptors, including but 
not limited to GABA receptors, ionotropic (iGluR)  and metabotropic glutamate 
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(mGluR) receptors and purinergic receptors (de Melo Reis et al., 2008).  The most 
prominent Ca2+ mobilizing receptor system in Muller cells is through several different 
P2Y family purinergic receptors (Fries et al., 2005).  Muller cells can respond to light-
induced neuronal activity with Ca2+ increases through the neuronal release of ATP 
(Newman, 2005).  This study confirmed pharmacological findings demonstrating that 
activation of purinergic receptors triggers Ca2+ increases and propagation of Ca2+ 
waves in retinal preparations (Newman, 2001). The neuronal activity-induced Ca2+ 
increases were found to be reliant on internal stores.  The evidence indicates 
involvement of IP3Rs in neuronal activity-dependent Ca2+ release in Muller cells 
since it can be blocked with cyclopiazonic acid (CPA), which depletes internal stores 
and heparin, which blocks IP3Rs (Newman and Zahs, 1997; Newman, 2005).  Muller 
cells modulate synaptic activity in the retina through the activity of neurotransmitter 
transporters.  Muller cells abundantly express several types of glutamate and GABA 
transporters (Biedermann et al., 1994; Eliasof and Jahr, 1996; Lehre et al., 1997).  
Blockade of glutamate transport influences synaptic activity in the retina by 
increasing the amplitude and durations of EPSCs (Higgs and Lukasiewicz, 1999) 
The physiological relevance of Ca2+ signaling in Muller cells is not entirely 
clear.  Muller cells release ATP in response to intracellular Ca2+ increases to 
modulate ganglion cell function through activation of neuronal adenosine receptors.  
However, no clear link has been established between Ca2+ increases and the 
release of ATP (Newman, 2003).  Muller cells express IP3R2 in the retina, where 
genetic deletion of this receptor is known to lead to deregulation of osmotic cell 
swelling, a potential mechanism of ATP release (Wurm et al., 2009).  Muller cell Ca2+ 
13 
 
signaling is involved in retinal vascular control through the arachidonic acid pathway, 
providing a link between blood flow and neuronal activity through Muller cell Ca2+ 
stimulation (Metea and Newman, 2006).  Further investigation using genetic models 
and in vivo imaging in response to physiological stimulation may provide evidence 
as to the role of Muller cell Ca2+ signaling in physiology. 
 
Bergmann Glia in the Cerebellum 
Apart from astrocytes, the cerebellum has a distinct glial subtype called 
Bergmann glia.  Bergmann glia are morphologically distinct from cerebellar 
astrocytes, having their cell soma in the Purkinje layer with a complex process arbor 
projecting upwards through the molecular layers toward the cerebellar surface 
(Grosche et al., 2002).  Bergmann glia are related to astrocytes in several ways 
despite their differing morphologies.  Bergmann glia are electrophysiologically 
related to astrocytes in their membrane properties due to high potassium leak 
current, linear current-voltage relationship and similar resting membrane potentials 
(~ -80mV) (Muller et al., 1994; Clark and Barbour, 1997).  Bergmann glia are 
electrically and chemically coupled by connexin gap junctions with neighboring 
Bergmann glia in a similar fashion to astrocytes (Muller et al., 1996).  They are 
responsible for removal of the excitatory neurotransmitter glutamate from the 
synaptic cleft of Purkinje cell synapses between climbing and parallel fibers.  
Bergmann glia express both the glutamate-aspartate transporter (GLAST) and 
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glutamate transporter-1 (Glt-1) glutamate transporters, with GLAST activity being the 
most abundant (Rothstein et al., 1994). 
Bergmann glia extensively ensheathe both climbing fiber-Purkinje cell (CF-
PC) and parallel fiber-Purkinje cell (PF-PC) synapses (Grosche et al., 2002).  
Bergmann glial cell coverage of these synapses is extensive; Bergmann glia cover 
close to 100% of CF-PC synapses and nearly 70% of PF-PC synapses in the 
cerebellum (Xu-Friedman et al., 2001).  This morphology, combined with the 
expression of glutamate transporters, enables Bergmann glia to modulate synaptic 
function at these synapses by regulating glutamate reuptake (Brockhaus and 
Deitmer, 2002; Bordey and Sontheimer, 2003; Huang and Bordey, 2004). 
Bergmann glia can detect synaptic activity at cerebellar synapses through 
activation of ionotropic glutamate receptors, primarily Ca2+ permeable AMPA 
receptors (Burnashev et al., 1992).  Activation of these receptors causes Ca2+ 
increases in processes of Bergmann glia (Muller et al., 1992).  Currently, the 
physiological roles of these Ca2+ increases, particularly in regard to causing 
feedback onto neuronal activity reported for other glial cells types, is not clear.  
AMPA receptor mediated Ca2+ increases play a critical role in the maintenance of 
Bergmann glial ensheathment of cerebellar synapses.  Elimination of Ca2+ 
permeable AMPA receptors from Bergmann glial leads to retraction of processes, 
which affects neuronal activity at Purkinje cells synapses (Iino et al., 2001).  Calcium 
increases through these receptors in Bergmann glia regulates the expression and 
function of glutamate transporters to affect synaptic activity (Lopez-Bayghen et al., 
2003; Lopez-Bayghen and Ortega, 2004). 
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Interestingly, Bergmann glia are targets for ectopic release of glutamate from 
both climbing fibers and parallel fibers in the cerebellum.  While Bergmann glia can 
sense glutamate release through both glutamate transporters and AMPA receptors, 
the source of glutamate for these two systems is different.  Bergmann glia glutamate 
transporters respond to spillover from the synaptic cleft with predicted kinetics based 
on the subtypes expressed (Bergles et al., 1997; Dzubay and Jahr, 1999).  In 
contrast, AMPA receptors on Bergmann glia respond to glutamate released from 
non-synaptic locations, referred to as ectopic release sites.  This was first shown by 
Matsui and Jahr (2003) who demonstrated that quantal events measured from 
Bergmann glia and post-synaptic Purkinje cells did not share the same source.  
Later work by the authors found that glutamate release from synaptic and ectopic 
release sites induces electrophysiological responses that can be used to 
differentiate between synaptic and ectopic release sites contacted by Bergmann glia 
(Matsui and Jahr, 2004; Matsui et al., 2005).   
Compared to other glial subtypes, relatively little is known about the function 
of Gq-GPCR linked Ca2+ release pathways in Bergmann glia.  Bergmann glia 
express a number of neurotransmitter receptors linked to Ca2+ mobilization from 
internal stores (Kirischuk et al., 1995; Kirischuk et al., 1996; Tuschick et al., 1997; 
Kirischuk et al., 1999; Singaravelu and Deitmer, 2006).  Immunohistochemical data 
suggests that Bergmann glia express primarily IP3R2, similar to other glial types in 
the brain (Holtzclaw et al., 2002).  However, the physiological roles of IP3R-mediated 
Ca2+ signals are not known and remain an open field of investigation.  
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1.8. Astrocytes in the Central Nervous System 
 Astrocytes are the predominant cell type in the brain, with the estimated 
percentage ranging from fifty to eighty percent of the volume of the brain.  Astrocytes 
were historically thought to solely serve a support role in the CNS with their function 
limited to structural and metabolic support, clearance of neurotransmitters from the 
synaptic cleft and potassium buffering.  In the last 30 years, the concept of 
astrocytes as solely support cells has evolved as an increasing amount of evidence 
having been found for astrocytes responding to neuronal activity with intracellular 
Ca2+ increases (Porter and McCarthy, 1997; Haydon and Carmignoto, 2006).  
Further, it was discovered that through these Ca2+ increases, astrocytes could 
actively release compounds to modulate neuronal activity.  This represented a 
significant shift in the study of how synapses operate, and suggested that astrocytes 
were critical for the proper function of neuronal systems.  In this section, there will be 
a discussion of the support roles performed by astrocytes and an overview of the 
concept of astrocyte modulation of synaptic activity, in particular the role of Ca2+-
dependent release of neuroactive compounds termed “gliotransmitters”. 
 
1.9. Astrocyte Support Roles in the Central Nervous System 
Neurotransmitter Uptake 
 Astrocytes have long been known to be responsible for the reuptake of 
neurotransmitters from the synaptic cleft.  Astrocytes in culture and in situ express a 
wide variety of neurotransmitter transporters including but not limited to, glutamate  
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(Huang and Bergles, 2004), adenosine (Nagai et al., 2005; Peng et al., 2005), 
dopamine (Karakaya et al., 2007) and GABA (Schousboe and Waagepetersen, 
2006).  Through the expression of transporters, astrocytes are capable of shaping 
synaptic transmission through alterations in transporter activity. 
 The most predominantly studied transporter expressed by astrocytes is the 
glutamate transporter.  Astrocytes express high levels of excitatory amino acid 
transporters GLAST and GLT-1 (Danbolt, 2001).  These transporters are expressed 
at sufficient density on the processes of astrocytes that even high frequency 
stimulation of glutamatergic neuronal afferents to release glutamate is not capable of 
overwhelming the glutamate transporters at most synapses (Diamond and Jahr, 
2000).  Changes in glutamate transporter activity leads to alterations in synaptic 
currents, due to prolonged accumulation of glutamate in the synaptic cleft (Barbour 
et al., 1994; Diamond, 2001).  Glutamate transporters also limit the spillover of 
glutamate to adjacent synapses, thereby reducing synaptic crosstalk at many 
synapses (Asztely et al., 1997; Min et al., 1998).  Expression of glutamate 
transporters can be regulated by presynaptic elements, providing a novel 
mechanism by which astrocytes and neurons interact to affect astrocyte function 
(Yang et al., 2009).   
 Transport of other neurotransmitters by astrocytes is less well defined than 
glutamate transport.  Adenosine clearance occurs primarily by reuptake by neurons, 
but astrocytes express the adenosine transporters ENT1 and ENT2 (Nagai et al., 
2005).  In cultured astrocytes, adenosine transport leads to rapid accumulation of 
intracellular adenosine, which is then used to synthesize adenine for cellular 
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metabolism (Peng et al., 2005).  Functional expression of the dopamine transporter 
DAT in striatal astrocyte cultures suggests they may be capable of affecting 
nigrostriatal transmission (Karakaya et al., 2007).  However, cultured cortical 
astrocytes were found to uptake dopamine not through the dopamine transporter 
(DAT), but through expression of the norepinephrine transporter (NET) (Takeda et 
al., 2002), raising the possibility that the mechanisms of dopamine uptake by 
astrocytes may be brain region-dependent.  GABA, the major inhibitory molecule in 
the central nervous system, is taken up by astrocytes through GABA transporters; 
however, the functional implications of this transport are not entirely understood 
(Gadea and Lopez-Colome, 2001; Wu et al., 2006). Recently, a role for astrocyte 
GABA transporters in modulating the inhibitory tone of the hypothalamic 
paraventricular nucleus was found (Park et al., 2009).  Surprisingly, astrocytes can 
release GABA through the reversal of GABA transport during glutamate uptake in 
vivo (Heja et al., 2009).  This proposes a novel mechanism for astrocytes to balance 
excitatory versus inhibitory transmission in the CNS. 
 
 Potassium Buffering 
 One of the most critical functions of astrocytes in the CNS is the uptake of 
potassium release during neuronal activity.  Orkland et al. (1966) was the first to 
propose that astrocytes act as a potassium sink for extracellular potassium during 
neuronal activity and shunts the potassium ions through the astrocyte syncytium via 
gap junctions.  The primary potassium channel responsible for this function is Kir4.1, 
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a weak inwardly rectifying potassium channel (Takumi et al., 1995).  This Kir channel 
is expressed by multiple glial cells types including astrocytes, Muller glia and 
oligodendrocytes (Butt and Kalsi, 2006; Olsen and Sontheimer, 2008).   
 Kir4.1 has been implicated in modulating synaptic strength through its 
potassium buffering function.  Cultured astrocytes and spinal cord astrocytes in situ 
revealed that knockdown of Kir4.1 leads to impairments in buffering capacity and 
glutamate uptake (Olsen et al., 2006; Kucheryavykh et al., 2007).  In agreement with 
this, Djukic et al. (2007) found that the hippocampal astrocytes of GFAP-Cre 
conditional Kir4.1 knockout mice had depolarized resting membrane potentials.  This 
reduced membrane potential interfered with both the ability of astrocytes to buffer 
potassium, as well as their glutamate transporter activity.  The impairment of 
glutamate transport activity can be attributed to the depolarized membrane potential, 
which would decrease the electrogenic drive required for the active transport of 
glutamate across the membrane (Tzingounis and Wadiche, 2007).  Potassium 
buffering by astrocytes is therefore important not only in the removal of excess 
potassium ions from the extracellular space, but necessary to the functioning of 
glutamate transporters, which in turn can affect synaptic strength. 
 
Cerebrovascular Control 
 In the last decade, astrocytes were recognized as major mediators of 
cerebrovascular responses in the brain.  Astrocyte endfeet are known to ensheathe 
the vast majority, if not all, of the vasculature in the mammalian brain (Mathiisen et 
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al., 2010).  In response to neuronal activity, astrocytes can release compounds that 
cause either constriction or dilation of the blood vessels that they contact (Koehler et 
al., 2006).  This provides a bridge connecting increases in blood flow and increases 
in metabolic demand during neuronal activity that underlies the hemodynamic 
response. 
 While there is abundant evidence that astrocytes are involved in the cerebral 
vascular response, the exact mechanism of how this response is mediated remains 
unresolved.  Published data implicates both potassium channels and the formation 
of arachidonic acid metabolites in the vascular response (Zonta et al., 2003; Filosa 
et al., 2006; Girouard et al., 2010).  One unifying feature of astrocyte-mediated 
regulation of vascular tone is the reliance on astrocytic Ca2+ responses.  There are 
two proposed mechanisms for Ca2+-mediated astrocytic control of vascular 
responses.  First, Ca2+ elevations in astrocyte endfeet open Ca2+ sensitive 
potassium channels, releasing potassium which activates smooth muscle cells to 
cause vasoconstriction or dilation (Filosa et al., 2006).  However, an argument has 
been made that potassium siphoning from glial cells is not involved in mediating 
vasoconstriction (Metea et al., 2007).  An alternate mechanism involves increases in 
intracellular Ca2+ that lead to the formation of arachidonic acid metabolites, primarily 
epoxyeicosatrienoic acid (EETs) and prostaglandins, which induces vasodilation and 
20-hydroxyeicosatetraenoic acid (20-HETE) which causes vasoconstriction (Mulligan 
and MacVicar, 2004; Metea and Newman, 2006; Petzold et al., 2008).  The 
predominant view is that the astrocytes modulate cerebral blood flow through 
arachidonic acid metabolites rather than potassium release (Koehler et al., 2009). 
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 Several in vivo studies support a role for astrocytes in the hemodynamic 
response.  Takano et al (2006) reported that uncaging Ca2+ in astrocytes of rodent 
somatosensory cortex lead to a cyclooxygenase-1 (COX-1)-dependent vasodilation 
of cerebral arteries.  Similar results were found by Zonta et al (2003) upon forepaw 
stimulation, which were blocked by use of an mGluR antagonist.  Astrocyte control of 
bloodflow has also been shown in the olfactory glomeruli of mice upon odorant 
stimulation (Petzold et al., 2008).  In that study, astrocytes were found to react to 
presynaptic release of glutamate through activation of mGluRs and COX-1 to induce 
vasodilation.  Interestingly, evidence was also found for a glutamate transporter-
dependent mechanism for changes in cerebral blood flow.  It was proposed that 
glutamate uptake may induce small localized changes in Ca2+ that could not be 
detected due to technical limitations.  In support of this, a glutamate transporter-
dependent mechanism of Ca2+ signaling in astrocytes was recently shown in the 
visual cortex of ferrets in response to visual stimulation in vivo (Schummers et al., 
2008).   
 Taken together, in situ and in vivo studies demonstrate that astrocytes are 
key regulators in cerebral blood flow.  While there remains some debate concerning 
the role of potassium channels in the control of cerebral blood flow, there is solid 
evidence for the involvement of arachidonic acid metabolites (Filosa and Blanco, 
2007; Iadecola and Nedergaard, 2007; Koehler et al., 2009).  Regardless of the 
mechanism, increases in intracellular Ca2+ in astrocytes appear to be a crucial 
component in the pathway. 
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 Metabolic Support 
 During neuronal activity, neurons consume glucose to produce energy to 
maintain synaptic transmission (Brown and Ransom, 2007). Astrocyte metabolism is 
critical in providing neurons with not only glucose, but also the glycolytic derivative 
lactate, as a means of metabolic support.  Glucose is taken up by astrocytes through 
glucose transporters (GLUTs), and is subsequently converted into glycogen 
(Vannucci et al., 1997).  Astrocytes represent a major, localized glycogen store in 
the brain, which can be utilized for metabolic support of neurons during periods of 
intense neuronal activity through the trafficking of glucose and lactate (Cataldo and 
Broadwell, 1986; Brown and Ransom, 2007). 
 Astrocyte metabolism and metabolic support of neurons remains a 
controversial topic in regards to the pathways and substrates involved.  One view is 
that glucose is the sole substrate for energy production in neurons, while an 
opposing viewpoint includes astrocyte derived lactate as a substrate (Pellerin and 
Magistretti, 2003; Schurr, 2006).  The currently held view of astrocyte metabolic 
support involves the astrocyte-neuron lactate shuttle hypothesis (ANLSH).  This 
pathway was originally postulated by Pellerin and Magistretti (1994), in which 
astrocyte glycogen is broken down into lactate and shuttled to neurons to serve as 
aerobic fuel.  Several lines of evidence now support the ANLSH as a critical pathway 
in the connection between astrocyte metabolism and neuronal activity (Brown and 
Ransom, 2007). 
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 Recently, two studies provided direct functional imaging of astrocyte 
metabolism in response to neuronal activity.  Kasischke et al. (2004) used two-
photon imaging of hippocampal astrocyte to show that stimulation of Schaffer 
collaterals leads to an increase in astrocyte glycolysis measured by the intrinsic 
fluorescence of β-nicotinamide adenine dinucleotide (NADH).  The authors 
concluded that this increase in glycolysis sustains neuronal oxidative metabolism 
through the ANLSH pathway.  In a separate study in hippocampal slices, Rouach et 
al (2008) used a fluorescent glucose derivative to image the trafficking of glucose 
and glucose metabolites through the astrocyte syncytium via gap junction coupling. 
Changes in fluorescence in the astrocyte syncytium were coupled to neuronal 
activity, indicating that astrocytes are capable of shuttling glucose and glucose 
derivatives to site of neuronal metabolic demand.  These studies provide strong 
evidence for the interaction between astrocytes and neurons in meeting the energy 
demands of the central nervous system. 
 In addition to being a major glycogen store in the brain and providing 
metabolic support for neuronal energy production, astrocytes are also involved in the 
synthesis and release of glutamine.  Astrocytes express glutamine synthetase (GS), 
which produces glutamine from glutamate that has been taken up into astrocytes by 
glutamate transporter activity (Norenberg and Martinez-Hernandez, 1979).  
Glutamine produced by astrocytes is released into the extracellular space and taken 
up by neurons to be converted into the neurotransmitter glutamate (Hertz, 2006).  
Further, glutamine released by astrocytes is also taken up by inhibitory neurons and 
converted into GABA (Liang et al., 2006).  It has been proposed that interference in 
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the glutamate-glutamine cycle in astrocytes rapidly leads to the depletion of synaptic 
GABA and may be involved in the generation of pathological processes (Ortinski et 
al., 2010).  The involvement of astrocytes in providing glutamine to neurons 
constitutes another pathway by which astrocytes can modulate synaptic 
transmission in the central nervous system. 
 
 Synapse Formation and Dendritic Spine Interactions 
 Astrocytes are involved in the development and maturation of synapses in the 
central nervous system; however, for some time the mechanism was not known.  
The expression of soluble factors, extracellular matrix proteins and downstream 
signaling cascades in astrocytes has placed glial cells as key players in the 
development and maturation of synaptic contacts in many regions of the brain 
(Faissner et al., 2010).  Astrocyte conditioned media in culture experiments can 
induce synapse formation in hippocampal neurons through a soluble factor released 
from astrocytes (Pfrieger and Barres, 1997; Nagler et al., 2001).  For example, 
secretion of thrombospondins (specifically TSP1 and TSP2) from immature 
astrocytes increases synapse number in cultured neurons (Christopherson et al., 
2005).  Further, in vivo data revealed that TSP1/2 deficient mice display a reduced 
number of synapses, providing support for TPS1/2 having a role in synapse 
formation.  It should be noted that while these synapses are structurally normal, they 
are postsynaptically silent, indicating that another mechanism is involved in 
triggering the trafficking of postsynaptic receptors to form functional synapses 
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(Christopherson et al., 2005).  A possible mechanism may be through release of 
tumor necrosis factor alpha (TNFα).  TNFα released by astrocytes has been 
reported to induce trafficking of AMPA receptors to postsynaptic sites to increase 
excitatory synaptic strength (Beattie et al., 2002).   Interestingly, while TSPs are able 
to induce synapse formation at glutamatergic synapses, they are not able to induce 
synaptogenesis of inhibitory connections (Hughes et al., 2010).  A unrelated and yet 
unidentified secreted protein contained in astrocyte conditioned media appears to be 
involved.   Therefore, astrocytes may be capable of selectively distinguishing and 
promoting synaptogenesis in varying neuronal cell types by release of distinct 
soluble factors. 
 Astrocytes are also involved in the maintenance of synaptic contacts and 
regulation of synaptic strength through ensheathment of synapses by fine 
processes.  A single astrocytes is estimated to contact 300-600 dendrites and 
100,000 synapses depending on the brain region examined (Bushong et al., 2002; 
Halassa et al., 2007b).  The extent of astrocyte ensheathment varies between brain 
regions, with Bergmann glia nearly completely surrounding the parallel fiber-Purkinje 
cell synapse and only coverage of  less than half of synaptic interface by astrocytes 
in the hippocampus (Grosche et al., 1999; Ventura and Harris, 1999).  Astrocyte 
process interaction with dendritic spines is highly dynamic, with processes rapidly 
approaching and retracting (Haber et al., 2006). These dynamic changes suggest 
that astrocytes are capable of controlling spine maturation and stabilization through 
interaction with surface receptors. 
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 Astrocytes can regulate synaptic strength through the interaction of astrocyte 
processes and dendritic spines involving signaling through ephrins and Eph 
receptors (Murai et al., 2003).  Activation of EphA4 receptors on neuronal spines by 
ephrin-A3 on astrocytes processes can induce spine retraction in hippocampal 
dendrites.  Further, this interaction can modulate LTP at CA3-CA1 synapses, not 
due to release of transmitters from astrocytes but due to changes in astrocyte 
glutamate transporter activity (Filosa et al., 2009).  This represents a novel 
mechanism by which dynamic interaction of astrocyte processes and dendritic 
spines may regulate synaptic strength. 
 
 Astrocytes in Physiology and Pathology 
 As discussed above, astrocytes are actively involved in regulating synaptic 
activity and more widespread processes such as cerebral vascular responses.  
Recently, several studies concerning astrocytes regulating specific behavioral 
processes have been published.  A dominant negative SNARE expressed in 
astrocytes was shown to block vesicular release of ATP/adenosine to affect the 
accumulation of the homeostatic sleep pressure (Halassa et al., 2009b).  Further, 
this mouse model showed that astrocytes can affect slow cortical oscillations 
through reduced ambient adenosine tone and hypofunction of NMDA receptors 
(Fellin et al., 2009).   Recently a novel role for astrocytes in the control of respiratory 
responses in the brainstem was published (Gourine et al., 2010).  Astrocytes 
responded to changes in pH with intracellular Ca2+ increases that triggered the 
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release of ATP to activate chemoreceptor neurons and modify breathing.  Taken 
together, the findings place astrocytes in position to regulate physiological processes 
in vivo.   
 Astrocytes have also been implicated in modulating physiological processes 
involved in addiction behaviors.  Acute reward behavior of alcohol can be modulated 
by astrocytes.  Astrocyte swelling triggers the release of taurine, an agonist of 
glycine receptors, and causes an increase in extracellular dopamine levels 
(Adermark et al., 2010).  Endocannabinoids can trigger the Ca2+-dependent release 
of glutamate from astrocytes to activate neuronal NMDA receptors, suggesting they 
may be involved in modulating endocannabinoid-related addiction (Navarrete and 
Araque, 2008).  Finally, astrocytes are implicated in cocaine addiction through Ca2+-
dependent glutamate release from astrocytes onto neurons in the nucleus 
accumbens (Haydon et al., 2009). 
 Astrocytes are known to play a part in pathological states, primarily through 
the reactive gliosis.  Astrocyte dysfunction leading to the onset or contributing to 
various pathological states has become an area of intense research.  Investigations 
into pathological response have indicated a role for astrocytes in Alzhiermer’s 
diseases, chronic pain, and epilepsy.  In Alzheimer’s disease (AD), astrocytes 
surround plaques and are critical to the clearance of amyloid-β (Wegiel et al., 2001).  
Further, transgenic mice that express human Aβ precursor protein and mutant 
presenilin 1 display deregulated Ca2+ signaling, with increased frequency of Ca2+ 
transients (Kuchibhotla et al., 2009).  Chronic pain has moved to the forefront of 
astroglial research in recent years, with evidence for the role of astrocytes in the 
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release of cytokines and chemokines in mediating neuropathic pain.  While there is a 
growing role for activated astrocytes in the production of pathological pain, there is 
also evidence for protective roles as well (Milligan and Watkins, 2009).     
 The role of astrocytes in epilepsy has received much attention, with work in 
both acute hippocampal slices and in vivo implicating astrocytic involvement in the 
generation of epilepsy.  However, the literature is not unified on a mechanism for 
how astrocytes may be regulating epilepsy.  There is evidence for the involvement of 
gap junctions (Lee et al., 1995), loss of astrocytic domain structure (Oberheim et al., 
2008), release of transmitters from astrocytes (Tian et al., 2005; Gomez-Gonzalo et 
al., 2010) and changes in the glutamate-glutamine cycle in reactive astrocytes 
(Ortinski et al., 2010).  This is in addition to numerous functional changes displayed 
by astrocytes in response to epilepsy such as alterations in membrane channel 
expression; transporter and neurotransmitter receptors (Binder and Steinhauser, 
2006). 
 Collectively, there is little doubt as to the involvement of astrocytes in 
pathological states and disease.  Further investigation using in vivo techniques and 
genetic models will be crucial to determining what mechanisms in astrocytes are 
playing a role in the formation and maintenance of pathological disease. 
 
1.10. Astrocyte Calcium Signaling 
 One of the most distinguishing features of astrocytes is that they are non-
excitable cells.  Astrocytes membrane currents are passive and they display no 
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ability to generate action potentials.  Given these findings, the majority stance was 
that astrocytes were silent support elements in the brain.  This viewpoint radically 
shifted when it was discovered that astrocytes both in culture and in situ express a 
wide variety of G protein coupled receptors (GPCRs) that could elicit downstream 
signaling cascades (McCarthy and de Vellis, 1978; van Calker et al., 1978; Porter 
and McCarthy, 1997).  The most widely studied GPCR signaling cascade in 
astrocytes is the canonical phospholipase C (PLC)/inositol 1,4,5-trisphosphate (IP3) 
pathway. Upon GPCR activation, PLC hydrolyzes the membrane lipid 
phosphatidylinositol 4,5-bisphosphate to generate diacylglycerol (DAG) and IP3, 
leading to IP3 receptor (IP3R) activation and Ca2+ release from the endoplasmic 
reticulum (ER). This is based on an exhaustive amount of data from both cultured 
astroglia and in situ astrocytes and has been the subject of numerous reviews 
(Scemes, 2000; Parri and Crunelli, 2003; Volterra and Steinhauser, 2004; Fiacco 
and McCarthy, 2006; Scemes and Giaume, 2006).  
 In contrast to other glial cells types, there is surprisingly little data for alternate 
Ca2+ signaling mechanisms in astrocytes in situ which has lead to a discrepancy 
between culture and in situ data.  While cultured astrocytes express several voltage 
gated calcium channels (VGCC) (Latour et al., 2003; D'Ascenzo et al., 2004), there 
is less evidence for their functional role in situ.  Astrocytic Ca2+ elevations following 
stimulation of neuronal afferents are attributed to activation of astrocytic Gq-GPCRs 
and not to activation of VGCCs (Porter and McCarthy, 1995b, 1995a; Carmignoto et 
al., 1998; Nett et al., 2002; Beck et al., 2004; Straub and Nelson, 2007). However, 
while astrocytic VGCCs do not seem to play a role in the initiation of evoked 
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astrocytic Ca2+ increases, they may be important for initiating Ca2+ oscillations that 
occur independent of neuronal input, generally referred to as spontaneous or 
intrinsic astrocytic Ca2+ oscillations (Parri and Crunelli, 2001; Aguado et al., 2002).  
However, there is a possibility that specific subpopulations of astrocytes may 
express VGCCs.  Recently evidence suggests that SVZ astrocyte-like cells express 
functional VGCCs that open in response to activation of GABAA receptors (Young et 
al., 2010).  There is also indirect evidence for VGCCs on hippocampal astrocytes, 
where GABAB receptor activation (a Gi/o coupled receptor) was necessary for the 
release of ATP/adenosine from astrocytes (Serrano et al., 2006).  While there is no 
electrophysiological data supporting expression of VGCCs in astrocytes in situ, the 
passive nature of the astrocyte membrane plus technical limitations on imaging in 
fine processes of astrocytes may occlude their detection. 
 Ryanodine receptors (RyRs) are another major class of ER Ca2+ release 
channels found in many cells types (Zalk et al., 2007).  There is little convincing data 
that astrocytes in situ exhibit RyR-mediated increases in Ca2+ (Nett et al., 2002; 
Beck et al., 2004; Hertle and Yeckel, 2007). However, it remains possible that this 
alternate Ca2+ source could be important in the fine processes of astrocytes where it 
is difficult to study Ca2+ regulation.   
 Lastly, there is evidence for the expression of both Ca2+ permeable and 
impermeable AMPA receptors on astrocytes like those found in other glial subtypes 
such as Bergmann glia, oligodendrocytes and NG2 positive glia (Burnashev et al., 
1992; Butt, 2006; Hamilton et al., 2010).  However, this appears to occur only in 
specific astrocyte subpopulations such as those found in white matter tracks of optic 
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nerves and on GFAP positive astrocytes in the hippocampus that lack glutamate 
transporter currents (Zhou and Kimelberg, 2001; Hamilton et al., 2008).  Therefore, 
based on the current state of the literature, the vast majority of Ca2+ signaling in 
astrocytes is mediated solely through Gq-GPCR activiation and downstream activity 
of the PLC/IP3 pathway. 
 Astrocytes express an exceptionally broad range of Gq-coupled GPCRs 
linked to the mobilization of intracellular Ca2+ through the PLC/IP3 pathway (Agulhon 
et al., 2008).  Receptors on astrocytes can be activated both by agonist application 
and by release from presynaptic terminals (Shelton and McCarthy, 1999) (Porter and 
McCarthy, 1995b, , 1996; Pasti et al., 1997; Kang et al., 1998; Araque et al., 2002; 
Perea and Araque, 2005b; Navarrete and Araque, 2008).  The ability of astrocytes to 
respond to neuronal activity with increases in intracellular Ca2+ provided evidence of 
a direct neuron to astrocyte signaling pathway, opening up speculation as to the role 
of this signaling modality in astrocytes and its functional consequences.   The first 
report for a functional role came when Gq-GPCR agonists triggered intracellular 
Ca2+ release in astrocytes resulting in changes to ionotropic glutamate receptor 
(iGluR) activity on neurons (Parpura et al., 1994; Pasti et al., 1997).  This astrocyte 
mediated change in neuronal activity occurs not only upon agonist stimulation of 
intracellular Ca2+ release, but can occur through spontaneous Ca2+ oscillations in 
astrocytes (Parri et al., 2001).  These finding laid the ground work for one of largest 
paradigm shifts in neuroscience, with astrocytes releasing neurotransmitters (now 
referred to as gliotransmitters) to modulate and even drive neuronal activity in the 
brain. 
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1.11. The Tripartite Synapse 
 The tripartite synapse model is the theory that astrocytes, in response to 
neuronal activity, increase intracellular Ca2+ and release transmitters to affect 
synaptic transmission (Araque et al., 1999).  The tripartite synapse is structurally 
composed of the presynaptic terminal, the postsynaptic bouton and an ensheathing 
astrocyte process (see Figure 1.1).  This structural arrangement, in addition to the 
expression of GPCRs linked to Ca2+ mobilization, allows astrocytes to sense 
synaptic activity and respond with the release of what are termed gliotransmitters 
(Halassa et al., 2007a).  The most commonly studied gliotransmitters are glutamate, 
ATP and D-serine; all of which are released from cultured astrocytes as well as 
astrocytes in situ (Hamilton and Attwell, 2010).  This topic has been extensively 
reviewed, and therefore only a summary of the salient finding for gliotransmission 
will be presented below.  For more comprehensive reviews see Agulhon et al. (2008) 
and Halassa et al. (2010).  
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1.12. Gliotransmitters and Modulation of Synaptic Activity 
 The currently defined gliotransmitters are glutamate, ATP (which is rapidly 
converted to adenosine in the extracellular space) and D-serine (Halassa et al., 
2007a).  The first of these gliotransmitters identified was glutamate.  Gq-GPCR 
     
Figure 1.1. The tripartite synapse and gliotransmission.  The tripartite synapse is 
defined as the interaction between a presynaptic terminal, postsynaptic bouton 
and an astrocyte process.  Gliotransmission refers to the release of transmitter 
from astrocytes to modulate synaptic activity.  Release of neurotransmitter from 
the presynaptic terminal (1) activates postsynaptic receptors (4) on neurons and 
receptors on astrocytes.  Activation of astrocytic Gq GPCRs (2) elicits an IP3R-
dependent release of Ca2+ from the ER that triggers the release of 
gliotransmitters  that can activate extrasynaptic receptors, both pre- (1) and 
postsynaptically (4) .  Astrocytes also uptake released neurotransmitters through 
active transport to curtail spillover and modulate the time course of synaptic 
events (3). 
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stimulation of cultured astrocytes triggered release of glutamate in response to 
intracellular Ca2+ increases to activate neuronal NMDA receptors (Parpura et al., 
1994).  These results were corroborated by further experiments in neuron-astrocyte 
co-cultures and in acute hippocampal slices  (Pasti et al., 1997; Araque et al., 
1998b).  This led to a series of high profile papers describing modulation of neuronal 
activity through the Ca2+-dependent release of glutamate from astrocytes.  
Glutamate release from astrocytes can activate presynaptic mGluR receptors 
(Fiacco and McCarthy, 2004; Andersson et al., 2007a; Perea and Araque, 2007) or 
pre- and postsynaptic NMDA receptors on excitatory neurons (Pasti et al., 2001; 
Angulo et al., 2004; Fellin et al., 2004; Jourdain et al., 2007; Navarrete and Araque, 
2008). 
 Astrocyte Ca2+ -dependent release of glutamate is also implicated in 
modulating inhibitory neuron activity.  Stimulation of astrocyte intracellular Ca2+ 
release leads to an increase in miniature inhibitory post synaptic currents (mIPSCs) 
in CA1 pyramidal neurons (Kang et al., 1998).  Further, Ca2+-dependent glutamate 
release from astrocytes can increase spontaneous IPSCs (sIPSCs) in hippocampal 
interneurons through activation of AMPA/KA receptors (Liu et al., 2004a).  
Paradoxically, it was found upon blockade of action potential driven activity that 
intracellular Ca2+ increases in astrocytes lead to a reduction in the frequency of 
mIPSCs on interneurons and was not affected by AMPA/KA receptor blockers.  
These findings were later clarified when data indicated that Ca2+-dependent release 
of glutamate from astrocytes also activated presynaptic group II/III mGluRs to inhibit 
presynaptic activity (Liu et al., 2004a).  These findings implicate astrocyte Ca2+-
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dependent release of glutamate as a modulatory element of both excitatory and 
inhibitory synaptic transmission.        
 In the last decade, increasing evidence supporting the Ca2+-dependent 
release of ATP from astrocytes has warranted its inclusion as a gliotransmitter.  
Upon release into the extracellular space ATP acts on purinergic receptors and is 
rapidly converted into adenosine by ectonucleotidases (Zimmermann, 2006).  
Activation of adenosine receptors, particularly A1 adenosine receptors (A1R), is 
important in the regulation of presynaptic release at many synapses including CA3-
CA1 and MF-CA3 synapses (Manita et al., 2004; Kukley et al., 2005).  Cultured 
astrocytes are known to release ATP/adenosine in response to Gq-GPCR-mediated 
Ca2+ increases (Pangrsic et al., 2007; Zhang et al., 2007).   
 Evidence in situ for astrocytic ATP release indicates that interfering with 
vesicular release of ATP through the expression of a dominant negative SNARE 
protein reduced the dynamic range of long term potentiation in dnSNARE mice 
(Pascual et al., 2005).  Further, this blockade of ATP release prevented the 
formation of activity-dependent heterosynaptic depression at CA3-CA1 synapses.  
These finding were supported by a separate study, which also found that ATP 
released from astrocytes is involved in the formation of heterosynaptic depression 
(Serrano et al., 2006).  However, while both these studies describe an effect on 
heterosynaptic depression, the pathways involved appear to differ.  Pascual et al 
(2005) reported a SNARE-dependent release of ATP from astrocytes upon Schaffer 
collateral stimulation suggesting that astrocytes are responding to excitatory 
transmitter release from neurons.  In contrast, Serrano et al (2006) provided data 
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that GABA released from interneurons triggered a GABAB receptor-dependent 
increase in astrocyte intracellular Ca2+ to trigger the Ca2+-dependent release of ATP.  
While the findings of the two papers do not directly contradict each other, they raise 
questions as to the neuronal pathways involved in astrocyte mediated regulation of 
heterosynaptic depression. 
 The third currently recognized, though less studied, gliotransmitter is D-
serine.  Astrocytes are proposed to be the sole source of D-serine released in the 
brain (Schell et al., 1997; Oliet and Mothet, 2006), though this stance has recently 
been challenged (Rosenberg et al., 2010). Several studies indicate that the enzyme 
responsible for synthesis of D-serine is highly localized to astrocytes in nearly all 
regions of the brain (Williams et al., 2006).  Cultured astrocytes release D-serine in a 
Ca2+ and vesicular-dependent manner upon stimulation of both ionotropic and 
metabotropic glutamate receptors (Schell et al., 1995; Mothet et al., 2005).  
Currently the best evidence for astrocytic D-serine release in situ comes from 
studies in acute slices of the supraoptic nucleus (SON).  Electrophysiological 
recordings of SON neurons indicate that D-serine levels in the synaptic cleft change 
as a function of astrocyte coverage of neurons (Panatier et al., 2006).  These 
fluctuations in astrocyte derived D-serine levels were found to modulate NMDA 
receptor function, and affect synaptic processes such as LTP and LTD of SON 
neurons.  The most recent study concerning D-serine release by astrocytes 
proposed an even more critical role in modulating synaptic transmission. 
Henneberger et al. (2010) found that by “clamping” intracellular Ca2+ levels in 
astrocytes to block Ca2+-dependent release of D-serine that formation of LTP at 
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CA3-CA1 synapses was completely blocked in the hippocampus.  This effect was 
reversed by the addition of exogenous D-serine or glycine.  It should be noted that 
this technique has not been widely used for the examination of Ca2+-dependent 
release from astrocytes; therefore, further study will be required to place the findings 
of Henneberger et al. (2010) into a physiological context. 
 
1.13. Release Mechanisms of Gliotransmitters 
Studies using cultured astrocytes have provided evidence for a number of 
non-vesicular, gliotransmitter release mechanisms.  Detectable gliotransmitter 
release through volume regulated anion channels (Takano et al., 2005; Abdullaev et 
al., 2006; Ramos-Mandujano et al., 2007), connexin hemichannels (Stout et al., 
2002; Ye et al., 2003), and large conductance pores such as P2X7 receptors (Duan 
et al., 2003; Fellin et al., 2006a; Suadicani et al., 2006) has been reported.  
However, as astrocytes are known to alter their morphology and gene expression in 
culture, it remains unresolved which of these alternate mechanisms, if any, are 
physiologically relevant to gliotransmission in vivo (Hamilton and Attwell, 2010; 
Parpura and Zorec, 2010). 
 The most widely held mechanism for gliotransmitters release, particularly 
glutamate, is through IP3R-medited, Ca2+ and SNARE-dependent vesicular release 
(Halassa and Haydon, 2010).  This view is based on findings that suggest, but are 
not conclusive, that astrocytes possess the mechanisms for vesicular release.  
Vesicular release by astrocytes is argued to be blocked in mice expressing a 
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dominant negative SNARE (dnSANRE) or by use of tetanus toxin to cleave 
synaptobrevin 2 (Pascual et al., 2005; Perea and Araque, 2007).  However there is 
no evidence that vesicular release of glutamate is blocked in the dnSNARE, as 
expected in that model, only that exocytosis of ATP is affected.  Tetanus toxin 
dialyzed into astrocytes via path pipette blocked the release of glutamate to affect 
synaptic strength, which the author interpreted as evidence of vesicular release 
(Perea and Araque, 2007).   However, tetanus toxin may also affect the insertion 
and recycling of plasma membrane proteins involved in non-exocytotic, Ca2+-
independent release of gliotransmitters (Hamilton and Attwell, 2010).  Further, 
glutamate transporter density at the plasma membrane is regulated by Ca2+-
dependent exocytosis and therefore could be affected by tetanus toxin and results in 
changes to synaptic activity (Stenovec et al., 2008) 
 There are conflicting reports on the expression of vesicular machinery 
between cultured and in situ astrocytes.  Astrocytes in culture express several of the 
proteins associated with the cellular machinery for vesicular release such as SNAP-
25 and syntaxin (Wilhelm et al., 2004; Zhang et al., 2004a; Montana et al., 2006).  
While Wilhelm et al. (2004) found abundant expression of release machinery in 
cultured astrocytes, expression in situ was lacking for several of the proteins found 
in culture.  Gene array profiling of astrocytes from the cortex also found no evidence 
for the expression of several exocytotic machinery components (Cahoy et al., 2008).  
Further, there is no evidence for the expression of proteins such as Munc13 or 
Rab3, which are associated with exocytotic release in neurons, in astrocytes to date.   
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 Finally, the presence of vesicles and the transporters necessary for their filling 
in astrocytes is not convincing.  Astrocytes in situ display small, synaptic-like 
microvesicles, but their density is far less than found in neurons (Bezzi et al., 2004; 
Jourdain et al., 2007).  Recent reports in acute hippocampal slices describe 
trafficking of vesicles in astrocytes, but there is little evidence that these are vesicles 
involved in regulated Ca2+-dependent exocytosis of gliotransmitters (Potokar et al., 
2009).  Further, the expression of vesicular glutamate transporters (VGLUTs) in 
astrocytes is debatable.  There is evidence both for and against the expression of 
VGLUT1 and 2 in situ (Bezzi et al., 2004; Zhang et al., 2004b; Potokar et al., 2009), 
with expression of VGLUT3 confined to a subpopulation of white matter astrocytes 
(Fremeau et al., 2002).  It should be noted that there is abundant evidence that 
VGLUT1 and 2 are solely expressed by asymmetric terminals of excitatory neurons 
(Gras et al., 2002; Herzog et al., 2006).  Based on the available evidence, it seems 
unlikely that astrocytes possess the necessary cellular machinery for Ca2+-
dependent exocytosis of vesicles on the time scale required for gliotransmission as it 
is currently defined (Fiacco et al., 2009).   
 The theory of vesicular release from astrocytes, in spite of the evidence 
against it, remains an integral part of astrocyte modulation of neuronal activity, 
regardless of the gliotransmitters studied or the brain region examined.  No matter 
the release mechanism involved, the primary unifying feature to nearly all studies 
describing neuromodulation by astrocytes in situ and in vivo is IP3R-mediated 
intracellular Ca2+ increases that are deemed necessary and sufficient to trigger the 
release of gliotransmitters (Parpura and Haydon, 2000).  Further, GPCR activation 
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of the PLC/IP3 pathway and Ca2+ release through IP3Rs is generally considered to 
be the responsible for intracellular Ca2+ elevations triggering the release of 
gliotransmitters.  
 
1.14. The Stirrings of Controversy 
 One persistent problem exists in the study of gliotransmission:  How does one 
selectively stimulate intracellular Ca2+ increases in astrocytes without causing direct 
stimulation of neurons?  Astrocytes express an extensive compliment of GPCRs, the 
vast majority of which are found also on neurons (Agulhon et al., 2008).  Therefore, 
application of Gq-GPCRs agonists to elicit astrocyte Ca2+ increases runs a high 
probability of causing direct changes to neuronal activity by activating the same 
GPCRs on neurons (Pasti et al., 1997; Lee et al., 2007; Shigetomi et al., 2008).  An 
example is the use of DHPG, a group 1 mGluR agonist that was used to show 
astrocyte derived effects on neurons (Angulo et al., 2004; Fellin et al., 2004).  Group 
1 mGluRs are also expressed by neurons, where they can cause increases in Ca2+ 
and activation of NMDA receptors, all things that have been attributed to 
gliotransmission (Mannaioni et al., 2001; Choe et al., 2006).  While this method of 
stimulation is still used for the study of gliotransmission, unless extensive controls 
are conducted it remains difficult to distinguish between direct neuronal effects and 
astrocyte-derived effects on synaptic activity. 
 Alternative methods for selectively activating astrocytes have been used by 
the field in recent years, each with their own technical caveats.  These include 
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mechanical stimulation of astrocytes, where a pipette is used to contact the surface 
of the astrocyte to elicit intracellular Ca2+ increases and gliotransmitters release 
(Kozlov et al., 2006; Hamilton et al., 2010).  However, mechanical stimulation can 
potentially be damaging to the cell membrane, and is certainly not physiological. 
 Intense depolarization of astrocytes through either patch clamp electrodes or 
application of high potassium solutions has been used to demonstrate intracellular 
Ca2+ increases in astrocytes and release of glutamate (Jourdain et al., 2007; 
Yaguchi and Nishizaki, 2010).  However, depolarization of astrocytes can interfere 
with the electrogenic drive of glutamate transporters, resulting in reduced clearance 
from the synaptic cleft and transmitter spillover to activate extrasynaptic receptors on 
neurons (Danbolt, 2001).  Further, high potassium solutions will result in 
depolarization of synaptic terminals to drive exocytosis from neurons. 
 The most commonly used methods of selectively increasing intracellular Ca2+ 
in astrocytes is the uncaging of either Ca2+ or IP3 in astrocytes.  Astrocytes can be 
patch loaded with a salt caged form of Ca2+ or IP3, which can be activated in 
response to UV laser light.  Numerous reports have used these methods to show 
that selective increases in astrocyte intracellular Ca2+ result in the release of 
gliotransmitters (Fellin et al., 2004; Fiacco and McCarthy, 2004; Perea and Araque, 
2007; Gordon et al., 2009).  While these methods do allow researchers to selectively 
increase Ca2+ in astrocytes, the Ca2+ increases that result from these techniques are 
spatially and temporally distinct from endogenous responses.   
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 Uncaging of Ca2+ increases intracellular Ca2+ beyond what is seen normally 
by Gq-GPCR activation, and it does not engage a number of second messenger 
systems activated by GPCRs.  For example, this method bypasses the activation of 
PLC, which produces not only IP3 but diacylglycerol (DAG).  Downstream effects of 
DAG include the activation of protein kinase C (PKC), which can modulate vesicular 
release (Lin et al., 2009; Kelm et al., 2010) and can modulate astrocyte intracellular 
Ca2+ increases (Parri and Crunelli, 2003).  IP3 uncaging activates the endogenous 
ER receptor, but produces supra-physiological levels of IP3 that modify the response 
of the IP3 receptor itself.  In saturating levels of IP3, the IP3R becomes less sensitive 
to inhibition by Ca2+, thereby increasing the open probability of the channel resulting 
in a prolonged Ca2+ increase (Foskett et al., 2007).  While these methods appear to 
be the best solution, uncaging of Ca2+ or IP3 results in a nonphysiological level of 
Ca2+ that may result in a nonphysiological release of gliotransmitters.  
 The methods for the blockade of intracellular Ca2+ increases in astrocytes are 
less problematic.  Inhibition of IP3R through selective antagonists such as herparin 
(Ehrlich et al., 1994) or xestospongins (Gafni et al., 1997) is possible, but for most 
studies into gliotransmission this is not ideal as these blockers will also inhibit 
neuronal IP3Rs and make data interpretation problematic.  The most commonly used 
method of blocking intracellular Ca2+ increases in astrocytes is through the use of 
Ca2+ chelators such as BAPTA.  The overwhelming majority of studies into the Ca2+-
dependent release of gliotransmitters involve the use of patch loaded or bulk loaded 
BAPTA to block intracellular Ca2+ increases in astrocytes.  While BAPTA chelation is 
an effective method, it may not block Ca2+ increases in fine processes of astrocytes 
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nor does it specifically address IP3R-mediated Ca2+ increases.  Further, it is likely 
that bulk loaded BAPTA affects neuronal as well as astrocytic Ca2+ fluxes. 
 Recently, two genetic models were developed to address these issues.  The 
first is the MrgA1 receptor mouse model published by Fiacco et al (2007).  This 
mouse model uses a inducible promoter to drive astrocytic expression of the orphan 
receptor MrgA1, normally found in a specific subset of sensory neurons in the spinal 
cord and whose endogenous agonist is unknown (Han et al., 2002).  MrgA1 is a Gq-
linked GPCR that responds to synthetic RF amide neuropeptides with increases in 
intracellular Ca2+ from internal IP3R-mediated stores (Dong et al., 2001).  This allows 
selective activation of astrocytic intracellular Ca2+ increases through bath application 
of a synthetic agonist without any direct effects on neuronal Gq-GPCRs. 
 In a seminal paper by Fiacco et al (2007), selective activation of astrocyte 
intracellular Ca2+ increases was found to be unable to produce changes in CA1 
pyramidal neuron excitatory synaptic activity.  Further, use of endogenous ligands to 
endothelin receptors, which are highly expressed by astrocytes in the brain (Schinelli 
et al., 2001; Ostrow and Sachs, 2005), was unable to affect neuronal NMDA 
mEPSCs.  However, uncaging of IP3 in MrgA1 astrocytes caused the release of 
glutamate from astrocytes to increase AMPA sEPSC frequency of CA1 pyramidal 
neurons (Fiacco et al., 2007).   This was a critical finding of the study as it showed 
that MrgA1+ astrocytes could be driven to release glutamate using non-physiological 
methods but that selective activation of both exogenous and endogenous Gq-
GPCRs do not trigger release.  These findings called into question the role of Gq-
GPCRs and IP3 receptors in the theory of gliotransmission. 
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 The second model is the IP3R2 knockout (KO) mouse model.  These mice 
were originally developed to study the role of IP3Rs in Ca2+ signaling of atrial 
myocytes (Li et al., 2005).  In astrocytes, immunohistochemical and gene profiling 
data suggested that IP3R type 2 (IP3R2) was the primary IP3R expressed by 
astrocytes (Sharp et al., 1999; Holtzclaw et al., 2002; Hertle and Yeckel, 2007; 
Cahoy et al., 2008).  Evidence for IP3R2 in astrocytes and its role in generating 
intracellular Ca2+ transients had only been shown in cultured astrocytes, and did not 
rule out functional expression of other IP3R isoforms (Sheppard et al., 1997; Weerth 
et al., 2007). 
 In Petravicz et al (2008), the first functional data in situ that Gq-GPCR 
activation of astrocytic intracellular Ca2+ increases is solely mediated by IP3R2 was 
presented.  Calcium imaging studies in mice lacking IP3R2 expression revealed that 
bath application of several Gq-GPCR agonists was completely incapable of eliciting 
a Ca2+ response in astrocytes.  Further, lack of IP3 receptor mediated Ca2+ increases 
in astrocytes did not affect basal excitatory synaptic activity, contrary to predictions 
made from computer models using experimental evidence of gliotransmission 
(Nadkarni and Jung, 2007).  The findings in this paper combined with the findings of 
Fiacco et al (2007), present a startling viewpoint that Gq-GPCR-mediated, IP3R-
dependent Ca2+ increases in astrocytes may not be involved in the release of 
gliotransmitters to modulate neuronal activity. 
 Recently, an additional paper from the McCarthy lab utilized both the MrgA1 
and IP3R2 KO mouse models to investigate the role of Gq-GPCR-mediated, IP3R-
dependent Ca2+ increase in astrocytes on the formation of hippocampal short- and 
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long-term potentiation (Agulhon et al., 2010).  No effect of either selectively 
activating (MrgA1) or selectively blocking (IP3R2 KO) was found on the formation of 
short- or long-term potentiation of CA3-CA1 synapses.  This directly contradicts 
reports that release of gliotransmitters from astrocytes modulates synaptic 
potentiation and the formation of LTP in the hippocampus (Pascual et al., 2005; 
Perea and Araque, 2007; Henneberger et al., 2010).   This series of papers from the 
McCarthy laboratory illustrate that there needs to be a critical reevaluation of the 
theory of gliotransmission.  A key area that needs reevaluation is the role of IP3Rs 
as a physiological Ca2+ source for Ca2+-dependent release from astrocytes.  In the 
next section, we will discuss IP3R in general and more specifically the findings 
concerning IP3R2 relevant to astrocytes. 
 
1.15. Inositol Trisphosphate Receptors: Structure and Function 
 Inositol 1,4,5-trisphosphate receptors (IP3Rs) are a major class of 
endoplasmic reticulum (ER) proteins responsible for the release of Ca2+ from internal 
ER-based stores in the majority of mammalian cell types.  There are three genes 
(itpr1, itpr2 and itpr3) that encode three IP3Rs (Ross et al., 1992).  Each of the IP3R 
genes displays multiple mRNA splice variants, with itpr1 being the most heavily 
spliced and iptr2 only having two known splice variants (Iwai et al., 2005; Foskett et 
al., 2007).  The IP3R protein is large, having a molecular mass of ~300kDa, and 
forms into a homo- or heterotetramer (Regan et al., 2005).  Given the diversity of 
splice variants and formation of heterotetramers, this can potentially result in a wide 
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array of channel compositions with differing biophysical, spatial and temporal 
properties. 
 The IP3R protein itself has four domains: an N-terminal IP3 binding region, a 
coupling domain, a transmembrane domain and a C-terminal tail.  The N-terminal IP3 
binding region is further broken down into a core and suppressor domain, both of 
which are required for IP3 to induce conformational changes needed for channel 
gating (Mignery and Sudhof, 1990; Yoshikawa et al., 1996).  Deletions in this region 
can either prevent channel gating, or interfere with binding of IP3 to the receptor.  
The coupling domain is around 1700 amino acids and contains a large number of 
sites for phosphorylation, regulatory protein interactions, and modulation by ATP and 
Ca2+ (Patterson et al., 2004).    The transmembrane domain contains the channel 
pore and activation gate that allows the flow of Ca2+ down its electrochemical 
gradient from the ER lumen to the cytoplasmic compartment (Taylor et al., 2004).  
Lastly, the C-terminal tail is functional site for modulation by several interacting 
proteins, primarily resulting in enhancement of IP3R binding affinity for IP3 (Patterson 
et al., 2004).  The C-terminal also interacts with the N-terminal ligand binding region 
as part of the activation of the IP3R (Nakade et al., 1991).  
 While the receptor is named after its IP3 agonist, the channels itself requires 
both IP3 and Ca2+ as co-agonists to fully activate (see review by Foskett et al., 
2007).  This dependence gives the receptor a dynamic range of activation, since 
channel gating depends on both the relative concentrations of IP3 and Ca2+ available 
at a given time point and the receptor’s sensitivity to these co-agonists.  This can be 
regulated by Ca2+ itself, as well as the vast array of interacting proteins and 
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phosphorylation states which affect the channel mean opening rate (Patterson et al., 
2004).  Due to the extensive regulatory domains it possesses, IP3Rs function as 
signal integrators that possess the ability be modified by signaling networks to 
produce spatially and temporally distinct Ca2+ events.  In addition, IP3Rs can also act 
as scaffolding proteins, binding to GPCR complexes at the plasma membrane to 
tether and coordinate the signaling complex to ER calcium release sites (Fagni et 
al., 2002; Weerth et al., 2007).   
  
1.16. Inositol Trisphosphate Receptors:  Expression in Neurons and 
Astrocytes 
 IP3Rs are expressed throughout all regions of the brain and spinal cord.  
Individual cell types in the CNS may express multiple IP3Rs, providing functional 
redundancy or dynamic Ca2+ signals in cell types expressing more than one IP3R 
subtype.  Immunocytochemical and mRNA in situ hybridization studies have 
reported that the majority of neurons in the brain express primarily IP3R1 and to 
varying degrees IP3R3 (Fujino et al., 1995; Sharp et al., 1999; Holtzclaw et al., 2002; 
Hertle and Yeckel, 2007). Functional evidence that neurons in the brain express 
IP3R1 comes from the generation of an IP3R1 knockout mouse model (Matsumoto et 
al., 1996).  This mouse is near embryonic lethal, with very few IP3R1 KO pups being 
born.  Pups that are born typically die by p14-p21 and suffer from seizures and 
ataxia.  Additionally, neuronal cultures made from IP3R1 KO pups show that these 
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neurons have severely impaired Ca2+ handling ability that contributes to the 
behavioral phenotype (Hayashi et al., 1999; Matsumoto and Kato, 2001).   
 In contrast to neurons, glial cells express primarily IP3R2 in the brain.  
Astrocytes solely express IP3R2 with no significant detection of IP3R1 or IP3R3 
expression in immunocytochemistry studies from brain sections (Sharp et al., 1999; 
Holtzclaw et al., 2002; Hertle and Yeckel, 2007).  This is supported by gene array 
data of acutely isolated astrocytes from the cortex of mice (Cahoy et al., 2008).   
Further support for expression of IP3R2 and its primary role in generating astrocyte 
Ca2+ signals comes from cultured astrocytes, where clusters of IP3R2 correspond to 
Ca2+ release sites (Sheppard et al., 1997) and that IP3R2 associates with other 
components of the Gq-GPCR-PLC pathway in membrane lipid rafts through its 
ability to bind to Homer (Weerth et al., 2007). 
 
1.17. Functional Aspects of IP3R2 and Their Role in Astrocyte Ca2+ Signaling 
 The isoforms of the IP3R display some similarities and differences in their 
functional activation and structural properties.  IP3R2 shares a 70% homology with 
IP3R1, and a higher degree of homology with IP3R3 (Bezprozvanny, 2005).  Among 
the IP3Rs, IP3R2 is the least understood isoform, relative to what is known for IP3R1 
and IP3R3.  However, there are several known properties of IP3R2 that may be 
important in their functional role as the primary Ca2+ release mechanism in 
astrocytes. 
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 Functional evidence indicates that the IP3R2 is involved in the generation of 
long lasting, regular Ca2+ increases, as determined by studies using a DT40 chick B 
cell line that has multiple IP3R deletions (Miyakawa et al., 1999).  This is attributed to 
the IP3R2 not exhibiting appreciable inhibition in the presence of high Ca2+ 
concentrations, possessing a mid-range affinity (in relation to other IP3Rs) for Ca2+, 
and the highest affinity for IP3 among IP3Rs (Ramos-Franco et al., 1998b; Ramos-
Franco et al., 1998a; Tu et al., 2005).  This combination of high IP3 affinity, mid-
range Ca2+ affinity and lack of significant inhibition in high Ca2+ concentrations would 
result in increased open probability and prolonged channel openings that could 
explain long time scale (tens of seconds) of astrocyte Ca2+ increases. 
 Activity-dependent and independent clustering of IP3R has been observed for 
IP3R2 (Iwai et al., 2005). Both activity-dependent and independent clustering is a 
function of IP3 or Ca2+ binding to IP3Rs, though there is disagreement over IP3 or 
Ca2+ being the key binding event.  Activity independent clustering of IP3R2 may be 
attributable to the receptors high IP3 affinity, thereby causing clustering at basal IP3 
levels.  This promotes stable IP3R2 cluster formation, which underlies elemental 
Ca2+ events such as Ca2+ puffs (Smith et al., 2009).  Finally, in addition to IP3R2 
there are two identified splice variants, designated TIPR and IP3R2 SIm2-.  TIPR is 
found only in heart and skeletal muscle (Futatsugi et al., 1998), while the IP3R2 
SIm2- splice variant shows a more ubiquitous expression pattern (Iwai et al., 2005).  
IP3R2 SIm2- produces a IP3R2 subunit that is incapable of binding IP3, displays no 
Ca2+ channel activity when expressed as a homotetramer, and interferes with 
activity-dependent clustering of IP3R2. Further, this splice variant significantly 
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reduces ATP-induced Ca2+ entry without effecting Ca2+ release in cells; however, the 
entry mechanism involved was not investigated.  This provides a possible functional 
role for IP3R2 SIm2-  in regulating store operated Ca2+ entry, which can affect the 
temporal dynamics of late phase Ca2+ signals (Golovina and Blaustein, 2000; Iwai et 
al., 2005). 
 Taken together, these biophysical properties fit well with the data concerning 
IP3R-mediated Ca2+ increases in astrocytes (Fiacco and McCarthy, 2006).  
Astrocytic IP3R2-mediated Ca2+ increases are typically longer lasting (on the time 
scale of seconds) and more resistant to desensitization than IP3R1 mediated 
neuronal responses, which reflects the different biophysical properties of IP3R2 
versus IP3R1 (Foskett et al., 2007).  The high affinity of IP3R2 may be involved in the 
frequency and rhythmic nature of IP3R-mediated spontaneous Ca2+ events found in 
several populations of astrocytes (Parri and Crunelli, 2001; Nett et al., 2002; Wang 
et al., 2006).   
 Calcium microdomains exist in astrocytes, where discrete sites of Ca2+ 
release can be detected in the absence of a global response (Fiacco and McCarthy, 
2006).  This was demonstrated to occur both in cultured and in situ astrocytes in 
response to Gq-GPCR agonist application and low-frequency electrical stimulation 
(Sharp et al., 1999; Matyash et al., 2001; Fiacco et al., 2007).  Calcium 
microdomains in astrocytes may represent activation of stable, local clusters of 
IP3R2 that are not of sufficient amplitude to propagate the Ca2+ signal past the 
diffusion barrier to reach the next cluster of IP3Rs.  This has been demonstrated to 
occur in neuronal dendrites, where localized Ca2+ signal can fail to propagate due to 
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the distance to the next IP3R cluster (Fitzpatrick et al., 2009).  Lastly, it is interesting 
to note that the IP3R2 SIm2- splice variant of IP3R2 comprises ~20% of the total 
IP3R2 mRNA in the brain (Iwai et al., 2005).  While the localization for the mRNA of 
this splice variant in the brain has not been addressed, it is not unreasonable to 
speculate that it is functionally expressed in astrocytes and may play role in 
regulation of IP3R-mediated Ca2+ increases. 
 
1.18. Goals of Dissertation 
  In summary, a primary functional role assigned to IP3R-mediated Ca2+ 
signaling in astrocytes is to trigger the release of gliotransmitters in response to 
neuronal activity.   The theory of gliotransmission, where modulation of synaptic 
activity (both excitatory and inhibitory) in a Ca2+-dependent manner from astrocytes 
is currently wholly reliant on the Gq-GPCR-PLC-IP3 pathway and functional 
activation of IP3Rs in astrocytes.  However, despite numerous lines of evidence that 
astrocytes modulate synaptic activity by releasing gliotransmitters in an IP3R-
mediated, Ca2+-dependent manner, the pathway has never been selectively blocked 
at the level of the IP3R.  The field has relied on the non-specific block of Ca2+ 
increases by Ca2+ chelators such as BAPTA, which blocks all Ca2+ sources in 
astrocytes.  Therefore, a fundamental knowledge gap exists concerning the specific 
role of astrocytic IP3R-mediated responses in gliotransmission and physiology.   
 To determine if astrocyte gliotransmitters release is dependent upon Ca2+ 
signaling through the Gq-GPCR-PLC-IP3R pathway, several novel genetic knockout 
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mouse models were used.  First, an IP3R2 full knockout (IP3R2 KO) mouse model 
was used to determine if genetic ablation of IP3R2 blocks astrocytic Ca2+ increases 
in response to Gq-GPCR stimulation and its affect on basal CA1 pyramidal neuron 
activity in the hippocampus.  Second, an IP3R2 conditional knockout (IP3R2 cKO) 
mouse model was generated to restrict the deletion of IP3R2 to the CNS.  The IP3R2 
cKO was used to expand on the studies in the IP3R2 KO model and for an analysis 
of the result of blocking IP3R2-mediated release in astrocytes on physiological 
behaviors.  The findings of these studies provide valuable insight into the role of 
astrocytic IP3R-mediated Ca2+ increases in gliotransmission and the regulation of 
physiological processes governing behavior.
  
Chapter II: Loss of IP3 receptor-dependent Ca2+ increases in 
hippocampal astrocytes does not affect baseline CA1 pyramidal 
neuron synaptic activity. 
 
Author’s note: This work has been previously published in the Journal of 
Neuroscience under the title: 
Loss of IP3 receptor-dependent Ca2+ increases in hippocampal astrocytes does not 
affect baseline CA1 pyramidal neuron synaptic activity. Petravicz, J., Fiacco, T. A., 
McCarthy, K. D. (2008), J Neurosci 28: 4967-4973 
 
2.1. INTRODUCTION 
Astrocytes have recently been reported to have a functional role in neuronal 
excitability (Araque et al., 1998a; Haydon and Carmignoto, 2006), heterosynaptic 
depression (Pascual et al., 2005; Serrano et al., 2006; Andersson et al., 2007b), 
cerebrovascular dynamics (Zonta et al., 2003; Straub and Nelson, 2007) and 
pathological states such as epilepsy (Kang et al., 2005; Tian et al., 2005; Fellin et 
al., 2006b).  One unifying feature of these findings is that astrocyte modulation of 
these processes occurs via a Ca2+-dependent release of “gliotransmitters” including 
 54 
 
ATP (which is converted to adenosine by ectonucleotidases) and glutamate 
(Montana et al., 2006).  Astrocytes primarily utilize spatially and temporally encoded 
increases in Ca2+ as an intracellular signaling mechanism (Cornell-Bell et al., 1990; 
Jensen and Chiu, 1990; Scemes and Giaume, 2006).  Astrocytes display Ca2+ 
increases both spontaneously (Parri et al., 2001; Nett et al., 2002; Hirase et al., 
2004) and in response to neuronal stimulation (Porter and McCarthy, 1996; Aguado 
et al., 2002; Perea and Araque, 2005a) and have been reported to modulate 
synaptic transmission through activation of both metabotropic (mGluR) and 
ionotropic glutamate receptors (iGluRs), and adenosine receptors (Haydon and 
Carmignoto, 2006). 
Calcium increases in astrocytes are predominantly elicited by Gq-linked 
GPCR activation, driving the production of IP3 and the activation of IP3Rs coupled to 
endoplasmic reticulum (ER) Ca2+ stores.  IP3Rs are a family of genes expressing 
three isoforms (Types 1-3) of an ER Ca2+ release channel that are found in nearly 
every cell type (Foskett et al., 2007).  Immunohistochemical studies aimed at 
identifying the expression profile of IP3Rs in the brain suggest that hippocampal 
astrocytes express primarily IP3R2.  Evidence for IP3R2 expression in neurons is 
inconclusive (Sharp et al., 1999; Holtzclaw et al., 2002; Hertle and Yeckel, 2007).  
These data point to IP3R2 as a potential key mediator of astrocyte intracellular Ca2+ 
release and Ca2+-dependent signaling cascades, but functional evidence for IP3R2 in 
astrocytes is limited and has not been demonstrated in situ (Sheppard et al., 1997; 
Weerth et al., 2007). 
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We used an IP3R2 KO mouse model to determine if IP3R2 has a functional 
role in Ca2+ increases of hippocampal astrocytes and neurons of the CA1 region.   
We present the novel finding that genetic deletion of IP3R2 results in complete loss 
of spontaneous and agonist evoked IP3R-dependent Ca2+ increases in astrocytes 
but leaves intact agonist evoked IP3R-dependent Ca2+ increases in CA1 pyramidal 
neurons.  These data indicate that IP3R2 is the primary functional IP3R in astrocytes, 
and that IP3R2 does not play a demonstrated role in CA1 pyramidal neurons.  We 
performed electrophysiological recordings of CA1 pyramidal neuron sEPSCs to 
determine the effect of eliminating astrocytic Ca2+ responses on basal neuronal 
excitatory synaptic activity.  No significant changes were found in any of the AMPA-
R and NMDAR sEPSC parameters of mice lacking astrocytic Ca2+ responses 
compared to littermate controls.   
Our results indicate that Gq-GPCR-mediated, IP3R-dependent Ca2+ 
responses in astrocytes are not modulating basal neuronal excitatory synaptic 
activity, contrary to the current state of the literature.  We also found no differences 
in activation of NMDARs by ambient glutamate, providing additional evidence that 
ambient glutamate of glial origin is not released in a Ca2+-dependent manner 
(Jabaudon et al., 1999; Cavelier and Attwell, 2005).   This study provides the first 
functional evidence that IP3R2 is the only IP3R isoform expressed by astrocytes; that 
IP3R2 is not required for neuronal Gq-GPCR-mediated Ca2+ elevations, and that 
removal of astrocyte Ca2+ increases has no effect on basal neuronal excitatory 
activity. 
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2.2. MATERIALS AND METHODS 
Generation of IP3R2 KO mice 
IP3R2 KO mice were generated as previously described (Li et al., 2005).  
Briefly, a 539-bp fragment of exon 3 of IP3R2 (116 bp) was inserted into a targeting 
vector between two loxP sites.  The targeting vector was injected into R1 embryonic 
stem (ES) cells, screened for homologous recombination and injected in C57Bl/6 
blastocystes to generate male chimeras.  Male chimeras were bred to Black Swiss 
females to generate mice heterozygous for the floxed allele (IP3R2+/flox).  IP3R2+/flox 
mice were crossed to Pro-Cre mice to obtain mice double heterozygous for the 
floxed IP3R2 and Pro-cre alleles.  Pro-Cre, IP3R2+/flox were crossed to generate 
germline heterozygous null mutant offspring (IP3R2+/-), which were interbred to 
generate homozygous full mutant mice (IP3R2-/-) and littermate controls (IP3R2+/+ and 
IP3R2+/-).  Mice were genotyped by PCR analysis using genomic DNA with IP3R2 WT 
and mutant allele specific primers as given in Li et al (2005).  
 
Hippocampal slice preparation 
All procedures followed the guidelines of the IACUC of UNC-Chapel Hill.  
Littermate control and IP3R2 knockout mice 10 to 16 days old (P10-16) were 
anesthetized by isoflurane inhalation.  The brains were rapidly removed after 
decapitation and submerged into 4oC slicing buffer containing the following in mM: 
125 NaCl, 10 glucose, 1.25 NaH2PO4, 26 NaCHO3, 2.5 KCl, 3.8 MgCl2 and 0.1 
kynurenic acid and bubbled with 95% O2 and 5% CO2.  Brains were cut sagittally at 
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a thickness of 300 µm on a Leica (Bannockburn, IL) vibratome.  During sectioning 
brains were kept submerged in 4oC oxygenated slicing buffer.  Hippocampi were 
dissected out of each brain slice and incubated 45 min in artificial cerebral spinal 
fluid (ACSF) warmed to 35-37oC and bubbled continuously with 95% O2 and 5% 
CO2.  The ACSF contained the following in mM: 125 NaCl, 10 glucose, 1.25 
NaH2PO4, 26 NaCHO3, 2.5 KCl, 2.5 CaCl2, and 1.3 MgCl2. 
 
Calcium imaging 
Astrocytes were bulk loaded with either the Ca2+ indicator Calcium Green-1 
AM or Fluo-4 AM as previously described (Nett et al., 2002).  Slices were incubated 
for 45 min at 35-37oC in oxygenated ACSF that included either 16 µM Fluo-4 AM or 
11µM Calcium Green 1-AM ester dye and 0.07% pluronic acid (final DMSO 
concentration, 0.4%).  For measuring neuronal Ca2+ increases, CA1 pyramidal 
neurons were patch-clamped with 200 µM Alexa 568 and 400 µM Fluo-4 calcium 
indicator dye made up in neuronal internal solution (see below).  The pipette was 
then removed and the neuron was allowed to recover for 10 min.  Regions of 
interested were placed over the cell bodies of astrocytes and over the cell body and 
primary dendrite of CA1 pyramidal neurons.  Increases in average fluorescence in 
regions of interest indicate increase in Ca2+ concentration. Fold increase over 
baseline was calculated for each trace and reported as ∆F/F0. 
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Neuronal patch clamp recordings   
For  AMPA-R sEPSC recordings, CA1 pyramidal neurons were patch 
clamped using pipettes (4.0-6.0 MΩ resistance)  and a gap free recording was 
performed for 10 min in ACSF as previously described (Fiacco and McCarthy, 2004).  
For NMDA sEPSCs, neurons were voltage-clamped at -70 mV and superfused with 
ACSF containing 5 µM Mg2+ and 10 µM CNQX to block AMPA responses.  For the 
ambient glutamate recordings, neurons were patch clamped at a holding potential of 
+40 mV in normal ACSF with an internal solution containing the following in mM: 100 
cesium methanesulfonate (CH3CsO3S), 10 TEACl, 4 NaCl, 1 MgCl2, 10 HEPES, 10 
BAPTA, 5 phosphocreatine, 2 ATP, 0.3 GTP, the pH was adjusted to 7.3 with CsOH.  
Ambient glutamate current was recorded in ACSF containing 1 µM TTX and 100 µM 
picrotoxin. 
 
Data Collection and Analysis 
Membrane currents were recorded using an Axopatch 200B amplifier (Axon 
Instruments).  Traces were analyzed for sEPSCs in Clampfit 10.2 software (Axon 
Instruments) using a template constructed from 4-6 sEPSCs intrinsic to each 
recording.  The event statistics were taken for each individual event and then 
averaged.  The averaged event statistics from each cell were then averaged 
together and reported as mean + SEM.  For tonic NMDA currents from ambient 
glutamate recordings, membrane currents were normalized to the amplitude of the 
currents blocked by a saturating concentration of D-AP5.  Statistical differences 
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between two samples were evaluated using Student’s t-test performed using Prism 4 
software (Graphpad, San Diego, CA).  
 
Histology 
Littermate control and IP3R2 KO brains were fixed with formalin and 
embedded sagittally in paraffin.  Brains were sectioned at 6 µm thickness with a 
Leica (Nussloch, Germany) microtome from p30 littermate controls and IP3R2 KOs.  
Sections were stained with hematoxylin and eosin and imaged using a Zeiss 
(Oberkochen, Germany) Axioscope light microscope. 
 
Reagents 
D-AP5, tetrodotoxin (TTX), CNQX, DHPG, histamine, carbachol, thapsigargin, 
DL-TBOA, and picrotoxin were obtained from Tocris Biosciences (UK).  Calcium 
Green-1 AM, Fluo-4, Fluo-4 AM and Alexa 568 were obtained from Invitrogen 
(Carlsbad, CA). 
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2.3. RESULTS 
Histological analysis of IP3R2 KO mouse brains 
It has been previously reported that mice homozygous for the IP3R2 KO allele 
are viable and fertile and that the mice display no overt behavioral abnormalities (Li 
et al., 2005).  We performed histological staining of paraffin embedded sections from 
adult IP3R2 KO mice to determine if there were any obvious abnormalities in brain 
cytoarchitecture indicative of improper proliferation or neurite outgrowth during 
development.  Hematoxylin and eosin staining of P30 littermate control (n = 3) and 
IP3R2 KO (n = 3) brains revealed that lack of IP3R2 does not significantly affect brain 
cytoarchitecture.  The hippocampus, cortex and cerebellum of IP3R2 KO mice were 
examined and did not show any obvious structural abnormalities (Figure 2.1).  These 
findings suggest that IP3R2-mediated release of Ca2+ is not critical to the overall 
development of the brain or that alternate IP3Rs may be expressed in glial cells 
during development. 
 
IP3R2 KO hippocampal astrocytes lack spontaneous and Gq-linked GPCR Ca2+ 
increases 
 Astrocytes are known to respond to a wide variety of Gq-GPCR agonists with 
Ca2+ elevations (Verkhratsky and Kettenmann, 1996).  To address the functional role 
of IP3R2 in hippocampal astrocytes, we performed Ca2+ imaging experiments on 
bulk loaded slices from littermate control and IP3R2 KO mice.  Bath application of a 
Gq-linked GPCR agonist cocktail (DHPG, histamine, carbachol; 10 µM each) to 
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hippocampal slices taken from littermate controls elicited robust increases in 
astrocyte intracellular Ca2+ (65% of 144 cells from 17 slices, 5 animals total; Figure 
2.2A,B). In striking contrast, the GPCR cocktail failed to elicit Ca2+ increases in 
IP3R2 KO hippocampal astrocytes (0% of 104 cells from 11 slices; 5 animals total; 
Figure 2.2A, B).  Similar results were obtained in experiments using 100 µM ATP, 
with 80% of 40 astrocytes from littermate controls (4 slices total from 1 animal) and 
0% of 38 astrocytes from IP3R2 KOs (3 slices total from 1 animal) responding with 
Ca2+ increases (Figure 2.2B). In experiments where thapsigargin (2 µM) was applied 
as a control for Ca2+ increases, both littermate control (45% of 40 cells, 4 slices total 
from 1 mouse) and IP3R2 KO (45% of 38 cells, 3 slices total from 1 mouse) 
astrocytes responded to thapsigargin with increases in intracellular Ca2+, indicating 
that the Ca2+ stores themselves were intact (Figure 2.2A, B). 
 Astrocytes have also been reported to exhibit spontaneous Ca2+ oscillations 
in the absence of neuronal activity (Nett et al., 2002).  To determine if IP3R2 is 
necessary for spontaneous Ca2+ oscillations, Ca2+ measurements were analyzed in 
astrocytes in the absence of agonist application.  In bulk loaded slices from 
littermate controls, spontaneous Ca2+ increases were observed in 21% of 144 total 
astrocytes (17 slices from 5 animals), but were absent in IP3R2 KO astrocytes (0% 
of 104 total cells, 11slices from 5 animals).  Taken together, these data indicate that 
astrocytes lacking IP3R2 are incapable of releasing Ca2+ from internal stores either 
spontaneously or in response to agonists for Gq-linked GPCRs.   
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 Neuronal Ca2+ increases are intact in IP3R2 KO CA1 pyramidal neurons 
 To address the question of a potential functional role of IP3R2 in hippocampal 
neurons, we conducted Ca2+ imaging experiments on CA1 pyramidal neurons 
loaded with Ca2+ indicator via a patch pipette.  Application of a Gq-linked GPCR 
agonist cocktail (in µM: 50 DHPG, 10 histamine, 10 carbachol) in 1 µM TTX to block 
action potentials elicited Ca2+ transients in IP3R2 KO neurons (Figure 2.3A, 6 cells 
from 6 slices, 5 animals total) not significantly different in amplitude (Figure 2.3B, 
left; p > 0.05) or duration (Figure 2.3B, right; p > 0.05) from those measured in 
littermate controls (8 cells from 8 slices, 5 animals total).  These results indicate that 
lack of IP3R2 does not significantly alter IP3R-dependent Ca2+ signaling in CA1 
pyramidal neurons. 
 
 Lack of spontaneous Ca2+ oscillations in astrocytes does not affect CA1 pyramidal 
neuron sEPSCs.   
 It has been reported that spontaneous and evoked astrocyte Ca2+ elevations 
lead to gliotransmitter release which modulates basal neuronal excitatory and 
inhibitory synaptic activity via the activation of neuronal mGluRs and iGluRs 
(Hassinger et al., 1995; Araque et al., 1998b; Kang et al., 1998; Parri et al., 2001; 
Fiacco and McCarthy, 2004; Liu et al., 2004b; Liu et al., 2004a).  The effect of 
blocking astrocyte Ca2+ elevations and therefore Ca2+-dependent gliotransmitter 
release on basal neuronal excitatory activity has not been thoroughly addressed.  
Therefore, we performed whole cell patch clamp experiments on CA1 pyramidal 
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neurons and found that basic neuronal properties such as resting membrane 
potential (Control: - 61.7 + 1.1 mV, IP3R2 KO: - 60.3 + 0.8 mV; p > 0.05), membrane 
resistance (Control: 274.5 + 26.2 MOhms, IP3R2 KO: 249.1 + 15.5 MOhms; p > 
0.05) and membrane capacitance (Control: 89.6 + 5.5 pF; IP3R2 KO: 96.4 + 4.8 pF; 
p > 0.05) were not significantly different between littermate control and IP3R2 KO 
neurons (Control: 21 cells from 20 slices, 10 animals total; IP3R2 KO: 22 cells from 
17 slices, 10 animals total).  In addition, there were no significant differences found 
between littermate control and IP3R2 KO AMPA-R sEPSCs peak amplitude (p = 
0.62), 10-90% rise time (p > 0.05), decay tau (p > 0.05), and event frequency (p > 
0.05) (Figure 2.4B.  Control: 15 cells from 14 slices, 9 animals total; IP3R2 KO: 16 
cells from 11 slices, 9 animals total).  Additionally, no significant differences were 
found in NMDAR-mediated sEPSCs in peak amplitude (p > 0.05), 10-90% rise time 
(p > 0.05), decay tau (p > 0.05), and event frequency (p > 0.05) (Figure 2.4D.  
Control: 15 cells from 13 slices, 6 animals total; IP3R2 KO: 9 cells from 8 slices, 3 
animals total).  Taken together, these results indicate that lack of IP3R-dependent 
Ca2+ increases in astrocytes has no significant effect on either spontaneous AMPA-
R or NMDAR-mediated excitatory synaptic currents in CA1 pyramidal neurons. 
 
 Ambient glutamate of astrocyte origin is not released in a Ca2+-dependent manner 
 Ambient glutamate levels in the hippocampus have been the focus of several 
recent studies (Herman and Jahr, 2007; Le Meur et al., 2007).  Findings in this area 
suggest that the majority of ambient glutamate present in the hippocampus is of glial 
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origin and might be released in a Ca2+-independent manner (Jabaudon et al., 1999; 
Cavelier and Attwell, 2005).  To address if ambient glutamate release occurs in an 
Ca2+-independent manner, whole cell currents were recorded from CA1 pyramidal 
neurons held at +40mV in ACSF containing 1 µM TTX and 100 µM picrotoxin to 
isolate NMDAR-mediated currents.  Similar to previous reports (Herman and Jahr, 
2007; Le Meur et al., 2007), application of the NMDAR antagonist D-APV (50 µM) 
revealed a tonic NMDAR current of 33.7 + 6.0 pA in littermate control neurons (6 
cells from 6 slices, 4 animals total; Figure 2.5A, B).  Recordings done in IP3R2 KO 
neurons found a D-APV-sensitive current that was not significantly different from that 
found in littermate control neurons (35.7 + 9.2 pA; p > 0.05; 5 cells from 5 slices, 3 
animals total; Figure 2.5A, B). 
 To determine if removal of astrocytic Ca2+ increases affects ambient 
glutamate accumulation during elevated extracellular glutamate, glutamate 
transporters were blocked using 100 µM TBOA.  Application of TBOA caused a 7.0 
+ 1.3 fold  change in the tonic NMDAR current of littermate control neurons (6 cells 
from 6 slices, 4 animals total) and a similar fold change in KO neurons of 8.6 + 1.1 (5 
cells from 5 slices, 3 animals total; p > 0.05; Figure 2.5C, D).  Overall, these data 
indicate that astrocyte Ca2+ elevations do not play a significant role in regulating the 
ambient extracellular concentration of glutamate.   
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2.4. DISCUSSION 
 Astrocytes display both spontaneous and evoked intracellular Ca2+ increases 
using a variety of stimulation protocols (Montana et al., 2006).  Astrocyte Ca2+ 
increases are due to the release of Ca2+ from internal stores upon activation of IP3Rs 
(Sheppard et al., 1997; Scemes, 2000).  In this communication, we show that 
genetic disruption of IP3R2 abolishes both spontaneous and Gq-linked GPCR 
agonist evoked IP3R-dependent Ca2+ increases in astrocytes.  To our knowledge, 
the findings presented here are the first demonstration that astrocyte Ca2+ release in 
situ is functionally reliant on IP3R2.  In contrast, IP3R-dependent Ca2+ increases in 
CA1 pyramidal neurons remains intact, indicating that IP3R2 is not necessary for 
neuronal IP3R-mediated Ca2+ increases, or that IP3R2 may not be expressed by CA1 
pyramidal neurons.  This is supported by immunostaining data showing that IP3R2 is 
not expressed in neurons (Sharp et al., 1999; Hertle and Yeckel, 2007).  It is 
somewhat surprising that in astrocytes, in which IP3R-dependent intracellular Ca2+ 
signals are thought to modulate an increasingly large number of key processes in 
brain (neuronal excitability, synaptic plasticity, and cerebrovascular control), that 
deletion of IP3R2 should result in the complete loss of Ca2+ activity without any 
apparent form of compensation.  It is even more surprising that these mice: i) are not 
embryonic lethal, ii) do not show early mortality, and iii) do not exhibit any obvious 
histological or behavioral phenotype.  They appear healthy, breed well and live 
normal lifespans. This is in stark contrast to the IP3R1 KO mouse model, which 
displays tonic-clonic seizures, ataxia and either die in utero or by weaning (P21) age  
(Matsumoto et al., 1996).  Further behavioral testing of the IP3R2 KO mouse model 
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will provide a valuable insight into the role of astrocyte Ca2+-dependent signaling in 
specific animal behaviors, such as learning and memory. 
 Astrocytes have been implicated as a major source of ambient glutamate in 
the hippocampus (Jabaudon et al., 1999; Cavelier and Attwell, 2005; Herman and 
Jahr, 2007; Le Meur et al., 2007).  In the present study, removal of astrocyte Ca2+ 
increases has no effect on the amplitude of the tonic NMDAR-mediated current 
activated by ambient glutamate.  Furthermore, use of TBOA to block glutamate 
transporters revealed that the extent to which ambient glutamate accumulates during 
transporter block is unaffected by removal of IP3R2 in astrocytes (Figure 2B).  These 
findings are in agreement with the hypothesis that ambient glutamate release from 
astrocytes occurs in a Ca2+-independent manner, possibly through non-vesicular 
release mechanisms such as connexin hemichannels, P2X channels or anion 
channels (Cavelier and Attwell, 2005; Malarkey and Parpura, 2008). 
 A substantial literature has developed in the field of astrocyte biology 
concerning the role of Ca2+-dependent release of gliotransmitters such as ATP 
(which is converted to adenosine by ectonucleotidases) and glutamate on neuronal 
activity (see reviews by Carmignoto and Fellin, 2006; Fellin et al., 2006c; see 
reviews by Fiacco and McCarthy, 2006).  These findings led to the development of 
the tripartite synapse model, in which astrocytes are active participants in synaptic 
transmission through IP3R-mediated, Ca2+-dependent gliotransmitter release 
(Araque et al., 1999).  While the majority of studies have focused on the outcome of 
pharmacologically evoking astrocyte Ca2+, very few studies have directly described 
the effect of blocking IP3R-dependent Ca2+ release on basal excitatory neuronal 
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activity.  Furthermore, it has been reported that spontaneous Ca2+ increases and 
subsequent glutamate release from astrocytes directly evokes NMDAR-mediated 
currents in neurons (Parri et al., 2001).  Additionally, astrocyte Ca2+ increases have 
been associated with neuronal Ca2+ increases mediated by iGluRs (Hassinger et al., 
1995; Pasti et al., 2001; Fellin et al., 2004).   
 A mathematical model incorporating data from numerous studies, including 
our own (Fiacco and McCarthy, 2004), on the role of astrocytes at the tripartite 
synapse predicts that astrocytes enhance synaptic release (Nadkarni and Jung, 
2007).  This is reflected by an increase in spontaneous postsynaptic events during 
and immediately following astrocyte Ca2+ elevations that trigger astrocytic release of 
glutamate compared to synapses lacking an associated astrocyte (Nadkarni and 
Jung, 2007).  According to this model, a lack of astrocyte Ca2+ increases would 
produce a reduced event frequency, reflecting reduced synaptic release.  It has also 
been reported that heterosynaptic depression due to Ca2+-dependent ATP release 
from astrocytes suppresses glutamate release at CA3-CA1 synapses (Pascual et al., 
2005).  Based on these findings, it is reasonable to speculate that abolishment of 
Ca2+ increases in IP3R2 KO astrocytes would lead to significant changes in basal 
excitatory neuronal activity and perhaps long term changes in brain activity and 
behavior.  In recordings of sEPSCs from IP3R2 KO and littermate control CA1 
pyramidal neurons, we found no significant differences in peak amplitude, 10-90% 
rise time and decay tau of both AMPA-R and NMDAR-mediated synaptic currents.  
Furthermore, we find no change in the frequency of AMPA-R and NMDAR-mediated 
sEPSCs suggesting that lack of Ca2+ increases and Ca2+-dependent gliotransmitter 
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release may not significantly affect baseline release probability from neuronal 
synaptic terminals.    
 The IP3R2 KO mouse model offers a compliment to another mouse model 
developed in our laboratory that enables selective stimulation of Gq-GPCR signaling 
cascades in astrocytes (Fiacco et al., 2007).  The findings presented here support 
our recent discovery using the MrgA1 transgenic mice that selective, widespread 
astrocyte Ca2+ elevations have no effect on baseline neuronal excitatory synaptic 
activity.  It has been reported previously by a number of labs (including our own) that 
mechanical stimulation or uncaging Ca2+ or IP3 in astrocytes leads to gliotransmitter 
release and changes in neuronal excitatory activity (Parpura and Haydon, 2000; 
Fiacco and McCarthy, 2004), neuronal inhibitory activity (Kang et al., 1998; Liu et al., 
2004b; Liu et al., 2004a) and cerebrovascular tone (Zonta et al., 2003; Straub et al., 
2006).  While use of these pharmacological tools may elicit such responses, they 
may represent a non-physiological level of stimulation that does not occur in vivo 
and therefore does not accurately recapitulate endogenous IP3 generating signaling 
pathways.  There may be important regulatory mechanisms activated in GPCR 
signaling that work downstream of Ca2+ to inhibit vesicular release of glutamate by 
astrocytes.  The IP3R2 KO and MrgA1 mouse models together fully corroborate the 
concept that stimulation of astrocytic Gq-GPCRs and spontaneous astrocyte Ca2+ 
activity are not sufficient to cause vesicular release of glutamate from astrocytes, 
and that astrocytic IP3R-mediated Ca2+ elevations are not necessary for normal 
neuronal excitatory synaptic activity in hippocampal CA1 pyramidal neurons. 
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 The IP3R2 mouse model also affords significant improvement over previously 
used techniques to examine the necessity of evoked IP3R-dependent Ca2+ increases 
to changes in neuronal synaptic activity.  Calcium chelators such as BAPTA or the 
bulk loadable BAPTA-AM have been used to block astrocyte Ca2+ increases.  There 
are technical issues with the use of BAPTA and Ca2+ chelators that are eliminated 
by the use of the IP3R2 KO mouse model.  In the IP3R2 KO, release of Ca2+ from 
astrocyte internal stores is removed specifically, without causing a global change in 
the resting cytoplasmic Ca2+ concentration or blocking Ca2+ increases from other 
cellular sources. 
 In conclusion, the IP3R2 KO mouse model represents a significant step 
forward in our ability to study the astrocyte Ca2+ contribution to key physiological 
processes.  Use of this model has the potential to clarify and further define the role 
of astrocytes in physiology and pathology without the use of pharmacological 
manipulations to block astrocyte Ca2+ increases.  This model can be used to identify 
Ca2+-dependent and Ca2+-independent mechanisms and their influence on 
astrocyte-neuronal communication, as well as re-evaluate the many important brain 
functions to which Ca2+-dependent gliotransmitter release has been reported to play 
a significant role.   
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2.5. FIGURES AND TABLES 
 
 
 
 
Figure 2.1 Histological analysis of IP3R2 KO brains reveals no obvious 
abnormalities.  Histological staining of brain sections taken from littermate control (n 
= 3) and IP3R2 KO mice (n = 3).  Six micron thick paraffin embedded sections were 
cut and stained with hematoxylin and eosin to visualize brain cytoarchitecture.  No 
difference in the gross overall morphology or in the general cell layering was 
apparent between the IP3R2 KO mice and littermate controls in any brain region; 
data from hippocampus, cortex and cerebellum are shown. 
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Figure 2.2 Knockout of IP3R2 abolishes astrocyte GPCR-mediated Ca2+ increases.  
A.  Representative Ca2+ traces from astrocytes of Calcium Green AM loaded 
hippocampal slices.  Regions of interest were placed over the cell bodies of bulk 
loaded hippocampal astrocytes to measure Ca2+ increases in response to agonist 
application (upper panels). Application of ATP (100 µM) or a Gq-linked GPCR 
agonist cocktail (Ct: 10 µM DHPG, 10 µM histamine and 10 µM carbachol) elicited 
Ca2+ responses in astrocytes from littermate control but not IP3R2 KO hippocampal 
slices.  The arrows indicate the astrocyte Ca2+ traces shown in the lower panels.. 
Thapsigargin (Tg, 2 µM) was used as a control and increased Ca2+ in astrocytes of 
both littermate control and IP3R2 Kos.  Data presented as fold increases over 
baseline.  B.  Percentage of astrocytes responding to application of ATP or the Gq-
linked GPCR agonist cocktail from all experiments.  
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Figure 2.3 Lack of IP3R2 does not affected neuronal Ca2+ signaling.  A.  
Representative Ca2+ traces from CA1 pyramidal neurons patch clamped with internal 
solution containing Fluo-4 Ca2+ indicator in response to application of a Gq-linked 
GPCR cocktail (50 µM DHPG, 10 µM histamine, 10 µM carbachol) in the presence 
of 1µM TTX to block action potentials.  B. Amplitude and duration of IP3R-mediated 
Ca2+ responses in CA1 pyramidal neurons (Control n = 8; IP3R2 KO n = 6).  There 
were no significant differences for amplitude (left panel; p > 0.05) or duration (right 
panel; p > 0.05)   Error bars indicate SEM. 
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Figure 2.4 Spontaneous EPSCs from CA1 pyramidal neurons are unchanged in 
IP3R2 KO mice.  A.  Representative AMPA-R sEPSC traces from littermate control 
(n = 15) and IP3R2 KO (n = 16) CA1 pyramidal neurons.  B.   AMPA-R sEPSC peak 
amplitude (p > 0.05), 10-90% rise times (p > 0.05), decay tau (p > 0.05), and event 
frequency (p > 0.05) were not significantly different between littermate control and 
IP3R2 KO CA1 pyramidal neurons as determined by Student’s t-test.  C.  
Representative NMDAR sEPSC traces from littermate control (n = 15) and IP3R2 KO 
(n = 9) CA1 pyramidal neurons.  D.  NMDAR sEPSC peak amplitude (p > 0.05), 10-
90% rise times (p > 0.05), decay tau (p > 0.05), and event frequency (p > 0.05) were 
not significantly different between littermate control and IP3R2 KO CA1 pyramidal 
neurons as determined by Student’s t-test.  Error bars indicate SEM. 
 74 
 
 
 
 
Figure 2.5.  Ambient glutamate is unaffected by the lack of Ca2+ increases in 
astrocytes.  A.  Bath application of 50 µM D-AP5 blocked a tonic NMDAR current in 
CA1 pyramidal neurons held at + 40mV in ACSF from both littermate control and 
IP3R2 Kos.  B.  The amplitude of the D-AP5 sensitive NMDAR current was not 
significantly different (p > 0.05) in IP3R2 KO neurons (n = 5) versus littermate 
controls (n = 6).  C.  Representative traces showing that bath application of 100 µM 
TBOA induced a large fold increase of the tonic current in CA1 pyramidal neurons 
held at + 40mV from both littermate control and IP3R2 KOs.  D.  The fold increase 
over baseline induced by TBOA is not significantly different (p > 0.05) between IP3R2 
(n = 5 cells) and littermate controls (n = 6 cells).  Error bars indicate SEM. 
  
 
Chapter III: Gq-GPCR-mediated, IP3R-dependent Ca2+ increases in 
astrocytes does not affect CA3 pyramidal neuron excitatory 
synaptic activity. 
  
3.1. INTRODUCTION 
The modulation of neuronal synaptic activity by astrocytes has become an 
increasingly investigated area of neurophysiology.  The hippocampus has been used 
as a model system for the investigation of astrocyte-derived neuromodulation, in 
particular at the Schaffer collateral – CA1 pyramidal neuron (SC-CA1) synapse 
(Fellin et al., 2004; Pascual et al., 2005; Fiacco et al., 2007; Perea and Araque, 
2007).  Numerous reports show that astrocytes can affect a wide range of synaptic 
activity of various scales, from synaptic currents at single synapses to the formation 
of long term potentiation (LTP) on a network-wide scale.  At the synaptic scale 
astrocytes enhance the efficacy of single synapses of CA1 pyramidal neurons in 
response to stimulation and modulate the function of inhibitory synapses by targeting 
both metabotropic (mGluR) and ionotropic (iGluRs) glutamate receptors (Kang et al., 
1998; Liu et al., 2004a; Perea and Araque, 2007).  On the network level astrocytes 
affect heterosynaptic depression through the release of ATP/adenosine and the
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formation of LTP through the release of D-serine (Pascual et al., 2005; Serrano et 
al., 2006; Henneberger et al., 2010). 
Astrocytes are theorized to modulate synaptic activity through the release of 
gliotransmitters including glutamate, ATP (which is broken down to adenosine) and 
D-serine.  These transmitters are released from astrocytes in a Ca2+-dependent 
manner in response to either electrical or pharmacological stimulation (Agulhon et 
al., 2008).    The primary mechanism for the elevation of intracellular Ca2+ levels in 
astrocytes is through the Gq-GPCR-PLC-IP3 pathway (Fiacco and McCarthy, 2006; 
Haydon and Carmignoto, 2006).  However, recent advances in genetic mouse 
models have provided evidence that the Gq-GPCR-PLC-IP3 pathway may not be 
involved in the release of gliotransmitters under physiological conditions (Fiacco et 
al., 2007; Petravicz et al., 2008; Agulhon et al., 2010).  Previous studies using 
selective activation the MrgA1 mouse model did not result in modulation of CA1 
pyramidal neuron synaptic activity or the formation of LTP (Fiacco et al., 2007; 
Agulhon et al., 2010).  We presented evidence in Chapter II that lack of IP3R-
mediated Ca2+ increases in the IP3R2 KO does not lead to changes in basal 
excitatory postsynaptic activity of CA1 pyramidal neurons as predicted by the 
gliotransmission literature (Petravicz et al., 2008).  Additionally, the IP3R2 cKO mice 
had no deficit in the induction of LTP (Agulhon et al., 2010).  These data call into 
question the functional relevance of IP3R- mediated Ca2+ increases in 
gliotransmission.   
 While the SC-CA1 synapse has been widely studied in regards to 
gliotransmission, the mossy fiber-CA3 pyramidal neuron (MF-CA3) synapse remains 
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a relatively unexplored.  The MF-CA3 synapse is marked by a low release 
probability due largely to the activity of adenosine A1 receptors (A1Rs) on voltage 
gated Ca2+ channels on the MF presynaptic terminals (Moore et al., 2003; Nicoll and 
Schmitz, 2005).  Mossy fiber terminals are also marked by high expression of 
metabotropic glutamate group II receptors (mGluR2 and 3) that serve as 
autoreceptors to diminish presynaptic release (Vogt and Nicoll, 1999). 
Postsynaptically, the MF-CA3 synapse contains high levels of iGluRs (primarily 
AMPA and KA receptors) that are responsible for the majority of excitatory post 
synaptic currents (McBain and Dingledine, 1992; Cossart et al., 2002).  It has been 
shown that a large percentage of MF-CA3 miniature excitatory post synaptic 
currents are AMPA/KAR-mediated (McBain and Dingledine, 1992).  Astrocytes 
release gliotransmitters (primarily glutamate and ATP/adenosine) capable of 
activating several of the receptor types involved in regulating MF-CA3 synaptic 
transmission, specifically quantal release measured by mEPSCs.  The MF-CA3 
synapse is a potential model for measuring gliotransmission, given the well 
documented regulation of MF-CA3 transmission by neurotransmitters thought to be 
released by astrocytes.  However, to date there are no direct investigations 
concerning the role of gliotransmission in activating pre- or postsynaptic receptors at 
the MF-CA3 synapse to modulate synaptic transmission. 
 In this chapter, we report that selective increase or blockade of astrocyte 
intracellular Ca2+ levels has no effect on CA3 pyramidal neuron mEPSC synaptic 
currents.  Activation of astrocytic Gq GCPRs, either with endogenous ligand or with 
the MrgA1 receptor ligand FMRF, resulted in Ca2+ increases in the majority of CA3 
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astrocytes.  However no effect was found on peak amplitude, decay tau, 10-90% 
rise time or frequency of CA3 pyramidal neuron mEPSCs in response to application 
of ligand shown to cause increases in astrocyte Ca2+.  Our results indicate that 
astrocyte IP3R-mediated, Ca2+-dependent release of gliotransmitters is not involved 
in the modulation of CA3 pyramidal neuron mEPSCs.   
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3.2. METHODS 
Generation of IP3R2 cKO Mice 
 Floxed IP3R2 mice were generated as previously described in Chapter 
2 and by Li et al (2005).  To generate IP3R2 conditional knockout (cKO) mice, 
IP3R2flox/flox mice were bred to mice expressing the Cre-recombinase protein under 
the control of a fragment of the glial fibrillary acidic protein (GFAP) promoter (Casper 
and McCarthy, 2006).   Mice double heterozygous for the floxed (IP3R2flox/flox) and 
Cre-recombinase alleles were interbred to IP3R2flox/flox mice to generate conditional 
knockout mice homozygous for the floxed IP3R2 allele and heterozygous for Cre-
recombinase (IP3R2 cKO).  Mice homozygous for IP3R2flox/flox but null for the Cre-
recombinase allele were designated as littermate controls (Control or WT).  Mice 
were genotyped by PCR analysis using genomic DNA and primers specific to Cre-
recombinase and the floxed IP3R2 allele. 
 
Histology 
 For cytoarchitectural analysis littermate control and IP3R2 cKO brains were 
fixed with formalin and embedded in paraffin.  Sections were prepared and then 
stained with hematoxylin and eosin to stain nuclei and cell bodies.  For the analysis 
of neuronal terminals in the CA3 region of the hippocampus, littermate control and 
IP3R2 cKO brains were fixed with sulfide perfusate and postfixed with 10% formalin 
and embedded sagitally in paraffin.  All brains were sectioned at 6-10 µM thickness 
with a Leica (Nussloch, Germany) microtome from p30 littermate controls and 
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sections were imaged using a Zeiss (Oberkochen, Germany) Axioscope light 
microscope. 
 
Dendritic Spine Density 
 Littermate control and IP3R2 cKO animals were stained using a Rapid 
GolgiStain Kit from FD Biosciences (Ijamsville, MD).  Briefly, brains were rapidly 
removed from deeply anesthetized mice, rinsed briefly in distilled water, and 
immersed in impregnation solution for one week at room temperature.  After 
incubation with cyroprotectant solution, coronal sections through the hippocampus 
(100-120 µM thick) were cut on a Leica VT1000S vibrating blade microtome, 
mounted on slides and sealed with Permount (Thermo Fisher Scientific) and imaged 
using a Zeiss (Oberkochen, Germany) Axioscope light microscope using a 40x lens 
and a Dage MTI XML Excel digital camera.    Spine numbers on primary and 
secondary dendrites in the stratum radiatum of CA3 pyramidal neurons were 
counted and spine density was calculated by dividing the number of spines by the 
dendritic length to determine spines per µm length. 
  
Preparation of Acute Hippocampal Slices 
 All procedures followed the guidelines of the IACUC of UNC-Chapel Hill.  
Littermate control and IP3R2 cKO mice 16 to 22 days old (P16-22) were 
anesthetized by isoflurane inhalation.  The brains were rapidly removed after 
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decapitation and submerged into 4oC slicing buffer containing the following in mM: 
130 NaCl, 10 glucose, 1.25 NaH2PO4, 24 NaCHO3, 3.5 KCl, 5 MgCl2, and 1 CaCl2 
and bubbled with 95% O2 and 5% CO2.  Brains were cut sagittally at a thickness of 
300 µm on a Vibratome (Bannockburn, IL) vibratory microtome.  During sectioning 
brains were kept submerged in 4oC oxygenated slicing buffer.  Hippocampi were 
dissected out of each brain slice and incubated 45 min in artificial cerebral spinal 
fluid (ACSF) warmed to 35-37oC and bubbled continuously with 95% O2 and 5% 
CO2.  The ACSF contained the following in mM: 130 NaCl, 10 glucose, 1.25 
NaH2PO4, 24 NaCHO3, 3.5 KCl, 2.5 CaCl2, and 1.5 MgCl2. 
 
Calcium Imaging 
 Hippocampal slices were prepared as described above except the brains 
were sectioned in a modified slicing buffer containing the following in mM: 130 NaCl, 
10 glucose, 1.25 NaH2PO4, 24 NaCHO3, 3.5 KCl, 5 MgCl2, and 1 CaCl2 and bubbled 
with 95% O2 and 5% CO2.  Hippocampal slices were incubated at 35-37oC for 20 
min in slicing buffer containing 1µM SR101 to preferentially load astrocytes 
(Nimmerjahn et al., 2004).  Hippocampal slices were then transferred for 10 min to 
warm (35-37oC) ACSF containing the following in mM: 130 NaCl, 10 glucose, 1.25 
NaH2PO4, 24 NaCHO3, 3.5 KCl, 2.5 MgCl2, and 1.5 CaCl2 and bubbled with 95% O2 
and 5% CO2.  Hippocampal slices were then removed from the incubator and kept at 
room temperature for the duration of the experiment.  The calcium indicator Oregon 
Green BAPTA-AM (OGB-1AM) was suspended in 100µl of a modified bolus loading 
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ACSF containing 20% pluronic acid (final DMSO concentration 0.4%).  The ACSF 
contained the following in mM: 150 NaCl, 2.5 KCl and 10 HEPES with the pH 
adjusted to 7.3-7.5 with 1M NaOH.   
 Hippocampal slices were placed in a perfusion chamber with a constant flow 
of oxygenated normal ACSF.  Pipettes (1-2MΩ resistance) filled with the OGB-1AM 
containing bolus loading ACSF were lowered to the surface of the slices and 
backpressure applied.  The pipette was then lowered 40 µm into the hippocampal 
striatum to the pyramidal cell layer of the CA3 region.  OGB-1AM was injected for 2-
3 minutes (based on the pipette resistance) and then lowered a further 35 µm 
deeper into the slice and injected for an additional 2-3 minutes.  The pipette was 
then removed and the slice transferred to room temperature (25oC) oxygenated 
ACSF and allowed to recover for a minimum of 45 min prior to imaging. 
 Astrocyte calcium increases were recorded using a two photon imaging 
system (Coherent Chameleon Ultra, Coherent Inc, Santa Clara, CA).  Astrocytes 
were identified by SR101 loading and regions of interest were drawn around the 
SR101 positive cell bodies.  Increases in average fluorescence in regions of interest 
indicate increase in Ca2+ concentration. Fold increase over baseline was calculated 
for each trace and reported as ∆F/F0. 
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Electrophysiology 
 For recording of AMPA/KA receptor mEPSCs, whole cell patch clamp of CA3 
pyramidal neurons was performed using pipettes (3.0-4.0MΩ resistance) filled with 
an internal solution containing in mM: 100 Cs-gluconate, 8 NaCl, 0.6 EGTA, 5 
MgCl2, 2 Na-ATP, 0.3 Na-GTP, 40 HEPES, 0.1 spermine, and 1 N-(2,6-
dimethylphenyl carbamoylmethyl)-triethylammonium bromide (QX-314), pH 7.2-7.3.  
Neurons were identified by their location and morphology and voltage clamped at a 
membrane potential of -60mV.  Neurons with an access resistance (Ra) of over 
40MΩ were used for mEPSCs recordings.  Any neurons that changed their Ra more 
than 20% over the course of the experiment were not included in the analysis.  
Neurons were recorded at room temperature (25oC) in ACSF containing 1µM TTX, 
10µM bicuculline and 50µM APV.    
 
Data Collection and Analysis 
 Membrane currents were recorded using an Axopatch 200B amplifier (Axon 
Instruments).  Traces were analyzed for EPSCs in Clampfit 10.2 software (Axon 
Instruments) using a template constructed from 4-6 mEPSCs intrinsic to each 
recording.  The event statistics were taken for each individual event and then 
averaged.  The averaged event statistics from each cell were then averaged 
together, normalized to the baseline and reported as mean + SEM.  For calcium 
imaging, data were collected and analyzed using Olympus Fluoview software 
(Olympus America Inc, Center Valley, PA).  Statistical analysis of 
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electrophysiological recordings was performed using Statview v5.0 software.  A 
repeated measure ANOVA was used to analyze the normalized whole cell mEPSC 
recordings.  Student’s t-test was used to analyze the basal mEPSC frequency and 
dendritic spine density. 
 
Reagents 
D-AP5, tetrodotoxin (TTX), CNQX, DHPG, histamine, carbachol, and 
spermine were obtained from Tocris Biosciences (UK).  Oregon Green BAPTA-AM 
was obtained from Invitrogen (Carlsbad, CA).  SR101, FMRF, QX-314, bicuculline, 
and other chemicals were purchased from Sigma-Aldrich Co (St. Louis, MO, USA). 
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3.3. RESULTS 
Histological analysis of IP3R2 cKO mouse brains. 
 It has been shown that IP3R based signaling in radial glial cells is important 
for the proliferation of neurons in the neocortex (Weissman et al., 2004).  
Additionally, the GFAP-Cre expresses in a developmentally timed manner that could 
have an effect on the proper formation of brain structures (Casper and McCarthy, 
2006).  We performed histological staining of paraffin embedded section from adult 
IP3R2 cKO and littermate control mice to determine if there were any obvious 
abnormalities in brain cytoarchitecture indicative of improper proliferation during 
development.  Hematoxylin and eosin staining of P30 littermate control (n = 4) and 
IP3R2 cKO (n = 4) brains revealed no significant abnormalities in cytoarchitecture 
(Figure 3.1, A-D).  This is in agreement with our previous study in the full IP3R2 KO, 
in which the lack of IP3R2 during development was shown to not affect gross brain 
cytoarchitecture (see Figure 2.1, Chapter II). 
 
Dendritic spine density of CA3 hippocampal pyramidal neurons 
Astrocytes extensively interact with dendritic spines in both organotypic 
hippocampal slice cultures and in vivo and can promote synaptogenesis 
(Christopherson et al., 2005; Haber et al., 2006).  Changes in dendritic spine density 
can also influence synaptic activity and signal integration in neurons (Tsay and 
Yuste, 2004).  We performed Golgi staining of littermate control and IP3R2 cKO 
brains to determine if there was a change in CA3 pyramidal neuron dendritic spine 
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density.  Spines from primary and secondary dendrites of CA3 pyramidal neurons 
were counted and the spine density per dendritic shaft length was determined.  
There was no significant difference found in the density of dendritic spines between 
IP3R2 cKO (0.37 + 0.02 spines per 1µm; n = 487 spines.  Figure 3.2) and littermate 
controls (0.32 + 0.01 spines per µm; n = 468 spines; p > 0.05.  Figure 3.2).  This 
provides anatomical data that is in agreement with our findings that lack of IP3R2-
mediated Ca2+ increases has not affected the properties of CA3 pyramidal neuron 
mEPSCs. 
 
IP3R2 cKO hippocampal astrocytes lack Gq-GPCR-mediated Ca2+ increases. 
 Astrocytes respond to a wide variety of Gq-GPCRs with Ca2+ increases , both 
through agonist application and in response to electrical stimulation (Porter and 
McCarthy, 1996; Verkhratsky and Kettenmann, 1996).  We previously reported that 
lack of IP3R2 in astrocytes completely abolishes both spontaneous and agonist 
evoked Ca2+ increases in hippocampal astrocytes ((Petravicz et al., 2008) Chapter 
II).  To examine the efficiency of the GFAP-Cre system in recombining the floxed 
IP3R2 allele, we performed Ca2+ imaging on bolus loaded hippocampal slices from 
littermate control and IP3R2 cKO mice.  Hippocampal slices were loaded with SR101 
to selectively label astrocytes (Nimmerjahn et al., 2004).  Calcium increases were 
recorded from SR101 positive astrocytes in the stratum radiatum of the CA3 region 
of the hippocampus.  Bath application of a Gq-GPCR agonist cocktail (DHPG, 
histamine, carbachol; 10 μM each) to hippocampal slices taken from littermate 
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controls elicited robust Ca2+ increases in the majority of SR101-positive astrocytes 
(92.8% of 69 cells from 10 slices, 5 animals total; Figure 3.3B, upper left traces).  
The majority of astrocytes also responded to bath application of agonists to Gq-
GPCR endothelin receptors 1 and 3 (ET1 and ET3, 10 nM each) with Ca2+ increases 
(85.7% of 42 cells from 6 slices, 4 animals total; Figure 3.3B, upper right traces). 
In contrast, bath application of the same Gq-GPCR agonist cocktail or 
ET1/ET3 to hippocampal slices from IP3R2 cKO mice was incapable of eliciting a 
Ca2+ response in SR101 positive astrocytes (0% of 40 cells, 6 slices from 4 animals 
for Gq-GPCR agonist cocktails; 0% of 39 cells, 6 slices from 4 animals for ET1/ET3 
agonist; Figure 3.3B, lower traces).  This is in agreement with studies in Chapter II 
using the full IP3R2 KO mouse model indicating that IP3R2 is a key element in the 
Gq-GPCR pathway in astrocytes.  Furthermore, these data indicate that GFAP-Cre 
is effective at recombining the floxed IP3R2 allele in the hippocampus. 
 
Lack of Gq-GPCR evoked IP3R2 mediated Ca2+ increases in astrocytes does not 
affect CA3 pyramidal neuron mEPSCs.  
It has been reported that Gq-GPCR evoked, IP3R2-mediated Ca2+ increases 
in astrocytes trigger the release of gliotransmitters to modulate both excitatory and 
inhibitory synaptic activity (Liu et al., 2004b; Jourdain et al., 2007).  We performed 
whole cell voltage clamp recordings of mEPSCs from CA3 pyramidal neurons to 
determine if lack of spontaneous IP3R2-mediated Ca2+ increases affected the basal 
frequency of mEPSCs and if application of endothelin receptor agonists  (ET1/3) 
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shown to increase astrocyte Ca2+ cytosolic levels triggers the release of 
gliotransmitters to modulate mEPSCs parameters.  CA3 pyramidal neurons were 
identified by their location and morphology.  Whole cell recordings of mEPSCs were 
done in the presence of the sodium channel blocker TTX (1µM), the GABAA 
receptor antagonist bicuculline (10 µM), and the NMDA receptor antagonist D-APV 
(50 µM) to isolate AMPA/KA mediated currents.   
Basal mEPSCs were recorded for 3 min prior to a 2 min application of ET1/3 
(20 nM), followed by a 9 min ACSF wash period and a 3 min application of CNQX 
(50 µM) to block the AMPA/KA mEPSCs.  No significant differences were found in 
the basal mEPSC frequency between CA3 pyramidal neurons from littermate 
controls and IP3R2 cKO (0.45 + 0.11 Hz for controls; 0.57 + 0.19 Hz for IP3R2 cKO; 
p > 0.05; Figure 3.4B insert).  Additionally, there was no effect upon application of 
Gq-GPCR agonists to endothelin receptors ETA and ETB either during the 2 min 
application or during the 9 min ACSF wash period in frequency (p >0.05), peak 
amplitude (p > 0.05), decay tau (p > 0.05) or 10-90% rise time (p > 0.05) of the 
mEPSCs during any of the condition analyzed (Figure 3.4B).  Application of CNQX 
blocked all occurrences of mEPSCs, confirming that the events recorded were 
mediated by activation of AMPA/KA receptors.  As a positive control, application of 
the A1R antagonist 8-Cyclopentyltheophylline (CPT, 1 µM) was used to detect 
changes to A1R mediated inhibition.  CPT induced a 286.5 + 46.2% (n = 3) increase 
in CA3 pyramidal neuron mEPSC frequency.  Taken together, these results indicate 
that lack of Gq-GPCR, IP3R2-mediated Ca2+ increases in astrocytes has no 
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significant effect on miniature excitatory post synaptic current of CA3 pyramidal 
neurons. 
Selective activation of astrocyte Ca2+ increases in the MrgA1 mouse model does not 
affect CA3 pyramidal neuron mEPSCs. 
To selectively activate Ca2+ increases in astrocytes of the CA3 pyramidal 
layer in the hippocampus, we used the MrgA1 mouse model.  The MrgA1 mouse 
model enables selective activation of Ca2+ increases in GFAP+-cells in situ in CA1 
astrocytes and SVZ GFAP+ cells (Fiacco et al., 2007; Platel et al., 2010).  Ca2+ 
imaging was performed on acute hippocampal slices from control and MrgA1+ mice 
to determine if CA3 astrocytes respond to bath application of the MrgA1+ synthetic 
agonist FMRF. Hippocampal slices were loaded with SR101 to identify astrocytes.  
Bath application of FMRF (15µM) elicited robust Ca2+ increases in MrgA1+ 
astrocytes (87.8% of 33 cells; 3 slices from 2 animals) but not in littermate controls 
(0% of 28 cells; 3 slices from 2 animals, Figure 2.5C).  Bath application of a Gq-
GPCR agonist cocktail (DHPG, histamine, carbachol; 10 μM each) elicited Ca2+ 
increase in both the MrgA1+ (87.8% of 33 cells; 3 slices from 2 animals) and 
littermate controls (78.5% of 28 cells; 3 slices from 2 animals, Figure 2.5C).  All 
SR101 positive astrocytes from MrgA1+ hippocampal slices that responded to FMRF 
responded to the agonist cocktail.  These results indicate FMRF application 
activates a similar percentage of MrgA1+ CA3 astrocytes as a cocktail of 
endogenous Gq-GPCR agonists.   
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Whole cell recordings of mEPSCs were done in the presence of the sodium 
channel blocker TTX (1µM), the GABAA receptor antagonist bicuculline (10 µM), and 
the NMDA receptor antagonist D-APV (50 µM) to isolate AMPA/KA mediated 
currents resulting from quantal release from both MF and A/C synapses.  Basal 
mEPSCs were recorded for 3 min prior to a 3 min application of FMRF (15 µM), 
followed by a 9 min ACSF wash period and a 3 min application of CNQX (50 µM) to 
block the AMPA/KA mEPSCs.  No significant differences were found in the 
frequency (p > 0.05), peak amplitude (p > 0.05), decay tau (p > 0.05) or 10-90% rise 
time (p > 0.05) of the mEPSCs during any of the conditions analyzed (Figure 3.6B). 
Taken together, these results indicate that selective activation of the MrgA1+ 
receptor to increase Ca2+ in hippocampal CA3 astrocytes does not trigger the 
release of gliotransmitters to modulate miniature excitatory post synaptic currents. 
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3.4. DISCUSSION 
 There is increasing evidence that astrocytes actively modulate neuronal 
synaptic activity; however the mechanisms and conditions are not clearly 
understood.  It has been established that astrocytes are capable of responding to 
neuronal activity with increases in intracellular Ca2+ through activation of Gq-GPCRs 
and downstream activation of PLC and IP3Rs (Fiacco and McCarthy, 2006).  This 
has led to numerous published studies and reviews arguing that Gq-GPCR-
mediated, IP3R-dependent increases in intracellular Ca2+ trigger the release of 
gliotransmitters from astrocytes (Volterra and Steinhauser, 2004; Zhang and 
Haydon, 2005; Halassa et al., 2009a; Hamilton and Attwell, 2010).  The SC-CA1 
synapse of the hippocampus has been widely used a model system for the study of 
gliotransmitter-dependent neuronal modulation.  In the hippocampus, astrocytes are 
capable of modulating SC-CA1 excitatory synaptic activity by the release of 
glutamate (Angulo et al., 2004; Fellin et al., 2004; Perea and Araque, 2007), 
ATP/adenosoine (Pascual et al., 2005; Serrano et al., 2006), and D-serine (Oliet and 
Mothet, 2009; Henneberger et al., 2010).  Further, modulation by gliotransmitters 
occurs from the single synapse level up to the network level (Pascual et al., 2005; 
Perea and Araque, 2007),.  Astrocytes have also been reported not only to modulate 
excitatory synaptic activity, but inhibitory activity as well through the Ca2+-dependent 
release of gliotransmitters (Kang et al., 1998; Liu et al., 2004a).  Reports of astrocyte 
derived modulation of neuronal activity vary between pre- or postsynaptic effects on 
neurons, with glutamate and ATP/adenosine positively or negatively regulating 
release probability and driving iGluR currents (Agulhon et al., 2008).   
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 The SC-CA1 synapse represents only one of the major synapses present in 
the hippocampus.  Equally critical is the synaptic connections between the mossy 
fiber axons of dentate gyrus granule cells and CA3 pyramidal neurons.  These 
specialized synapses are markedly different from SC-CA1 synapses in both 
structure and release probabilities (Carnevale et al., 1997; Nicoll and Schmitz, 2005; 
Lauri et al., 2007).  Release probability is low at MF-CA3 synpases, resulting in 
enhanced paired pulse facilitation and frequency facilitation not found at SC-CA1 
synapses (Salin et al., 1996).  This is due to tonic presynaptic inhibition by 
adenosine A1 receptors and to lesser degree group II metabotropic glutamate 
receptors (Vogt and Nicoll, 1999; Moore et al., 2003).  Under certain condition, 
astrocytes release glutamate and ATP/adenosine to target A1Rs and mGluRs on 
presynaptic terminals at SC-CA1 synapses (Fiacco and McCarthy, 2004; Pascual et 
al., 2005; Perea and Araque, 2007).  This provides a foundation for investigating if 
astrocytes are actively participating in the regulation of CA3 pyramidal neuron 
synaptic activity.  In the present study, we have employed two different genetic 
mouse models designed to evaluate the role of astrocytic IP3R-mediated Ca2+ 
increases.  We present the novel finding that astrocyte IP3R-mediated Ca2+ 
increases do not affect CA3 pyramidal neuron synaptic activity measured by 
mEPSCs. 
 Calcium increases in radial glia have are critical to neurogenesis during 
development (Weissman et al., 2004) and astrocytes can regulate the formation and 
maintenance of dendritic spines in the brain (Ullian et al., 2001; Christopherson et 
al., 2005).  Histological staining of IP3R2 cKO brains revealed no significant 
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differences in cytoarchitecture, which is in agreement with our previous findings in 
the full IP3R2 KO ((Petravicz et al., 2008), Chapter II).  Golgi staining of CA3 
pyramidal neurons revealed that spine density of primary and secondary dendrites is 
unaffected by lack of IP3R-mediated Ca2+ increases in astrocytes.  This novel finding 
indicates that astrocytes may not regulate spine formation or maintenance in an 
IP3R-mediated, Ca2+-dependent manner.  Further experiments are required fully 
investigate any changes that may not be reflected by dendritic spine density. 
 To determine the role of IP3R2 in Gq-GPCR mediated increases in Ca2+, 
IP3R2 cKO mice were evaluated using two-photon Ca2+ imaging.  Astrocytes from 
the CA3 region of IP3R2 cKO hippocampi were found to be incapable of responding 
to Gq-GPCR agonist application with intracellular Ca2+ increases.  This data is in 
agreement with our previous finding that IP3R2 is a critical component to the Gq-
GPCR-PLC-IP3 pathway thought to underlie gliotransmission (Chapter II, Petravicz 
et al., 2008).  Additionally, these data illustrate that GFAP-Cre is highly efficient at 
excising the floxed portion of the IP3R2 gene and present advancement in the IP3R2 
genetic mouse model by restricting the knockout to the central nervous system.  
 Activation of A1Rs by adenosine and group II mGluRs by glutamate regulate 
synaptic transmission at the MF-CA3 synapse (Vogt and Nicoll, 1999; Moore et al., 
2003) .  Electrophysiological recording of CA3 pyramidal neuron mEPSCs were 
conducted to evaluate how lack of IP3R-mediated Ca2+ responses may affect 
synaptic transmission. No change was found in mEPSC frequency between IP3R2 
cKO and littermate control, indicating that lack of spontaneous or Gq-GPCR evoked 
Ca2+ increase in astrocytes has not affected basal CA3 pyramidal neuron excitatory 
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activity.  Further, application of a Gq-GPCR agonist failed to elicit changes to any of 
the mEPSC parameters measured either during drug application of during the 
subsequent wash period.  Therefore, lack of IP3R2 Ca2+ increases in astrocytes in 
response to Gq-GPCR drug application does not affect CA3 pyramidal neuron 
excitatory synaptic activity measured by mEPSCs.   
 As a correlate to the IP3R2 cKO model, the MrgA1 mouse model was used in 
near identical experiments.  Calcium imaging of CA3 astrocytes showed that 
application of the synthetic MrgA1 ligand FMRF resulted in Ca2+ increases in the 
majority of astrocytes.  These data support the use of the MrgA1 mouse model for 
studies of astrocyte involvement in the modulation of CA3 pyramidal neuron synaptic 
activity.  Analysis of CA3 pyramidal neuron mEPSCs from IP3R2 cKO hippocampi 
revealed no significant changes in mEPSC parameters upon application of FMRF to 
stimulate MrgA1 receptors on CA3 astrocytes.  Taken together, the IP3R2 cKO and 
MrgA1 data indicate that astrocyte IP3R-mediated Ca2+ increases are not involved in 
the modulation of CA3 pyramidal neuron excitatory synaptic activity measured by 
mEPSCs.  Further experiments using these mouse models to explore potential 
changes to paired pulse ratio and frequency facilitation will be valuable to 
determining if astrocytes may be modulating more intensive modes of evoked 
release at mossy fiber-CA3 pyramidal neuron synapses. 
 A potential role for astrocytes at this synapse may be inferred from 
ultrastructural studies.  Rollenhagen et al (2007) recently showed that astrocyte 
processes ensheathe the majority of the surface area of the mossy fiber bouton and 
their postsynaptic targets, but that the astrocyte processes do not come in contact 
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with the majority of active zones.  Based on this structural arrangement, astrocytes 
may not be in a position to affect the majority of active zones made by the mossy 
fiber bouton by either the release of gliotransmitters or reuptake of neurotransmitters 
from the synaptic cleft.  However, as noted in Rollenhagen et al (2007), this 
structural arrangement may facilitate synaptic cross-talk between active zones in the 
mossy fiber bouton and contribute to their efficacy.  Studies involving changes to 
astrocyte process coverage of mossy fiber boutons may provide insight into 
modulation of CA3 pyramidal neuron synaptic activity.  There is also potential for this 
form of regulation to be involved the generation or modulation of pathological states 
of CA3 pyramidal neuron activity such as epilepsy. 
 The IP3R2 cKO mouse model presented in this chapter represents 
advancement over the model described in Petravicz et al (2008) and Chapter II.  The 
use of the GFAP-Cre recombinase limits the deletion of IP3R2 to the CNS, reducing 
peripheral effects.  This newer version of the IP3R2 KO mouse model is ideal for 
further studies; in particular behavioral experiments that will provide valuable insight 
in determining brain regions where astrocyte-neuronal communication may be 
playing a critical role.  In conclusion, presynaptic release at the MF-CA synapse is 
known to be heavily regulated by neurotransmitter release and cross-talk between 
active zones.  Astrocytes ensheathe the MF-CA synapse, however no evidence was 
found for Ca2+-dependent release of gliotransmitters to modulate synaptic 
transmission. 
 96 
 
3.5. Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 3.1 Histological analysis of IP3R2 cKO brains reveals no obvious 
abnormalities.  Histological staining of brain sections taken from littermate control (n 
= 4) and IP3R2 cKO mice (n = 4).  Six micron thick paraffin embedded sections were 
cut and stained with hematoxylin and eosin to visualize brain cytoarchitecture.  No 
difference in the gross overall morphology or in the general cell layering was 
apparent between the IP3R2 cKO mice and littermate controls in any brain region; 
data from hippocampus, cortex (A, C) and cerebellum (B, D) are shown. 
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Figure 3.2.  Dendritic spine density is not affected in the IP3R2 cKO.  Golgi staining 
of brains from littermate control (IP3R2 WT, n = 3) and IP3R2 cKO (n = 3) animals.  
Coronal sections 100-120 µm thick were cut from Golgi impregnated brains to 
examine hippocampal CA3 pyramidal neuron spine density.  A.  Primary and 
secondary dendrites from WT (28 dendrites from 15 neurons; 468 spines total) an 
IP3R2 cKO (28 dendrites from 15 neurons; 487 spines total) were imaged and the 
spine density calculated.  Representative dendrites are shown.  B.  There was no 
significant difference found in the spine density between WT and IP3R2 cKO (p > 
0.05). 
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 Figure 3.3.  Conditional knockout of IP3R2 abolishes Gq-GPCR elicited, IP3R-
mediated Ca2+ increases in CA3 astrocytes.  A.  Images of hippocampal slices from 
littermate control (IP3R2 WT) and IP3R2 cKO brains.  Slices were bulkloaded with 
SR101 (left panels) and pressure loaded with OGB-1AM (middle panels).  The right 
panel shows co-localization of the SR101 and OGB-1AM in astrocytes 
simultaneously imaged for both.  B.  Bath application of either a Gq-GPCR agonist 
cocktail (DHPG, histamine, carbachol; 10µM each, left traces) or agonist for the 
endothelin receptors (ET1/ET3; 10nM each, right traces) failed to elicit increases in 
astrocyte Ca2+ in IP3R2 cKO astrocytes (bottom traces).  Both the agonist cocktail 
A 
B C 
A 
B 
C 
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and ET1/ET3 elicited robust Ca2+ increases in IP3R2 WT astrocytes.  Three 
representative traces are shown for IP3R2 WT and IP3R2 cKO for each condition.   
C.  Table quantifying percentage of SR101 positive astrocytes that responded to 
application of agonist cocktail or ET1/ET3 from all experiments.
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Figure 3.4.  Lack of Gq-GPCR evoked IP3R-mediated Ca2+ increases in astrocytes 
does not affect mEPSC parameters.  A.  Representative traces of CA3 pyramidal 
neuron mEPSCs recorded from WT and IP3R2 cKO hippocampal slices.  CA3 
pyramidal neuron mEPSCs were recorded for 3 min, followed a 2 min bath 
application of ET1/ET3 (10 nM each); a 9 min ACSF wash period and ended with 3 
min of CNQX (50 µM) to block AMPA/KA receptors.  B.  Analysis of normalized data 
shows no significant changes in frequency, peak amplitude, decay tau or 10-90% 
rise time of CA3 pyramidal neuron mEPSCs during agonist application during the 
ACSF wash period.  There was no difference in basal CA3 pyramidal neuron 
mEPSC frequency (insert graph in B). 
A 
B 
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Figure 3.5.  FMRF selectively increases Ca2+ in CA3 astrocytes.  A.  Images of 
hippocampal slices from littermate control (WT) and MrgA1+ brains.  Slices were 
bulkloaded with SR101 (left panels) and pressure loaded with OGB-1AM (middle 
panels).  The right panel shows co-localization of the SR101 and OGB-1AM in 
astrocytes simultaneously imaged for both.  B.  Bath application of Gq-GPCR 
agonist cocktail (DHPG, histamine, carbachol; 10µM each, left traces) elicited robust 
Ca2+ increase in both WT and MrgA1+ astrocytes.  The MrgA1+ selective agonist 
FMRF (15 µM; right traces) increased Ca2+ in CA3 astrocytes from MrgA1+ 
A 
B 
C 
A 
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hippocampal slices (bottom right trace), but failed to elicit increases in WT astrocytes 
(top right trace).  Three representative traces are shown for IP3R2 WT and IP3R2 
cKO for each condition.  C.  Table quantifying percentage of SR101 positive 
astrocytes that responded to application of agonist cocktail or ET1/ET3 from all 
experiments. 
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Figure 3.6.  Selective Gq-GPCR-mediated Ca2+ increases in astrocytes does not 
affect mEPSC parameters.  A.  Representative traces of CA3 pyramidal neuron 
mEPSCs recorded from WT and MrgA1+ hippocampal slices.  CA3 pyramidal 
neuron mEPSCs were recorded for 3 min, followed a 3 min bath application of 
FMRF (15 µM each); a 9 min ACSF wash period and ended with 3 min of CNQX (50 
µM) to block AMPA/KA receptors.  B.  Analysis of normalized data shows no 
significant changes in frequency, peak amplitude, decay tau or 10-90% rise time of 
CA3 pyramidal neuron mEPSCs during agonist application or the ACSF wash 
period.  
A 
B 
  
Chapter IV: Astrocyte IP3R2-Mediated Ca2+ Increases and Behavior  
4.1. INTRODUCTION 
 In recent years, our understanding of the role of astrocytes in physiology has 
increased dramatically, with published reports supporting a role for astrocytes in 
control of vascular responses, modulation of neuronal activity and pathological 
responses (Haydon and Carmignoto, 2006; Halassa et al., 2007a; Iadecola and 
Nedergaard, 2007).  The primary mechanism by which astrocytes are thought to 
modulate neuronal activity is through the release of neuroactive substances (termed 
gliotransmitters) such as glutamate, ATP/adenosine, and D-serine (Hamilton and 
Attwell, 2010).  The release of gliotransmitters has been theorized to be triggered by 
the activation of Gq-GPCR receptors on astrocytes, which elicit IP3R-dependent 
Ca2+ increases from endoplasmic reticulum stores (Scemes, 2000; Fiacco and 
McCarthy, 2006).  Immunohistochemistry has shown that IP3R2 is the predominant 
IP3 receptor subtype expressed in astrocytes, whereas neurons express IP3R1 and 
to a lesser degree IP3R3 (Sharp et al., 1999; Holtzclaw et al., 2002; Hertle and 
Yeckel, 2007).   
 While there are numerous studies investigating the role of Ca2+-dependent 
release of gliotransmitters in cultured cells and in situ brain slices, there is little data 
demonstrating a role for Ca2+-dependent gliotransmitter release in vivo and its 
impact on behavior.  However, several studies have been published showing a 
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physiological role for other astrocyte proteins in behavior.  A conditional knockout of 
the gap junction protein connexin 43 (Cx43) in astrocytes causes enhanced 
locomotor activity in open field testing (Frisch et al., 2003; Theis et al., 2003).  A 
knock out mouse model of the glial protein S100β, a Ca2+ binding protein, leads to 
enhanced LTP in situ and enhanced performance in the Morris water maze, as well 
as changes to T-maze exploratory activity, in behavioral studies (Roder et al., 1996; 
Nishiyama et al., 2002).  Findings from these studies indicate that alterations in 
astrocyte function can lead to functionally significant behavioral changes.   
 We previously reported that in an IP3R2 full knockout mouse model, 
astrocytes are not capable of responding to Gq-GPCR stimulation with Ca2+ 
responses from internal endoplasmic reticulum stores (Chapter II, Petravicz et al., 
2008).  We reported similar results in an astrocyte specific conditional knockout 
mouse model of IP3R2 (Chapter III). To investigate the potential role of astrocyte 
IP3R2-mediated Ca2+ increases in vivo, we conducted behavioral testing on two 
different background strains of the IP3R2 cKO mouse model.  We present the novel 
findings that lack of IP3R2-mediated Ca2+ increases in astrocytes leads to behavioral 
alterations in the acoustic startle response and reversal of acquisition learning 
evaluated by the Morris water maze.  Furthermore, we present the novel finding that 
the alteration in acoustic startle response is dependent on the strain of the mice 
suggesting that genetic background may influence astrocyte involvement in this 
behavioral reflex. 
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4.2. METHODS 
Generation of IP3R2 cKO mice 
 For behavioral testing, two different mouse strains were used to compare 
possible effects of strain differences on the IP3R2 cKO.  The first strain of mice used 
was generated as described in Chapter III.  Briefly, IP3R2flox/flox mice on a Black 
Swiss background were crossed to C57BL/6 mice expressing Cre-recombinase 
under a fragment of the human GFAP promoter (Casper and McCarthy, 2006) to 
generate mice heterozygous for the floxed IP3R2 allele and Cre-recombinase.  
These mice were then interbred with Black Swiss mice homozygous for the floxed 
IP3R2 allele to generate mice heterozygous for Cre-recombinase and homozygous 
for the floxed IP3R2 allele. Mice from these breeding were designated as IP3R2 cKO 
Black Swiss. 
 The second background strain was generated by backcrossing mice from the 
original Black Swiss background to C57BL/6J mice (obtained from Jackson 
Laboratory) for four generations to generate mice heterozygous for the floxed IP3R2 
allele (IP3R2+/flox).  These mice were then backcrossed to GFAP-Cre recombinase 
mice on a C57BL/6J background to generate IP3R2+/flox mice with or without Cre-
recombinase.  These mice were then interbreed to generate mice homozygous for 
the floxed IP3R2 allele (IP3R2flox/flox) and either heterozygous or null for Cre-
recombinase.  Mice from these breeding were designated as IP3R2 cKO BL6 for 
purposes of differentiating them from the original strain.  Mice from both strains were 
genotyped by PCR analysis using genomic DNA and primers specific to Cre-
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recombinase and the floxed IP3R2 allele.  Regardless of background, mice 
homozygous for IP3R2 flox and heterozygous for Cre-recombinase are designated 
as IP3R2 cKO.  Mice homozygous for floxed (IP3R2flox/flox) but null for Cre-
recombinase are designated as WT or Control.   
 In all behavioral tests, unless otherwise noted, data presented is from cohorts 
composed of mice from the IP3R2 cKO BL6 background and littermate controls.  
Mice were housed five to a cage and were placed in the experiment room for 20 
minutes prior to testing for acclimatization of the mice to the testing environment. 
 
Calcium Imaging 
 Hippocampal slices were prepared as previously described except the brains 
were sectioned in a modified slicing buffer containing the following in mM: 130 NaCl, 
10 glucose, 1.25 NaH2PO4, 24 NaCHO3, 3.5 KCl, 5 MgCl2, and 1 CaCl2 and bubbled 
with 95% O2 and 5% CO2.  Hippocampal slices were incubated at 35-37oC for 20 
min in slicing buffer containing 1µM SR101 which preferentially loads astrocytes 
(Nimmerjahn et al., 2004).  Hippocampal slices were then transferred for 10 min to 
warm (35-37oC) ACSF containing the following in mM: 130 NaCl, 10 glucose, 1.25 
NaH2PO4, 24 NaCHO3, 3.5 KCl, 2.5 MgCl2, and 1.5 CaCl2 and bubbled with 95% O2 
and 5% CO2.  The calcium indicator Oregon Green BAPTA-AM (OGB-1AM) was 
suspended in 100µl ACSF containing 20% pluronic acid (final DMSO concentration 
0.04%).  The ACSF contained the following in mM: 150 NaCl, 2.5 KCl and 10 
HEPES with the pH adjusted to 7.3-7.5 with 1M NaOH.   
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 Hippocampal slices were placed in a perfusion chamber with a constant flow 
of oxygenated normal ACSF.  Pipettes (1-2MΩ resistance) filled with the OGB-1AM 
containing ACSF were lowered to the surface of the slices and backpressure 
applied.  The pipette was then lowered 40 µm into the hippocampal striatum to the 
pyramidal cell layer of the CA3 region.  OGB-1AM was injected for 2-3 minutes 
(based on the pipette resistance) and then lowered a further 35 µm deeper into the 
slice and injected for an additional 2-3 minutes.  The pipette was then removed and 
the slice transferred to room temperature (25oC) oxygenated ACSF and allowed to 
recover for a minimum of 45 min prior to imaging. 
 Astrocyte calcium increases were recorded using a two photon imaging 
system (Coherent Chameleon Ultra, Coherent Inc, Santa Clara, CA).  Astrocytes 
were identified by SR101 loading and regions of interest were drawn around the 
SR101 positive cell bodies.  Increases in average fluorescence in regions of interest 
indicate increase in Ca2+ concentration. Fold increase over baseline was calculated 
for each trace and reported as ∆F/F0. 
 
Behavioral Testing Cohorts 
 Behavioral testing cohorts consisted of age matched IP3R2 cKO Black Swiss 
or IP3R2 cKO BL6 mice with littermate controls.  IP3R2 Black Swiss mice were only 
evaluated for Rotatod, Open Field and Acoustic Startle behaviors due to retinal 
degeneration in the background strain. 
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Elevated plus-maze test for anxiety-like behaviors 
 Mice were given one 5-min trial on the elevated plus-maze.  The elevated 
plus-maze apparatus consisted of two open arms and two closed arms with 40 cm 
high walls.  The maze is elevated 50 cm from the floor and the arms are 21cm long.  
Mice were placed in the center area of the maze (9.5 cm x 9.5 cm), and allowed to 
freely explore the maze.  Measures were taken of time in, and number of entries 
into, the open and closed arms.  Percent open arm time was calculated as 100 x 
(open arm time/(open arm time + closed arm time)).  Percent open arm entries were 
calculated using the same formula, but using the measure for entries. 
 
Open Field Activity.  
Exploration in a novel environment was assessed by a one hour trial in an 
open field (40 cm x 40 cm x 30 cm) crossed by a grid of photobeams (VersaMax 
system, AccuScan Instruments). Counts were taken of the number of photobeams 
broken during the trial in five-minute intervals, with separate measures for horizontal 
activity (), fine movements (repeated breaking of the same set of photobeams), and 
vertical activity (rearing 11 movements). Time spent in the center region of the 
activity chamber was used as a measure of anxiety-like behavior in a novel 
environment. 
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Rotarod 
 Mice were assessed for balance and motor coordination on an accelerating 
rotarod (Ugo-Basile, Stoelting Co., Wood Dale, Il).  The revolutions per minute were 
initially set at 3 rpm, and progressively increased to 30 rpm over the course of a 5 
min trial session.  Each mouse was given 5 trials in total, 3 trials on the first day and 
2 trials forty-eight hours later.  Each trial was separated by 45 sec between trials.  
Latency to fall or rotate off the top of the turning barrel was measured by the rotarod 
timer.  If the mouse immediately fell off at the beginning of the first trial, that trial was 
not counted, and the mouse was given a new trial. 
 
Acoustic Startle Response 
 The acoustic startle measure was based on the reflexive whole body flinch 
following exposure to a sudden noise.  Animals were tested using the San Diego 
Instruments SR-Lab system using the procedure described by Paylor and Crawley 
(Paylor and Crawley, 1997).  Briefly, mice were placed in small Plexiglas cylinder 
within a large sound chamber (San Deigo Instruments).  The cylinder is place upon a 
piezoelectric transducer, which allowed the vibration to be detected and quantified 
by computer software.  The chamber includes a fan, a house light, and a 
loudspeaker for the acoustic stimuli consisting of bursts of white noise.  Background 
sound levels were maintained at 70 dB.   
 Each mouse was given one session consisting of 42 trials following a 5 min 
habituation period.  Seven different types of trials were presented: no-stimulus trials, 
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trials with the acoustic startle stimulus (40 ms, 120 dB) alone, and trials with a 
prepulse stimulus (20ms, either 74, 78, 82, 86, or 90 dB) delivered 100 ms before 
the onset of the startle stimulus.  The different trial types were presented in blocks of 
7, in randomized order within each block, with an average interval of 15 sec (range: 
10 to 20 sec).  Measures were taken of the startle amplitude for each trial, defined 
as the peak response during a 65-ms sampling window that began with the onset of 
the startle stimulus.  An overall analysis was performed for each subject’s data for 
levels of prepulse inhibition at each prepulse sound level (calculated as 100 – 
[(responses amplitude for prepulse and startle stimulus together/response amplitude 
for the startle stimulus alone) x 100].   
 
Morris Water Maze 
 Mice were assessed for spatial learning using the Morris water maze.  The 
water maze consisted of a large circular pool (diameter = 122 cm) partially filled with 
water (45 cm deep, 24-26oC) located in a room with numerous visual cues.  Mice 
were tracked by an automated system (Noldus Ehtovision 3.0) using a camera 
suspended above the water maze pool.    Mice were tested for their ability to find an 
escape platform (diameter = 12 cm) on three different components: visible platform 
acquisition, hidden (submerged) platform acquisition, and subsequent probe trial in 
the absence of the platform.  Following the hidden platform probe trial, the platform 
was moved to a new location and the mice were trained again to find the platform 
and given a subsequent probe trial to measure reversal learning.  In both hidden and 
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reversal learning, the criteria for learning was an average group latency of 15 sec or 
less to locate a platform across four consecutive trials per day. 
 In the visible platform test, each animal was given four trials per day for three 
days to swim to an escape platform indicated by a patterned cylinder extended 
above the surface of the water on the hidden platform.  For each trial the mouse was 
placed into the pool, at one of four possible locations determined randomly and 
given 60 sec to find the visible platform.  If the mouse found the platform, the trial 
ended and the mouse was allowed to remain on the platform for 10-15 secs prior to 
the start of the next trial.  If the mouse did not find the platform, the mouse was 
placed on the platform for 10-15 sec and then given the next trial.  Measures were 
taken of latency to find the platform, swimming distance, and swimming velocity by 
the Nodulus Ethovision tracking system. 
 Mice were then trained on the hidden platform test.  The same testing 
procedure as described above was used, with each animal receiving four trials per 
day.  At the end of the day when the average group latency reached 15 sec or less, 
mice were given a 1 min probe trial in the pool with the platform removed.  In this 
probe trial, selective quadrant search was evaluated by measuring percent of time 
spent in each quadrant of the pool.  Spatial learning was demonstrated by greater 
swim times in the quadrant where the platform had previously been present in 
comparison to other quadrants in the pool.  Following 1-2 days after the hidden 
probe trial, mice were tested for reversal learning using the same training paradigm 
except that the platform was located in the diagonal opposite quadrant from its 
previous location.  Measures were taken for latency to find the platform, swimming 
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distance and swimming velocity.  Upon reaching the 15 sec or less criterion the 
platform was removed from the pool and the group was given the probe trial to 
evaluate reversal learning. 
 
Tail Suspension Test 
 Mice were assessed for depressive behaviors by measuring time spent 
immobile using the tail suspension test.  Mice were suspended by the tail with tape 
for 5 minutes inside of a plastic, open faced box and their activity recorded.  The 
total duration of immobility (defined as no struggling movements) for each mouse 
was manually scored.  Percent time immobile was calculated by dividing the duration 
of immobility by the total duration of the trial.  Percent immobile time was averaged 
among cohorts and reported as average + SEM. 
 
Statistical analysis 
 For the open field activity, rotarod performance, acoustic startle response and 
Morris water maze tests, data was analyzed using a repeated measure ANOVA test.  
For the plus maze and the tail suspension tests, data was analyzed using Student’s 
t-test.   Significant differences of p < 0.05 were reported. 
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4.3. RESULTS 
IP3R2 cKO BL6 animals do not display anxiety-like behaviors in the elevated plus 
maze.    
 Littermate control and IP3R2 cKO BL6 mice were tested for changes in 
anxiety-like and exploratory behavior in the elevated plus maze.  Mice were placed 
in the center of the elevated plus maze and allowed to freely explore for 5 minutes.  
The number of entries and the time spent in the open and closed arms of the plus 
maze were recorded.  No significant difference was found between control and 
IP3R2 cKO BL6 animals for the percent of time spent in the open arms of the plus 
maze (Figure 4.1A).  Additionally, no significant difference was found for the percent 
of open arm entries between controls and IP3R2 cKO BL6 (Fig 4.1B).  These data 
indicate the lack of IP3R2-mediated Ca2+ increases in astrocytes does not affect 
anxiety and exploratory behavior measured by the elevated plus maze. 
 
IP3R2 cKO Black Swiss or BL6 animals do not display changes in spontaneous 
motor function as measured by open field activity. 
 Littermate control and IP3R2 cKO Black Swiss and BL6 mice were tested for 
spontaneous motor function and exploratory behavior in the open field activity test.  
Mice were placed into the activity box and allowed to freely explore for 60 minutes.  
Mice from both the IP3R2 Black Swiss and IP3R2 BL6 backgrounds were tested.  No 
significant difference was found in horizontal activity between control and IP3R2 cKO 
mice on either background, indicating that IP3R2 cKO mice are neither hyper- or 
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hypoactive and habituate normally to the open field environment (Figure 4.2A, B).  
Neither IP3R2 cKO Black Swiss nor IP3R2 cKO BL6 mice showed a significant 
difference in number of rearing movements compared to their littermate controls 
(Figure 4.2C, only IP3R2 cKO BL6 data shown).  Finally, there was no significant 
difference in the percentage of time spent in the center of the open field between 
IP3R2 cKO BL6 and littermate controls indicating no change in anxiety like behavior 
(Figure 4.2D).  Percent center time was not analyzed in the IP3R2 cKO Black Swiss 
mice due to potential complications from the degenerative blindness present in these 
mice.  Taken together, these data indicate that there are no changes to spontaneous 
locomotor activity or anxiety due to lack of astrocytic IP3R2-mediated Ca2+ signaling.  
Additionally, this lack of effect is not background strain-dependent. 
 
IP3R2 cKO Black Swiss or BL6 mice do not display changes in motor coordination or 
learning measured by rotarod performance. 
 Motor coordination and learning were tested by rotarod performance.  Mice 
were given 5 trials (3 trials on day 1, followed by 2 trials 48 hours later), with a 45 
second wait period between trials.  Latency to fall off or rotate around the cylinder 
was measured and compared between control and IP3R2 cKO mice.  Animals from 
both the IP3R2 cKO Black Swiss and IP3R2 cKO BL6 strains were tested.  No 
significant difference was found between control and IP3R2 cKO mice on either 
background in the latency to fall (Figure 4.3A, B).   Further, no significant difference 
was found in the motor learning aspect of rotarod performance over the course of 
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five trials.  These results indicate that lack of IP3R2-mediated Ca2+ increases in 
astrocytes has no effect on motor coordination or learning. 
 
IP3R2 cKO Black Swiss mice display a strain-dependent effect on acoustic startle 
response, with no changes in pre-pulse inhibition. 
 The acoustic startle response test is a measure of auditory processing and 
gating in mice (Li and Yue, 2002).  The pairing of this test with a varying decibel pre-
pulse tone prior to the acoustic startle tone provides a measure of sensory motor 
gating.  Additionally, the acoustic startle response can be used as a measure of fear 
conditioning and stress (Davis et al., 2003).  Mice were placed in a cylinder attached 
to a peizoelectric transducer to record the startle reflex upon administration of a 120 
dB tone.  Pre-pulses of varying decibel levels (4 – 20 dB above background of 70 
dB) were delivered 100 ms prior to the onset of the 120 dB tone to measure pre-
pulse inhibition.  IP3R2 cKO Black Swiss mice displayed a significantly exaggerated 
startle reflex to the 120 dB tone compared to controls (Figure 4.4A).  Delivery of pre-
pulses prior to the 120 dB startle attenuated the startle reflex; however the amplitude 
of the response remained significantly higher than controls at all pre-pulse decibel 
levels (Figure 4.4A).  Pre-pulse inhibition in the IP3R2 cKO Black Swiss mice 
remained unaffected, indicating that there was no deficit in pre-pulse inhibiton 
(Figure 4.4C). 
 Surprisingly, IP3R2 cKO BL6 mice do not exhibit an exaggerated acoustic 
startle response for either the 120 dB tone itself or the delivery of a pre-pulse prior to 
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the onset of the 120 dB tone (Figure 4.4B).  A significant interaction between 
acoustic startle and genotype was found (p < 0.05), however post-hoc analysis did 
not find any significant differences for the 120 dB tone or at any pre-pulse decibel 
level.  Furthermore, IP3R2 cKO BL6 mice did not display any significant difference in 
their pre-pulse inhibition (Figure 4.4D).  Taken together, these results indicate that 
lack of IP3R2-mediated Ca2+ increases in astrocytes has no effect on sensory motor 
gating measured by pre-pulse inhibition in either background strain.  In contrast, 
there is a strain-dependent effect of the knockout on the startle reflex measured by 
the acoustic startle response.  This may indicate a differential effect of the lack of 
astrocyte IP3R2-mediated Ca2+ signaling upon auditory threshold or processing.  
Testing of the acoustic brain stem responses will be conducted to evaluate changes 
to the IP3R2 Black Swiss auditory processing, using IP3R2 BL6 mice as a 
comparison. Conversely, it may indicate that IP3R2 cKO Black Swiss mice have 
elevated stress levels leading to exaggerated startle responses.  Further testing will 
be required to determine if elevated stress levels are a factor in this phenotype. 
 
IP3R2 cKO BL6 mice do not display depressive behaviors in the tail suspension test 
 Depressive behavior measured by the tail suspension test was compared 
between control and IP3R2 cKO BL6 mice.  Mice were suspended by the tail from 
the ceiling of an open front testing chamber and their activity digitally recorded.  Mice 
were then scored manually for time immobile, defined as no signs of struggling or 
movement.  Percent time immobile was subsequently calculated.  No significant 
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difference was found between IP3R2 cKO BL6 and control mice in percent time 
immobile (Figure 4.5).  These data indicates that lack of IP3R2 cKO BL6 in 
astrocytes does not affect depressive behaviors measured by tail suspension test. 
 
IP3R2 cKO BL6 mice do not display differences in visual, acquisition or reversal 
learning in the Morris water maze. 
 IP3R2 cKO BL6 mice were tested for changes in learning and memory using 
the Morris water maze. Mice were tested as described in the Methods section.  
Briefly, mice were given three days of training using a visually cued escape platform 
to determine if the mice were capable of swimming and able to visually detect cues 
used in the water maze.  No significant difference was found between IP3R2 cKO 
BL6 and control mice in the ability to detect and swim to the visually cued escape 
platform (Figure 4.6). 
 Acquisition training of the location of a hidden escape platform was then 
conducted.  The visual cue for the escape platform was removed and the platform 
moved to the opposite quadrant (from quadrant 3 to quadrant 1).  Additionally, the 
visual cues surrounding the water maze pool were changed to provide different 
spatial cues for acquisition learning.  Mice were then given 4 trials per day of 
acquisition training for the location of the hidden escape platform.  The average 
latency to find the hidden escape platform was calculated for the behavioral cohort.  
Mice were considered to have met the threshold for acquisition when the cohort 
(defined as control and IP3R2 cKO BL6 mice combined) latency reached 15 sec or 
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less.  No significant differences were found between IP3R2 cKO BL6 and control 
mice in their ability to acquire the location of the hidden escape platform (Figure 
4.7A.  Combined genotype threshold was met on day 6 for Group 1, and day 5 for 
Group 2). 
 Reversal learning involves the moving of the hidden escape platform to the 
opposite quadrant of the water maze pool (from quadrant 1 to quadrant 3).  Mice 
were again given 4 trials per day of training for the relocated hidden escape 
platform.  The average latency to find the relocated hidden escape platform was 
calculated for the behavioral cohort.  Mice were considered to have met the 
threshold for reversal learning when the cohort latency reached 15 sec or less.  No 
significant differences were found between IP3R2 cKO BL6 and control mice in 
reversal learning of the location of the moved hidden platform (Figure 4.7B.  
Combined genotype threshold was met on day 6 for Group 1, and day 5 for Group 
2). 
 
IP3R2 cKO BL6 mice display a target quadrant preference acquisition, but not 
reversal of acquisition in the Morris water maze. 
 Upon reaching the group threshold in the acquisition and reversal learning 
trials, the mice were given a one minute probe trial with platform removed to assess 
target quadrant preference.  Measures were taken of the percentage of time spent in 
each quadrant.  No significant differences were found between IP3R2 cKO BL6 and 
controls in the probe trial performed after acquisition learning (platform located in 
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quadrant 1; Figure 4.8A).  Within genotype repeated measures ANOVA showed 
significant preference for the quadrant where the hidden platform was located for 
both IP3R2 cKO BL6 and control, indicating a preference for the quadrant where the 
platform had been located (Figure 4.8A).  The probe trial performed after reversal of 
acquisition learning revealed a significant difference between IP3R2 cKO BL6 and 
controls (Figure 4.8B).  The within genotype repeated measures ANOVA revealed 
that while control mice displayed a significant preference for the new target quadrant 
(quadrant 3), IP3R2 cKO BL6 mice showed no preference for any quadrant (Figure 
4.8B).  Taken together, these data indicate that IP3R2 cKO BL6 mice do not have a 
deficit in acquisition of the location of the hidden platform, shown by their significant 
preference for the target quadrant in the acquisition probe trial.  However, IP3R2 
cKO BL6 mice display a deficit in reversal of acquisition learning compared to control 
mice, shown by their lack of significant preference for the new target quadrant.  This 
suggests that while their learning and memory is intact, the IP3R2 cKO BL6 mice 
may have a deficit in cognitive flexibility. 
 
Ca2+ Imaging of IP3R2 cKO mice  
 To provide functional evidence that IP3R2 cKO BL6 mice have reduced or 
abolished astrocyte Gq-GPCR-mediated Ca2+ increases, we performed Ca2+ 
imaging on hippocampal slices taken from sample mice from behavior experiments.  
Hippocampal slices were bulk loaded with SR101 and pressure loaded with OGB-
1AM calcium indicator dye as described in the previous chapter (see Chapter III 
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Methods).  Bath application of a Gq-GPCR agonist cocktail (10µM DHPG, histamine 
and carbachol) evoked robust Ca2+ increases in hippocampal astrocytes from 
littermate control mice (Figure 4.9; 71.4% of 28 cells, 5 slices from 3 animals).  In 
contrast, bath application of the Gq-GPCR cocktail failed to elicit Ca2+ increases in 
hippocampal astrocytes from IP3R2 cKO mice (Figure 4.9C; 8.6% of 23 cells , 4 
slices from 3 animals).  This data confirms the Ca2+ imaging data from Chapter II 
(Figure 2.2) and Chapter III (Figure 3.4) and shows IP3R2 cKO BL6 mice have a 
functional lack of astrocytic IP3R-mediated Ca2+ signaling in the hippocampus. 
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4.4. DISCUSSION 
 In the last 30 years, our understanding of astrocytes has progressed from the 
belief that astrocytes solely provide structural and metabolic support to the 
understanding that astrocytes play an active role in key physiological processes in 
the brain.  Astrocytes control cerebral vasculature (Iadecola and Nedergaard, 2007), 
participate in synaptogenesis (Ullian et al., 2004), and are critical to the regulation of 
neuronal function (Halassa et al., 2007a; Verkhratsky and Kirchhoff, 2007; Olsen 
and Sontheimer, 2008).  Astrocytes respond to neuronal activity through activation of 
Gq-GPCRs that stimulate IP3R2-mediated release of Ca2+ from internal stores both 
in situ and in vivo (Fiacco and McCarthy, 2006; Agulhon et al., 2008).  However, our 
understanding of the role of astrocytic IP3R2-mediated Ca2+ release in synaptic 
processes governing behavioral responses is very limited.   
 IP3Rs are the primary Ca2+ release mechanism from internal stores in most 
cell types (Foskett et al., 2007).  Deregulation of IP3Rs can lead to cell death and 
may be involved in pathological processes such as Alzheimer’s disease and 
epilepsy (Kuchibhotla et al., 2009; Seifert et al., 2009).  There are knockout mouse 
models for each IP3R subtype, with varying physiological effects.  The IP3R1 KO 
mouse model is embryonic lethal; the few mice that survive to birth have a life 
expectancy of 3-4 weeks and display seizures and ataxia (Matsumoto et al., 1996).  
In contrast, a double knockout of IP3R2 and IP3R3 does not exhibit a striking 
neurological phenotype similar to the IP3R1 KO mice but displays metabolic 
problems and deficits in olfaction (Futatsugi et al., 2005; Fukuda et al., 2008).   
Further, a recent study selectively knocking down IP3R1, IP3R2 and IP3R3 using 
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antisense oligonucleotides reported that all three knockdowns displayed 
antidepressant effects in the forced swim test, but no changes to rotarod or 
locomotor activity were found (Galeotti et al., 2008). 
 In this chapter we present novel findings on the role of astrocytic IP3R2-
mediated Ca2+ release in behavior.  We report that the majority of behavioral testing 
showed no changes between control and IP3R2 cKO animals.  No significant 
differences were found in the percent open arm time or percent open entries in the 
elevated plus maze, indicating that lack of IP3R2-mediated Ca2+ increases does not 
affect anxiety behaviors measured by this test.  This is supported by the finding that 
there was no significant difference between control and IP3R2 cKO in the percent 
center time measured by the open field activity task, another measure of anxiety.  
Spontaneous locomotor activity, as measured in the open field test, was also 
unaffected in IP3R2 cKO mice indicating that the mice are not hyper- or hypoactive 
and habituate normally.  These data contrast to other astrocyte specific genetic 
mouse models, such as the Cx43 knockout which displays enhanced locomotor 
activity and the NOS2 mutant that has changes in elevated plus maze activity 
(Frisch et al., 2003).  These mouse models indicate that alterations in astrocyte 
function can lead to changes in these behavioral paradigms.  Our findings suggest 
that IP3R2-mediated Ca2+ release in astrocytes are not playing a role in modulating 
these particular behaviors. 
 Motor performance and learning were also unaffected in the IP3R2 cKO 
mouse model as measured by accelerating rotarod testing.  The brain area most 
involved in rotarod motor performance is the cerebellum.  Cerebellar glial cells, 
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particularly Bergmann glia, respond to neuronal activity in vivo with Ca2+ increases 
(Nimmerjahn et al., 2009).  However, the majority of Bergmann glial Ca2+ transients 
are due to activation of Ca2+ permeable AMPARs, not IP3Rs (Bellamy, 2006). 
Further, it is unclear what role astrocytic IP3R-mediated Ca2+ release plays in the 
modulation of neuronal activity in the cerebellum.  The lack of a deficit in rotarod 
performance in IP3R2 cKO mice may indicate that IP3R2 is not a key player in the 
Ca2+-dependent regulation of motor performance by cerebellar astrocytes.  Calcium 
imaging experiments will be required to determine if Bergmann glia display any 
changes in Ca2+ signaling in IP3R2 cKO mice. 
 No significant difference was found in the percent immobility time in the tail 
suspension test in IP3R2 cKO mice.  This is somewhat surprising since another 
measure of depression, the forced swim test, was found to be significantly different 
in mice that were treated with an antisense phosphodiester nucleotide (dODNs) 
against the IP3R2 protein (Galeotti et al., 2008).  Further testing of the IP3R2 cKO 
mice in the forced swim test may reveal test specific alterations in depressive 
behaviors not revealed by the tail suspension test. It is interesting to note however 
that while doses of phosphodiester nucleotides (ODNs) were effective at reducing 
IP3R1 expression, the authors did not find any side effects known to occur in the 
IP3R1KO mouse model.  In contrast, equal concentration of ODNs for IP3R2 or 
IP3R3 caused convulsions and death in mice; problems associated with IP3R1 
deletion which may indicate some nonspecific effects of the dODNs (Matsumoto et 
al., 1996; Galeotti et al., 2008).   
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 IP3R2 cKO mice displayed a strain-dependent difference in their reaction to 
acoustic startle.  IP3R2 cKO mice on the original Black Swiss background strain 
displayed an exaggerated startle response to the 120 dB tone, even when the tone 
was preceded by a pre-pulse, whereas mice from the C57BL/6 backcrossed strain 
were unaffected.  Surprisingly, while the Black Swiss background strain displayed an 
exaggerated response at all pre-pulse decibel levels, the pre-pulse inhibition was not 
significantly different than controls.  This may indicate IP3R2-mediated Ca2+ release 
in astrocytes or GFAP-expressing cell are involved in modulating auditory 
processing, potentially a modification in auditory threshold, but not in sensory motor 
gating in certain mouse strains.  Another potential explanation is that acoustic startle 
can be affected by stress upon the subject (Davis et al., 2003).  Alternatively, the 
exaggerated startle response of IP3R2 cKO mice on the original Black Swiss 
background strain may reflect a chronic elevated level of stress that is not present in 
the IP3R2 cKO C57BL/6 backcrossed mice.  Further testing involving acoustic brain 
stem responses or stress responses may provide valuable insights into 
understanding this phenotype.  
 Perhaps the most surprising finding of these experiments is that IP3R2 cKO 
BL6 mice only display significant deficits in specific aspects of spatial learning 
measured by the Morris water maze.  The current literature concerning the role of 
IP3R-mediated Ca2+-dependent release of gliotransmitters argues that astrocytes are 
critical for the formation of LTP and heterosynaptic depression (Fellin and 
Carmignoto, 2004; Halassa et al., 2009a; Hamilton and Attwell, 2010).  Numerous 
reports show that blockade of Ca2+ increases in astrocytes leads to impairments in 
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or blockage of LTP (Yang et al., 2003; Serrano et al., 2006; Henneberger et al., 
2010), which has been argued to be the neuronal basis of learning and memory in 
the Morris water maze (Cole et al., 1998).  IP3R2 cKO BL6 mice showed no deficit 
over repeated trials in learning the location of a visually cued platform, a hidden 
escape platform during acquisition training or a relocated escape platform during 
reversal training.  Furthermore, IP3R2 cKO BL6 mice showed no significant 
difference in quadrant selectivity in a single trial probe test following acquisition 
training compared to controls.  However, IP3R2 cKO BL6 mice show a deficit in 
quadrant selectivity following reversal of acquisition learning.  This may indicate that 
IP3R2 cKO BL6 mice have less cognitive flexibility or impaired synaptic plasticity.  It 
should be noted that while many studies use Morris water maze as a measure of 
learning and memory, it does not directly relate to electrophysiological LTP (Cain, 
1997; D'Hooge and De Deyn, 2001).  Further, Morris water maze does not solely 
involve the hippocampus but also the striatum, basal forebrain, cerebral cortex and 
cerebellum. Further anatomical and electrophysiological studies involving plasticity 
in those brain regions may yield insight into this phenotype. 
 Learning and memory in the Morris water maze may be related to changes in 
protein synthesis and the formation of new neuronal connections (Thomas et al., 
1994; Meiri and Rosenblum, 1998).  Astrocytes are known to be a major source of 
brain-derived neurotrophic factor (BDNF) in the adult brain (Friedman et al., 1998).  
BDNF is involved in synapse maturation in the CNS and is critical for activity-
dependent plasticity (Cohen-Cory et al., 2010).  Cultured astrocytes are known to 
produce BDNF in response to Gq-GPCR activated, IP3R-mediated Ca2+ increases, 
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potentially providing an activity dependent pathway to increase in BDNF (Jean et al., 
2008).  Thus, blockade of IP3R-mediated Ca2+ increases in astrocytes may lead to 
reduced levels of BDNF in response to neuronal activity and may affect either the 
formation or stability of new synaptic contacts in the brain, leading to a deficit in 
reversal acquisition in the Morris water maze.   
  Overall, we have shown that lack of IP3R2-mediated Ca2+ increases in 
astrocytes leads to distinct behavioral changes in the Morris water maze and a 
strain-dependent change in acoustic startle response.  Elevated plus maze, rotarod 
performance and open field activity were unaffected in this animal model.  These 
results provide a significant advancement in our understanding of the role of IP3R-
mediated Ca2+ increases in astrocytes and their role in physiological behaviors in 
vivo.  Further studies using different behavioral paradigms such as Barnes maze, a 
less stressful behavioral test for learning and memory, are currently being conducted 
to further characterize the IP3R2 cKO mouse model to elucidate unknown roles of 
astrocytes in regulating behavior. 
 In conclusion, it is extremely striking that given the multiple proposed roles of 
astrocyte Ca2+-dependent release in the modulation of synaptic transmission that the 
IP3R2 cKO mice are relatively normal.  A large number of high profile papers and 
reviews have been published concerning the critical role of astrocytes in vascular 
tone  (Zonta et al., 2003; Mulligan and MacVicar, 2004; Takano et al., 2006), 
neuronal migration (Platel et al., 2010), synaptogenesis (Nagler et al., 2001; 
Christopherson et al., 2005), and synaptic transmission (Fellin et al., 2004; Serrano 
et al., 2006; Jourdain et al., 2007; Perea and Araque, 2007; Gordon et al., 2009).  
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Our findings in this chapter are reflective of the argument that the majority of 
evidence for IP3R-mediated, Ca2+ dependent release of gliotransmitters is either the 
result of pharmacological or non-physiological stimulation and does not reflect the 
physiological role of astrocytes in the CNS. 
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4.5. Figures and Tables 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.  Loss of IP3R2-mediated Ca2+ increases in astrocytes does not affect 
anxiety measured by the elevated plus maze.  Littermate control and IP3R2 cKO BL6 
mice were evaluated for changes in anxiety-like behavior using the elevated plus 
maze test.  A.  There were no significant differences between littermate control and 
IP3R2 cKO BL6 mice for percent time spent in open arms (Control, n = 26; IP3R2 
cKO, n = 25; p > 0.05).  B. There were no significant differences between littermate 
control and IP3R2 cKO BL6 mice for percent entries into open arms (Control, n = 26; 
IP3R2 cKO, n = 25; p > 0.05).  Data are presented as mean + SEM.  
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Figure 4.2.  Blockade of IP3R2-mediated Ca2+ increases does not affect 
spontaneous motor function or anxiety measured by open field activity.  Mice were 
tested in an open field activity box to monitor changes in spontaneous activity.  A, B.  
No significant differences were found in horizontal activity between littermate control 
and IP3R2 cKO animals from either background strain (A.  IP3R2 Black Swiss: 
Control, n = 22; IP3R2 cKO, n = 24; p > 0.05 and B.  IP3R2 BL6: Control, n = 26; 
IP3R2 cKO, n = 26; p > 0.05).  C.  No significant difference were found in rearing 
movements in IP3R2 cKO BL6 mice (Control, n = 26; IP3R2 cKO, n = 26; p > 0.05).  
D. Percent center time was not significantly different between IP3R2 cKO BL6 and 
littermate controls (Control,  n = 26; IP3R2 cKO, n = 26; p > 0.05). Data are 
presented as mean + SEM.  
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Figure 4.3.  Lack of IP3R2-mediated Ca2+ increases does not affect rotarod 
performance.  No significant difference was found in the rotarod performance 
between littermate controls and IP3R2 cKO mice on either background.  A. IP3R2 
cKO Black Swiss mice (Control, n = 22; IP3R2 cKO, n = 24; p > 0.05).  B.  IP3R2 
cKO BL6 mice (Control, n = 26; IP3R2 cKO, n = 26; p > 0.05). X-axis indicates trial 
number.  Data are presented as mean + SEM.  
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Figure 4.4.  Lack of IP3R2-mediated Ca2+ increases has a strain-dependent effect 
on the acoustic startle response.  Both strains of mice were tested for sensory motor 
gating in the acoustic startle response test.  A.  IP3R2 cKO Black Swiss mice display 
an exaggerated startle response during testing compared to littermate controls 
(Control, n = 14; IP3R2 cKO, n = 18; main genotype effect: p < 0.01).  B.  IP3R2 cKO 
BL6 mice displayed no significant difference compared to littermate controls in the 
acoustic startle response test (Control, n = 25; IP3R2 cKO, n = 26; p > 0.05).  C. No 
significant difference was found for pre-pulse inhibition in the IP3R2 cKO Black 
Swiss background strain (Control, n = 14; IP3R2 cKO, n = 18; p > 0.05) or D. IP3R2 
cKO BL6: Control, n = 25; IP3R2 cKO, n = 26; p > 0.05).  Data are presented as 
mean + SEM. ** p < 0.01; * p < 0.05.  
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Figure 4.5.  Blockade of IP3R2-mediated Ca2+ increases does not affect depressive 
behaviors measured by tail suspension test.  No significant difference was found in 
the percent immobile time upon tail suspension between control and IP3R2 cKO BL6 
mice (Control, n = 15; IP3R2 cKO, n = 14; p > 0.05).  
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Figure 4.6.  Lack of IP3R2-mediated Ca2+ increases does not affect the latency to 
find a cued visible platform in the Morris water maze.  No significant differences 
were found between littermate control and IP3R2 cKO BL6 mice on the visible 
platform training.  Control, n = 26; IP3R2 cKO, n = 26; p > 0.05.  Data is presented 
as mean (+ SEM) of four trials per day.  
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Figure 4.7.  Loss of IP3R2-mediated Ca2+ increases does not affect acquisition or 
reversal of acquisition learning in the Morris water maze.  A. No significant 
difference was found between littermate control and IP3R2 cKO BL6 acquisition 
learning of the location of a hidden platform (Left panel: Group 1, p > 0.05; Right 
panel: Group 2, p > 0.05). B.  No significant difference was found between littermate 
control and IP3R2 cKO BL6 mice in the reversal of acquisition learning of the 
relocated hidden platform (repeated measures ANOVA: Left panel: Group 1, p > 
0.05; Right panel: Group 2, p > 0.05).  In both acquisition and reversal of acquisition, 
experimental groups differed in the length of time to reach threshold therefore the 
data was not combined.  (Group 1: Control, n = 16; IP3R2 cKO, n = 16 and Group 2: 
Control, n = 10; IP3R2 cKO, n = 9).  
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Figure 4.8.  IP3R2cKO BL6 mice display selective target quadrant preference during 
acquisition but not reversal of aquisition in the Morris water maze.  Mice were given 
a one minute probe trial with the hidden platform removed.  The target quadrant is 
indicated by the black bar.  A.  Both littermate controls and IP3R2 cKO BL6 mice 
spent significantly more time in the target quadrant following acquisition (Control: n = 
26, p < 0.001; IP3R2 cKO: n = 26, p < 0.001).  B.  Littermate control mice exhibit a 
significant preference for the target quadrant while IP3R2 cKO BL6 mice do not 
display a preference (Control: n = 25, p < 0.01; IP3R2 cKO: n = 25, p > 0.05).  Data 
is presented as mean + SEM.  p-values represent within-group ANOVA for 
significant main effect of target quadrant.  
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Figure 4.9.  IP3R2 cKO BL6 astrocytes do not display Gq-GPCR, IP3R-mediated 
Ca2+ increases.  A.  Images of hippocampal slices from littermate control (IP3R2 WT) 
and IP3R2 cKO BL6 brains.  Slices were bulkloaded with SR101 (left panels) and 
pressure loaded with OGB-1AM (middle panels).  The right panel shows co-
localization of the SR101 and OGB-1AM in astrocytes simultaneously imaged for 
both.  B.  Bath application of a Gq-GPCR agonist cocktail (DHPG, histamine, 
carbachol; 10µM each) failed to elicit increases in astrocyte Ca2+ in IP3R2 cKO 
astrocytes (right traces).  The agonist cocktail elicited robust Ca2+ increases in IP3R2 
WT astrocytes.  Three representative traces are shown for IP3R2 WT and IP3R2 
cKO BL6.  C.  Table quantifying percentage of SR101 positive astrocytes that 
responded to application of agonist cocktail from all experiments. 
  
Chapter V: General Discussion and Future Directions 
 
 
5.1. General Discussion  
 The field of neuroscience has undergone a significant shift in the 
understanding of synaptic function in the last several decades.  Communication 
between pre- and postsynaptic elements of the synapse through transmitter release 
was thought to only involve neurons.   The first indication that astrocytes were 
involved in synaptic communication occurred when cultured astrocytes were found 
to respond to the neurotransmitter glutamate with intracellular Ca2+ increases 
(Cornell-Bell et al., 1990; Porter and McCarthy, 1997).  Subsequently, astrocytes 
were reported to respond to a wide variety of neurotransmitters with increases in 
intracellular Ca2+ following agonist application or neuronal stimulation (Agulhon et 
al., 2008).  A functional role for astrocytic Ca2+ increases was reported by Parpura et 
al. (1994), who found that increases in astrocyte intracellular Ca2+ following 
stimulation with a Gq-GPCR agonist led to glutamate release and neuronal NMDAR-
mediated Ca2+ elevations.  This placed astrocytes in a position to modulate synaptic 
transmission in an activity-dependant manner and forever changed how the synapse 
was thought to function.  These findings provided the basis for the theory of 
gliotransmission and the tripartite synapse, with astrocytes playing an integral role in 
synaptic communication alongside neuronal elements (Araque et al., 1999).
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The study of gliotransmission has rapidly become a prominent area of 
research in the neuroscience, with evidence concerning this theory published in 
many high profile journals.  Gliotransmission, regardless of the model system used, 
is currently defined as the astrocyte-derived release of transmitters dependent upon 
activation of astrocytic Gq-GPCRs and subsequent Ca2+ from internal stores 
(Haydon and Carmignoto, 2006).  Published data providing evidence for 
gliotransmission and modulation of synaptic activity include changes in excitatory 
and inhibitory synaptic transmission (Kang et al., 1998; Angulo et al., 2004; Fellin et 
al., 2004; Liu et al., 2004b; Parri and Crunelli, 2007; Perea and Araque, 2007; 
Gordon et al., 2009; Ortinski et al., 2010), heterosynaptic depression and long term 
potentiation (Yang et al., 2003; Pascual et al., 2005; Serrano et al., 2006; Andersson 
et al., 2007a; Henneberger et al., 2010).  Gliotransmission has recently been 
expanded to include regulation of physiological processes such as cerebral vascular 
responses, respiration, and homeostatic sleep pressure (Halassa et al., 2009b; 
Koehler et al., 2009; Gourine et al., 2010).   
  
5.2. Evidence for Gliotransmission Is Not Monolithic 
 Despite what appears to be an overwhelming amount of data implicating 
astrocytes and gliotransmission in regulating synaptic transmission, a critical view of 
the literature reveals some potential issues.  First, there are discrepancies in the 
evidence for gliotransmission between cultured astrocytes and astrocytes in situ.  
While it has been firmly established that cultured astrocytes release glutamate, ATP 
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and D-serine, the currently defined gliotransmitters, the mechanisms by which 
release occurs differ among reports.  Release of gliotransmitters from cultured 
astrocytes can occur by vesicular release (Kreft et al., 2009), connexin 
hemichannels (Stout et al., 2002; Ye et al., 2003), volume regulated anion channels 
(Takano et al., 2005; Kimelberg et al., 2006; Ramos-Mandujano et al., 2007) and 
large conductance P2X7 receptors (Duan et al., 2003; Fellin et al., 2006a; Suadicani 
et al., 2006).  In contrast, astrocytes in situ are argued to release gliotransmitters 
primarily through vesicular release (Halassa et al., 2009a; Hamilton and Attwell, 
2010).  Second, the source of Ca2+ to trigger vesicular release from astrocytes has 
not been clearly defined in culture.  There are data implicating voltage gated calcium 
channels, IP3 receptors, ryanodine receptors, store operated calcium channels and 
mitochondria in the regulation of Ca2+-dependent exocytosis of gliotransmitters from 
astrocytes (Volterra and Steinhauser, 2004; Montana et al., 2006; Reyes and 
Parpura, 2009).  However, astrocyte release of gliotransmitters in situ is generally 
believed to occur through Gq-GPCR activated, IP3R receptor mediated Ca2+ 
increases (Fiacco and McCarthy, 2006; Scemes and Giaume, 2006).  Finally, in situ 
studies of the same physiological processes have yielded different, though not 
always conflicting, results.  Heterosynaptic depression of Schaffer collateral-CA1 
synapses in the hippocampus in acute hippocampal slices was reported to be 
modulated by Ca2+-dependent vesicular release of both ATP/adenosine and 
glutamate from astrocytes (Pascual et al., 2005; Serrano et al., 2006; Andersson et 
al., 2007a).  Similarly, the formation and dynamic range of long term potentiation at 
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this synapse is affected not only by ATP/adenosine release from astrocytes, but D-
serine as well (Henneberger et al., 2010).   
 Research on the effects of gliotransmission has a critical limitation: the 
methods researchers have used to stimulate or block intracellular Ca2+ increases in 
astrocytes are either non-selective or induce nonphysiological responses in 
astrocytes (Agulhon et al., 2008; Fiacco et al., 2009).  Application of endogenous 
ligand or specific agonists to astrocyte Gq-GPCRs suffer from the limitation that the 
same Gq-GPCRs are nearly all also expressed by neurons.  Mechanical stimulation 
and intense depolarization likely result in damage to the astrocyte, thereby eliciting a 
nonphysiological and potentially pathological Ca2+ response.  Lastly, uncaging of 
either Ca2+ or IP3 in astrocytes bypasses much of the second messenger systems 
regulating vesicular release and produces an intracellular Ca2+ response of 
nonphysiological spatial and temporal dynamics.  Conversely, widespread use of the 
calcium chelator BAPTA provides support for the Ca2+ dependency of 
gliotransmission, but also affects all Ca2+-dependent process in astrocytes.  
 Tools to selectively increase or block Gq-GPCR-activated, IP3R-mediated 
intracellular Ca2+ increases were necessary.  Two mouse models were developed to 
address this need:  the MrgA1 mouse model and IP3R2 KO mouse model, which 
selectively activates or blocks Gq-GPCR, IP3R-mediated intracellular Ca2+ increases 
in astrocytes, respectively.  The MrgA1 mouse model has revealed that selective 
activation of astrocytic Gq-GPCR signaling does not lead to the release of glutamate 
to affect excitatory synaptic transmission in the hippocampus (Fiacco et al., 2007).  
Further, activation of astrocyte intracellular Ca2+ increases does not affect the 
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formation or maintenance of long term potentiation (Agulhon et al., 2010).  While 
these data argue that Gq-GPCR activation of astrocyte Ca2+ increases does not 
trigger gliotransmitters release, the possibility remained that only certain Gq-GPCR 
elicited release of gliotransmitters.  Support of this possibility was found by 
Shigetomi et al (Shigetomi et al., 2008), who discovered that activation of PAR-1, but 
not P2Y1 receptors led to activation of neuronal NMDA receptors.  However, this is 
inconsistent with the literature, where numerous Gq-GPCRs have been shown to 
increase Ca2+ and elicit gliotransmitter release from astrocytes (Table 1, Agulhon et 
al., 2008) 
 Regardless of the GPCRs involved, the field is unified in the concept that 
Ca2+-dependent gliotransmission plays an important role in synaptic transmission 
and plasticity, and by extension, the function of the central nervous system.  All 
studies using chelation of intracellular Ca2+ by BAPTA demonstrate that intracellular 
Ca2+ is involved in mediating the astrocyte derived effects on synaptic activity.  It 
was published that astrocytic intracellular Ca2+ increases were necessary and 
sufficient to trigger the release of gliotransmitters in response to neuronal activity 
(Parpura and Haydon, 2000).  Therefore, the general consensus in glial biology was 
that Ca2+ increases in astrocytes were absolutely critical to gliotransmitter release.  
This viewpoint held that genetic deletion of IP3R-mediated Ca2+ increases in 
astrocytes would lead to severe neurological problems, vascular issues and potential 
lethality. 
 Evidence in this thesis demonstrates that IP3R2 is the sole functional IP3R 
expressed by astrocytes in situ (Petravicz et al., 2008).  This is in full agreement with 
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immunocytochemical data as well as functional data from cultured astrocytes (Sharp 
et al., 1999; Holtzclaw et al., 2002; Hertle and Yeckel, 2007; Weerth et al., 2007).  
Further, genetic deletion of IP3R2 in astrocytes completely blocks Gq-GPCR 
activated, IP3R-mediated Ca2+ release from intracellular stores in all brain regions 
examined (Petravicz et al., 2008) Chapter II and III].  Contrary to the view of the 
field, IP3R2 KO mice display no readily detectable physiological phenotype and on a 
gross level appear completely normal.  
 Astrocytic intracellular Ca2+ increases, whether agonist-evoked or 
spontaneous, are argued to trigger the release of gliotransmitters to modulate 
synaptic activity (Zhang and Haydon, 2005; Halassa et al., 2009a; Parpura and 
Zorec, 2010).  Surprisingly, no evidence of deregulation or impairment of synaptic 
activity was found in electrophysiological recordings in hippocampal neurons of 
IP3R2 cKO mice.  Synaptic activity measured by spontaneous and miniature EPSCs, 
was unaffected in mice with deletions of IP3R2 (Petravicz et al., 2008).  IP3R2 KO 
mice showed no change in the frequency of sEPSCs in CA1 pyramidal neurons, 
contradicting predictions that in the absence of gliotransmission, there would be 
significant changes in sEPSC frequency (Nadkarni and Jung, 2007).  Further, CA3 
pyramidal neuron excitatory synaptic transmission was also found to be unaffected 
in response to genetic removal of IP3R-mediated Ca2+ increases in the IP3R2 cKO 
model, or selective activation of Gq-GPCR, IP3R-mediated Ca2+ increases in the 
MrgA1 model. 
 Astrocytes are argued to be involved in the regulation of physiological 
processes governing behavior (Halassa and Haydon, 2010).  Studies involving the 
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blockade of IP3R-mediated Ca2+ signaling in astrocytes and its effect on behavior 
has been lacking until now.  Our data show that relatively few of the behaviors 
examined were affected by lack of IP3R2-mediated Ca2+ increases in vivo.  IP3R2 
cKO mice displayed an exaggerated acoustic startle response; however this effect 
was found to be strain-dependent, indicating the possible influence of factors 
unrelated to the lack of astrocyte Ca2+ increases.  This strain-dependent release 
may also reflect elevated stress levels or changes to auditory processes by 
peripheral factors in the affected mouse strain.  Further testing such as 
measurements of auditory threshold may elucidate the mechanism governing this 
strain-dependent difference. 
 
5.3. Does Gliotransmission Occur? 
 The data presented in this thesis, in addition to Fiacco et al (2007) and 
Agulhon et al (2010), at first glance appear to directly contradict the current state of 
the literature and the theory of gliotransmission.  This perception is incorrect, as the 
data presented herein merely suggest that the mechanism by which gliotransmission 
is thought to occur needs to be reexamined, specifically in regards to the necessity 
of IP3R-mediated intracellular Ca2+ increases in astrocytes.  This is supported by the 
current evidence for gliotransmission that has used either non-selective or non-
physiological stimuli to elicit Ca2+ increases in astrocytes.  These methods may 
produce experimental artifacts which can be interpreted as positive data for 
gliotransmission.  For example, non-physiological Ca2+ increases induced by 
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uncaging of IP3 do not travel through the cell with the same spatial profile as 
endogenous GPCR activation but can trigger the release of gliotransmitters (Fiacco 
and McCarthy, 2004).  Further, neuronal synaptic activity shows no modulation upon 
selective activation of astrocyte intracellular Ca2+ increases in the MrgA1 mouse 
model.  However, experiments using uncaging of IP3 in MrgA1 astrocytes displayed 
increases in the frequency of AMPA receptor-mediated sEPSCs, demonstrating that 
gliotransmission can occur from astrocytes in this model in a stimulus-dependent 
manner (Fiacco et al., 2007). 
 We propose that if gliotransmission does occur under physiological 
conditions, IP3R-mediated Ca2+ increases are not the predominant mechanism by 
which Ca2+ triggers release of gliotransmitters.  Recently, spontaneous near 
membrane Ca2+ events, not associated with Gq-GPCR activation, were observed 
using a membrane tethered genetic Ca2+ indicator protein in cultured astrocytes 
(Shigetomi et al., 2010).  These authors argue that based on their findings, that large 
global Ca2+ increases triggered by bath application of Gq-GCPR agonists are 
fundamentally different than spontaneous and neuronal activity evoked increases 
and may therefore represent non-physiological responses.  This is inconsistent with 
the fact that nearly all reports of gliotransmission involve global Ca2+ increases in 
astrocytes upon either uncaging of Ca2+ or IP3, or activation of Gq-GPCRs.   Our 
findings contradict the concept that Gq-GCPR, IP3R-meditated Ca2+ increases in 
astrocytes cause gliotransmission.  Activation of the MrgA1 receptor causes global 
Ca2+ increases in astrocytes similar to pharmacological activation of commonly used 
Gq-GPCR agonists without effecting synaptic transmission (Fiacco et al., 2007; 
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Agulhon et al., 2010).  Blockade of global intracellular Ca2+ increases in the IP3R2 
KO mouse model has no affect on basal synaptic transmission or long term 
potentiation (Petravicz et al., 2008; Agulhon et al., 2010).  These findings represent 
a significant conflict in the theory of gliotransmission that remains unresolved. 
 While the focus of Ca2+ signaling in astrocytes has been on IP3R-mediated 
increases, there are alternative mechanisms.  Calcium permeable AMPA receptors 
represent a mechanism for Ca2+ entry into glial cells.  These receptors are 
expressed on several glial cell types including NG2 cells (Ge et al., 2006; Hamilton 
et al., 2009), oligodendrocytes (Butt, 2006), and Bergmann glia (Bellamy, 2006).  
Astrocytes in the hippocampus of juvenile mice are known to express functional 
Ca2+-permeable AMPA receptors (Porter and McCarthy, 1995b; Seifert and 
Steinhauser, 1995).  AMPA receptors on astrocytes during development show an 
increase in expression of receptor subunits of relatively low Ca2+-permeability but 
still maintain appreciable levels of Ca2+ permeable behavior (Seifert et al., 2003).  
Further evidence for AMPA receptor expression on astrocytes was obtained via 
functional imaging using the sodium sensitive dye SFBI-AM in hippocampal 
astrocytes in situ (ages P12-P21).  This study reveals significant intracellular sodium 
transients in astrocytes in response to neuronal afferent stimulation (Langer and 
Rose, 2009).  Sodium signals using SFBI-AM were recorded in SR101 positive 
astrocytes with passive membrane properties indicative of protoplasmic 
hippocampal astrocytes.  While the majority of the sodium signal in these cells was 
blocked by the glutamate transporter TBOA, roughly 20% of the signal was 
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attributed to AMPA receptors.  It remains to be determined if the AMPA receptor 
component of the signal is from Ca2+-permeable or impermeable receptors.   
 There exists potential for a novel mechanism by which astrocytes may 
increase intracellular Ca2+ levels.  Electrogenic uptake of both GABA and glutamate 
from the synaptic cleft has been extensively demonstrated in astrocytes (Bergles 
and Jahr, 1997, , 1998; Diamond and Jahr, 2000).  Intracellular sodium increases as 
a result of the electrogenic requirements for transporter uptake of GABA or 
glutamate have been demonstrated by functional imaging studies in astrocytes of 
juvenile and young adult mice (Doengi et al., 2009; Langer and Rose, 2009).  
Doengi et al. (2009) proposed that GABA transport by astrocytes caused elevations 
in intracellular sodium levels in olfactory bulb astrocytes, thereby reducing the 
activity of the sodium/calcium exchanger.  This led to an increase in intracellular 
Ca2+ sufficient to activate Ca2+-induced Ca2+ release (CICR) from IP3 receptors.  
While this mechanism was shown only in juvenile animals, Langer and Rose (2009) 
used both juvenile and young adult mice (P12-P22) when showing significant 
increases in glutamate transporter mediated sodium concentrations in hippocampal 
astrocytes.  This raises the possibility of this release mechanism occurring in mature 
astrocytes, which express sodium/calcium exchangers (Blaustein et al., 2002; Minelli 
et al., 2007).  Evidence for a sodium/calcium exchanger modulation of Ca2+ signals 
exists in cultured astrocytes in response to potassium depolarization (Paluzzi et al., 
2007), osmotic swelling (Rojas et al., 2008), AMPA receptor activation (Smith et al., 
2000) and in response to glutamate transporter activity (Rojas et al., 2007).  Finally, 
astrocytes in the visual cortex of ferrets display finely tuned Ca2+ increases that 
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mapped in tight correlation to neuronal responses induced by orientation and spatial 
frequency stimuli (Schummers et al., 2008).  These activity-dependent Ca2+ 
increases in astrocyte were blocked by the glutamate transporter antagonist TBOA, 
implicating glutamate transport as a necessary component to the Ca2+ increases.  
These findings fit with the concept that transporter generated Ca2+ signals involving 
sodium and the sodium/calcium exchanger could underlie a physiological 
mechanism for intracellular Ca2+ increases both independent of and involving IP3R-
mediated Ca2+ release.  Further, it would be possible to generate small, localized 
microdomains of Ca2+ signals via a mechanism depending on the level of transporter 
activity.  Langer and Rose (2009) demonstrated activity-dependent scaling of 
transporter mediated sodium increases in patch-loaded hippocampal astrocytes that 
could potentially lead to localized Ca2+ increases through a glutamate transporter-
sodium/calcium exchanger mechanism. 
 While both of the mechanisms mentioned above present alternative Ca2+ 
sources that could be involved in regulated exocytosis, there exists no data in 
astrocytes in situ or in vivo to support this.  However, it is evident that studies into 
alternative mechanisms of intracellular Ca2+ increases in astrocytes will be crucial to 
understanding the role of astrocyte Ca2+ signaling in physiology and pathology.  
 
5.4. Future Directions 
 Overall, our findings suggest that astrocytic Gq-GPCRs are not directly 
coupled to the regulation of synaptic transmission.  What then is the role(s) of 
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astrocytic Gq-GPCR signaling in physiology?  While unclear, there are several 
possibilities that should be considered.  For example, Ca2+ increases in astrocytes 
through activation of Gq-GPCRs leads to the activation of phospholipase A2 (PLA2) 
to trigger arachidonic acid (AA) mobilization (Koehler et al., 2009).  Astrocytic AA is 
then used as a substrate for several enzymatic pathways that produce vasoreactive 
compounds such as PGE2 and 20-HETE (Gordon et al., 2007)  Therefore, the 
blockade of IP3R-mediated Ca2+ increases in the IP3R2 cKO mouse model may lead 
to deficits in vascular changes regulated by astrocytes in response in neuronal 
activity.  In vivo studies examining vascular responses in the IP3R2 cKO mice will be 
important in evaluating this possibility. 
 The regulation of gene transcription in astrocytes by IP3R-mediated Ca2+ 
increases presents another avenue of further research.  Astrocytes produce BDNF 
in response to Gq-GPCR activation of the PLC/IP3 pathway (Jean et al., 2008), a 
secreted factor involved in synapse formation and maintenance.  Further, data exists 
from cultured astrocytes that intracellular Ca2+ is involved in the pathways governing 
the expression of matrix metalloproteinase (MPP)-9 (Wu et al., 2009), 
cyclooxygenase-2 (COX-2) and Rcan 1-4 (an calcineurin inhibitor) (Canellada et al., 
2008), as well as c-fos transcription (Edling et al., 2007) which are involved in 
several physiological processes.  This raises the distinct possibility that IP3R2 cKO 
astrocytes will have altered transcriptomes.  Gene array studies like Cahoy et al. 
(2008) could provide valuable insight into genes regulated by Ca2+ increases in 
astrocytes and direct future areas of research. 
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 Finally, astrocytic Ca2+ signaling has been shown to be altered in AD 
(Kuchibhotla et al., 2009), cerebral ischemia (Ding et al., 2009), and thought to 
contribute to pathological states such as epilepsy (Seifert et al., 2010).  The IP3R2 
cKO mouse model represents an ideal in vivo model system to study the role and 
deregulation of Ca2+ signaling pathways in these pathological processes.  Research 
using these mice could provide potential drug targets against astrocyte Ca2+-
dependent pathways to develop treatments against neurological diseases. 
 In conclusion, the role of IP3R-mediated Ca2+ signaling in astrocytes has been 
presented as a critical component of their role in nervous system function, 
particularly in respect to synaptic function.  The theory of gliotransmission has 
become an increasingly accepted, though still controversial, concept in 
neuroscience, resulting in publication of numerous review articles in high profile 
journals and textbooks.  The data presented in this thesis, supported by Fiacco et al. 
(2007) and Agulhon et al. (2010), present a direct challenge to the current theory of 
gliotransmission, which gliobiologists and the neuroscience community needs to 
acknowledge and take into consideration. 
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